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IN TRO DUC TION
Vitiligo is one of dis or ders of mel a nin pig men ta -
tion in which depigmented patches of var i ous
shapes and sizes ap pear in the skin as a re sult of
the de struc tion of melanocytes. It is an ac quired
dis ease, af fect ing 1-2% of gen eral pop u la tion (1,2).
Con sid er ing etiopathogenesis of vitiligo, there
are three hy poth e ses, each hold ing dif fer ent fac tors 
re spon si ble for the dis ease: ner vous sys tem, cytot -
oxic fac tors, and im mune pathomechanism (1). In
im mune pro cesses, in clud ing au to im mune mech a -
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SUM MARY Vitiligo is a dis or der of mel a nin pig men ta tion, af fect -
ing 1-2% of gen eral pop u la tion. The etiopathogenesis of the dis -
ease is not clear, but prob a bly in cludes the in ter ac tion among ner -
vous sys tem, cytotoxic fac tors, and im mune mech a nisms. The
aim of the study was to eval u ate se rum con cen tra tions of inter -
leukin-2 sol u ble re cep tor (IL-2 sR) in pa tients with vitiligo and as -
sess a pos si ble as so ci a tion be tween IL-2 sR and clin i cal type, ex -
tent, and du ra tion of the dis ease. The study in cluded 51 pa tients
with vitiligo aged 7-70 years and 29 healthy con trols aged 10-60
years. Se rum con cen tra tions of IL-2 sR were de ter mined by
ELISA method. The se rum con cen tra tion of IL-2 sR in pa tients
with vitiligo was lower than that in the con trol group (1,164.2±
357.2 vs. 1,301.6±404.1 pg/mL, re spec tively). Sig nif i cantly de -
creased se rum IL-2 sR con cen tra tions were no ticed in pa tients
with non-dermatomal type A vitiligo (1,137.5±356.7 pg/mL), es pe -
cially those suf fer ing from type A1 (ac tive le sions) of the dis ease
(959.4±251.7 pg/mL), com pared with both healthy con trols and
pa tients with type B (dermatomal) vitiligo (1,105.2±346.5 pg/mL).
In pa tients with more ex ten sive vitiliginous changes of the skin,
IL-2 sR se rum con cen tra tions were sig nif i cantly lower. More over,
pa tients with type A1 vitiligo had sig nif i cantly de creased se rum
IL-2 sR con cen tra tions com pared with type A2 (non-ac tive le -
sions) pa tients. There was no dif fer ence in se rum IL-2 sR con cen -
tra tions be tween pa tients with dermatomal dis tri bu tion of vitiligo
and con trol group. Se rum IL-2 sR con cen tra tions in pa tients with
vitiligo were de creased and de pended on the ac tiv ity and in ten sity 
of the dis ease pro cess.
KEY WORDS adult; child; pig men ta tion dis or ders; re cep tors,
interleukin-2; vitiligo
nisms, a ba sic role is played by cytokines, se creted
by ac ti vated cells. They in flu ence other cells via
spe cific mem brane re cep tors, some of which have
sol u ble forms, known as sol u ble re cep tors (sR).
Interleukin-2 sol u ble re cep tor (IL-2 sR) is one of
them, and it is thought to be very im por tant pa ram e -
ter of im mune mech a nism of var i ous patho log i cal
pro cesses (3-19). The changes in se rum IL-2 sR
con cen tra tions were found in many dis eases, such
as pso ri a sis (14-16), atopic der ma ti tis (17,18), mul -
ti ple scle ro sis (12, 13), rheu ma toid ar thri tis (10),
con nec tive tis sue dis eases (3,5-7), cu ta ne ous T
cell lym phoma (19) and other ma lig nant neoplasms
(4,8,9,11). In some of these dis eases, se rum IL-2
sR con cen tra tion cor re lated with ac tiv ity and in ten -
sity of the dis ease (e.g. pos i tive re la tion ship be -
tween IL-2 sR con cen tra tion and PASI in pso ri a sis), 
and may be used as a prog nos tic fac tor (9,15-
 17,19).
The lit er a ture data on IL-2 sR in pa tients with
vitiligo are very lim ited and their re sults are con tro -
ver sial. There fore, the aim of our study was to eval -
u ate se rum con cen tra tions of IL-2 sR in vitiligo pa -
tients and as sess the re la tion be tween IL-2 sR and
clin i cal type, ex tent, and du ra tion of vitiligo and
patient sex.
PA TIENTS AND METH ODS
Pa tients
The study in cluded 51 vitiligo pa tients aged 7-70 
years (mean±SD age, 29±18 years). There were 23 
male pa tients aged be tween 10 and 70 years
(mean age, 30±19 years) and 28 fe male pa tients
aged 7-67 years (mean age, 28±17 years). The
con trol group con sisted of 29 gen er ally healthy peo -
ple aged be tween 10 and 60 years (mean age,
29±16 years). There were 15 male pa tients aged
be tween 10 and 60 years (mean age, 36±25 years)
and 14 fe male pa tients aged 11-43 years (mean
age, 21±12 years).
The pa tients who had re ceived any treat ment
within pre vi ous 2 months were ex cluded from the
study, as well as pa tients with any in fec tions or dis -
eases based on the im mune pathomechanism, which 
could in flu ence se rum con cen tra tions of IL-2 sR.
Ac cord ing to the clin i cal type of vitiligo, pa tients
were di vided into those with type A (with non- der -
matomal dis tri bu tion of vitiliginous skin) and those
with type B (dermatomally dis trib uted) of vitiligo.
Type A was fur ther di vided into ac tive (type A1) and
in ac tive (type A2). Pa tients with type A1 were those
who no ticed a new depigmented le sion or en large -
ment of pre vi ous le sions dur ing the three months
prior to the study, whereas pa tients with type A2
were those with no changes in the skin le sions dur -
ing the mentioned period.
Meth ods
Sera were sep a rated from heparinized ve nous
blood and stored at -75°C un til anal y sis. All sera
were mea sured at the same time. Se rum con cen -
tra tions of IL-2 sR were mea sured by an en zyme-
 linked immunosorbent as say (ELISA) tech nique,
us ing Quantikine Hu man IL-2 sRa Immunoas say
(R&D Sys tems, Min ne ap o lis, MN, USA).
In short, a monoclonal an ti body spe cific for IL-2
sR was pre-coated onto a microplate. Stan dards,
sam ples, and con ju gate (a polyclonal an ti body
against IL-2 sR con ju gated to horse rad ish peroxi -
dase) were pipetted into the wells and any IL-2 sR
pres ent was sandwiched by the im mo bi lized an ti -
body and the en zyme-linked polyclonal an ti body
spe cific for IL-2 sR (con ju gate). Fol low ing a wash to 
re move any un bound sub stances and/or an ti body-
 en zyme re agent, a sub strate so lu tion was added to
the wells and color de vel oped in pro por tion to the
amount of IL-2 sR bound. The color de vel op ment
was stopped and the in ten sity of the color was mea -
sured at 450 nm with a pho tom e ter ELISA STAT
FAX 2100 (Aware ness Tech nol ogy Inc., Palm City,
FL, USA). Se rum con cen tra tions of IL-2 sR were
taken from a stan dard curve, ob tained by di luted
stan dard so lu tion. The min i mum de tect able dose of
IL-2 sR was determined as less than 10 pg/mL.
Ex tent of the vitiligo pro cess was es ti mated on
the ba sis of the fol low ing in dexes: 1) the area of
depigmented skin (vitiliginous area); 2) per cent age
of the vitiliginous area in re la tion to body sur face
area of each pa tient (per cent age of vitiliginous
area); and 3) pro por tion of the vitiliginous area to
body mass in dex (BMI ratio).
The area of vitiliginous skin was mea sured for
each pa tient by draw ing con tours of all depigmen -
ted patches on the trans par ent A4 foils, which then
were scanned by Mustek Scan 6000 P scan ner.
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Fol low ing the scan ning pro cess, all ar eas were cal -
cu lated by us ing Win dows NT sys tem, as well as
Corel DRAW 9 and Auto Cad R14 software.
Body sur face area of each vitiligo pa tient was
cal cu lated ac cord ing to Mosteller for mula (20), by
cal cu la tion of square root of the value ob tained from 
the fol low ing for mula: body height (cm) x body
weight (kg) / 3600. BMI was cal cu lated as BMI =
body weight (kg) / body height (m)2.
Sta tis ti cal Anal y sis
Data were an a lyzed with Mann-Whit ney’s
U-test. The con fi dence level was set at a=0.05.
Statistica 5.1. soft ware pack age (Stat Soft Inc.,
Tulsa, OK, USA) and Microsoft Ex cel 7.0 for Win dows 
were used for all sta tis ti cal anal y ses.
RE SULTS
Serum IL-2 sR con cen tra tions were de creased
in vitiligo pa tients in com par i son with those in the
con trol group (1,164.2±357.2 vs 1,301.6±404.1
pg/mL, re spec tively), but not sig nif i cantly (p=0.059;
Ta ble 1). Sig nif i cant de crease of the se rum IL-2 sR
con cen tra tions was found in pa tients with type A
vitiligo (1,137.5±356.7 pg/mL) com pared with the
con trol group (p=0.04) and type B vitiligo pa tients
(p=0.04). Se rum con cen tra tions of IL-2 sR in pa -
tients with type B vitiligo did not sig nif i cantly dif fer
from those found in con trols.
Se rum con cen tra tions of IL-2 sR were sig nif i -
cantly lower in pa tients with ac tive A1 type vitiligo
(959.4±251.7 pg/mL) than in pa tients with in ac tive
type A2 of the dis ease (1,252.1±370.7 pg/mL,
p=0.004) and con trols (1,301.6±406.1 pg/mL,
p<0.001).
Anal y sis of IL-2 sR in adults and chil dren in the
con trol group revealed sig nif i cantly lower IL-2 sR
con cen tra tions (p=0.007) in adults (1,127.9±224.8
pg/mL) than in chil dren (1,547.7±483.4 pg/mL).
Among adults, the de crease in IL-2 sR con cen tra -
tion was sta tis ti cally sig nif i cant only in the group of
pa tients with ac tive A1 type of vitiligo (884.6±300.0
pg/mL) in com par i son to the con trol group
(p<0.001; Ta ble 2). In the group of ex am ined chil -
dren with vitiligo, the IL-2 sR se rum con cen tra tions
were sig nif i cantly lower in all type A pa tients, as well 
as in A1 and A2 type sep a rately, than in con trol chil -
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Ta ble 1. Se rum con cen tra tions (mean±SD) of interleukin-2 sol u ble re cep tor (IL-2 sR) in pa tients with vitiligo
di vided ac cord ing to clin i cal types of the dis ease in com par i son with the control group
Patients with vitiligo
Control (n=29) all (n=51) type A* (n=46) type A1† (n=18) type A2 (n=28) type B (n=5)
IL-2 sR (pg/mL) 1,301.6±406.1 1,164.2±357.2 1,137.5±356.7 959.4±251.7 1,252.1±370.7 1,409.4±282.5
p‡ 0.059 0.040 <0.001 0.4 0.3
*Type A vs type B, p=0.04.
†Type A1 vs type A2, p=0.004.
‡Difference vs. control.
Ta ble 2. Se rum con cen tra tions (mean±SD) of interleukin-2 sol u ble re cep tor (IL-2 sR) in adult pa tients and
chil dren with vitiligo suf fer ing from type A (A1-ac tive and A2-in ac tive) form of the dis ease com pared with
their age-group matched controls
Patients with vitiligo
Age group Control type A type A1* type A2
Adult (n): 17 31 12 19
IL-2 sR (pg/mL) 1,127.9±224.8 1,124.0±349.9 884.6±201.0 1,275.1±342.1
p† 0.5 0.003 0.08
Children (n): 12 15 6 9
IL-2 sR (pg/mL) 1,547.7±483.4 1,165.6±381.4 1,108.8±293.7 1,203.5±443.3
p† 0.01 0.03 0.055
*Type A1 vs type A2, p<0.001 for adults and p=0.400 for children.
†Difference vs. controls.
dren (p=0.01, p=0.03, and p=0.05, re spec tively; Ta -
ble 2).
In pa tients with large vitiliginous area (>200
cm2), mean con cen tra tion of IL-2 sR was sig nif i -
cantly lower than in the con trol group (p=0.04; Ta ble 
3). Pa tients with a small vitiliginous area (<200 cm2) 
had less re duced IL-2 sR con cen tra tion than the
con trol group or pa tients with large area of vitiligi -
nous skin. Only in pa tients with a high per cent age of 
vitiliginous area (>1%) was se rum con cen tra tion of
IL-2 sR sig nif i cantly lower (1,105.2±346.5 pg/mL)
than in the con trol group (p=0.03). The same re la -
tion ship was ob served in the group of pa tients with
high (>7.0) BMI ra tio (1,102.7±352.2 pg/mL) com -
pared with the controls (p=0.03; Table 3).
Pa tients with the dis ease last ing not lon ger than
1.5 year had sig nif i cantly lower con cen tra tion of
IL-2 sR (1,032.1±272.0 pg/mL) than that in the con -
trol group (p=0.04). No other re la tion ships be tween
se rum con cen tra tion of IL-2 sR and dis ease du ra -
tion were noted.
Se rum IL-2 sR con cen tra tions in fe male pa tients 
with vitiligo (1,111.8±314.4 pg/mL) were sig nif i -
cantly de creased com pared with those in the con -
trol group (p=0.03). This phe nom e non was not ob -
served in male pa tients (1,228.0±401.2 pg/mL,
p=0.30).
DIS CUS SION
Al though the etiopathogenesis of vitiligo has not
been fully un der stood, most re search ers think that it 
is con nected with im mune pro cesses. It has been
re ported that var i ous au to im mune dis eases of ten
co ex ist with vitiligo, and var i ous autoantibodies
against dif fer ent tis sues, in clud ing those di rectly
against melanocytes, have been no ticed in vitiligo
pa tients (21-25). They ob vi ously have in flu ence on
the de struc tion of melanocytes, al though it is not
clear whether it is humoral im mu nity that plays the
ba sic role in the dis ease or is it the sec ond ary pro -
cess due to the pri mary role of cell im mu nity. Van
den Wijngaard et al (26) re ported in creased num -
ber of CD4+ lym pho cytes at mar ginal skin of ac tive
vitiligo. Wolkentein et al (27) de scribed in duc tion of
vitiligo in 4 out of 25 pa tients treated with IL-2 alone
for met a static mel a noma. These stud ies sug gested 
that vitiligo could be caused by an au to im mune re -
sponse of cytotoxic T lym pho cytes against melano -
cyte an ti gens. As IL-2 sR plays the key role in both
cell and humoral im mu nity, our aim was to de tect
pos si ble changes in IL-2 sR se rum con cen tra tions
in vitiligo pa tients and as so ci a tion between these
concentrations and various clinical parameters of
the disease.
A lim ited num ber of stud ies on the prob lem were
con ducted by Honda et al (28) among Jap a nese,
Yeo et al (29) among Ko re ans, and Caixia (30)
among Chi nese pa tients. None of the au thors ob -
served sta tis ti cally sig nif i cant dif fer ences be tween
se rum con cen tra tions of IL-2 sR in pa tients with
type B vitiligo and those in healthy con trols (28-30).
Our find ings were sim i lar. How ever, our ob ser va -
tions on se rum con cen tra tions of IL-2 sR in pa tients
with type A vitiligo were in con trast to pre vi ous find -
ings (28-30). We found sig nif i cantly de creased se -
rum con cen tra tions of IL-2 sR in vitiligo type A pa -
tients, com pared with the con trol group and type B
vitiligo pa tients. As we thought that there could be
dif fer ences in IL-2 sR se rum con cen tra tions de -
pend ing on the ac tiv ity of the dis ease, we di vided
pa tients with type A vitiligo into those with ac tive
type A1 and in ac tive type A2 of the dis ease. We
found that IL-2 sR se rum con cen tra tions were sig -
nif i cantly de creased in pa tients with ac tive A1 type
vitiligo in com par i son with not only healthy con trols,
but also with in ac tive type A2 of the dis ease. The
ob served dif fer ences be tween our and other stud -
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Ta ble 3. Se rum con cen tra tions (mean±SD) of inter -
leukin-2 sol u ble re cep tor (IL-2 sR) in pa tients with
dif fer ent ex tent of vitiligo le sions in com par i son with
the control group
Lesion extent IL-2 sR (pg/mL) p*
Vitiliginous area:
small (<200 cm2) 1,213.2±369.3 0.30
large (>200 cm2) 1,123.89±348.37 0.04
p† 0.20
Percentage vitiliginous area:
small (<1%) 1,255.6±362.9 0.40
large (>1%) 1,105.2±346.5 0.03
p† 0.08
BMI ratio:
small (<7.0) 1,252.0±354.1 0.40
large (>7.0) 1,102.7±352.2 0.03
p† 0.08
*Difference vs. control (1,301.6±406.1 pg/mL).
†Small vs. large.
ies may have re sulted from dif fer ences in patient
population, as our study was the first one performed 
among Caucasian subjects.
Like Gotoh et al (31) and Zola et al (32), we also
no ticed sig nif i cantly lower IL-2 sR con cen tra tion in
healthy adults than in healthy chil dren. It seems that 
it is very im por tant to have ad e quately age-matched 
con trol and pa tient groups. In our study, mean age
of vitiligo pa tients was al most equal to that of the
healthy con trols. Pre vi ous in ves ti ga tors, how ever,
did not seem con cerned with this prob lem (28-30).
To the best of our knowl edge, our study is the first to 
have shown the sig nif i cantly lower se rum con cen -
tra tion of IL-2 sR only in pa tients with larger ar eas of 
vitiliginous le sions. De tailed stud ies in the re la tion -
ship be tween se rum IL-2 sR con cen tra tions and
sur face of depigmented skin, how ever, have not
been per formed yet. We also no ticed sig nif i cantly
de creased se rum con cen tra tion of IL-2 sR in pa -
tients with a short dis ease du ra tion. These re sults
seem to con firm the re la tion ship be tween se rum
con cen tra tions of IL-2 sR and the ac tiv ity of vitiligo
(shortly last ing or extensive vitiligo may frequently
be assumed as an active disease).
The ques tion re mains why the se rum con cen tra -
tions of IL-2 sR in our vitiligo pa tients were lower
than those in healthy peo ple, whereas in im mune
dis eases, such as pso ri a sis (14-16), atopic der ma ti -
tis (17,18), cu ta ne ous T cell lym phoma (19), and
other ma lig nant neoplasms (4,8,9,11), these con -
cen tra tions were sig nif i cantly in creased. One of the
ex pla na tions may be dif fer ent char ac ter of vitiligo
pro cess than that in the above men tioned dis eases. 
Vitiligo, in con trast to other dis eases, could be re -
garded as a de gen er a tive one, as there is ev i dent
lack of pig ment in the skin. More over, Mozzanica et
al (33) found the de creased num ber of CD4+ and
CD8+ cells in the blood of vitiligo pa tients in the ac -
tive stage of the dis ease. Re cently, it has been re -
ported that to tal num ber of ac ti vated lym pho cytes
was de creased in the cir cu la tion of vitiligo pa tients
(34). As these cells may con sti tute source of IL-2
sR, we could spec u late that their re duc tion may
con trib ute to the ob served de crease in the se rum
con cen tra tion of IL-2 sR. Gunduz et al (34) also no -
ticed de creased se rum con cen tra tion of IL-2 sR in
vitiligo pa tients, but the difference from healthy
controls did not reach statistical significance.
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IN TRO DUC TION
The in ci dence of fun gal in fec tions of the uro gen -
i tal sys tem is steadily ris ing (1). Yeasts of the
Candida ge nus are the most com mon caus ative
agents of these in fec tions, whereas Saccharomy -
ces and Trichosporon gen era are much less fre -
quent (1-5). Yeasts are most of ten iso lated from
urine sam ples of pa tients suf fer ing from some uri -
nary tract anom aly (re flux, ob struc tion) or di a be tes
mellitus, and from in di vid u als with catheterized uri -
nary blad der (1,6). Candida (C.) albicans ac counts
for the larg est num ber of fun gal iso lates from urine
sam ples, whereas isolations of the spe cies C.
glabrata, C. kefyr, C. tropicalis, and C. guilliermondii
are less common (1-3,6,7).
In fec tion of gen i tal mu cus with yeasts is one of
the most com mon clin i cal man i fes ta tions of
candidiasis and the most com mon fun gal in fec tion
of the gen i ta lia in women of fer tile age (1-3,6,7). It
also in fects male gen i ta lia, but to a lesser ex tent (6). 
The in ci dence of vulvovaginal candidiasis, which
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SUM MARY We an a lyzed the fre quency of iso la tion of in di vid ual fun gal spe -
cies in the sam ples of urine, vag i nal and cer vi cal swabs from 107 pa tients
(72% women and 28% men) aged 16-82 years, who were treated in pri mary
care for cys ti tis, vulvovaginitis, and cervicitis. The sam ples were an a lyzed at
the Mi cro bi o log i cal Lab o ra tory of Zagreb In sti tute of Pub lic Health, Croatia,
be tween Sep tem ber 1, 2002 and June 31, 2003. Eight spe cies of yeast were
iso lated from the sam ples. Candida (C.) albicans, C. glabrata, and C. krusei
were the most com mon iso lates, with the fre quency of 61.7%, 10.3% and
8.4%, re spec tively. Other spe cies (C. guilliermondii, C. famata, C. tropicalis,
C. parapsilosis, and C. kefyr) were less fre quently iso lated, be tween 0.9%
and 7.5%. In women, the fre quency of iso la tion of C. albicans spe cies from
urine sam ples ranged from 83.3% to 30.8%, and from uter ine cer vi cal swabs
from 85.7% to 50%, show ing a de creas ing trend with pa tients’ age. The fre -
quency of C. albicans iso lates from vag i nal swabs was equal in youn ger (<30
years) and older women (³51 years), but twice less fre quent in mid dle-aged
women. In men, the fre quency of C. albicans spe cies iso lated from urine
sam ples de creased with age from 100% to 52.4%. In the 107 an a lyzed sam -
ples with pos i tive fun gal cul ture, yeast isolations were sig nif i cantly more fre -
quent than pure cul ture (93.5%) and had a larger num ber of col ony counts
(57%). This sug gested that these yeast spe cies might have a patho genic role 
in the cau sa tion of uro gen i tal sys tem in fec tions.
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amounts to 5-20%, is higher in women aged be low
30 years, women in the third tri mes ter of preg nancy, 
fe male di a bet ics, women tak ing oral con tra cep tives 
and broad-spec trum an ti bi ot ics, and women with
HIV-in fec tion (1-3,6-13). Al though C. albicans is still 
the most com mon iso late from vag i nal swabs of
women with vulvovaginal candidiasis, an in crease
in the fre quency of iso la tion of other yeast spe cies
has been ob served in the last 10 years (1-12).
Non-Candida albicans spp. (C. glabrata, C. kefyr,
C. tropicalis, C. krusei, and C. parapsilosis) cause
about 10-16% of all cases of vulvovaginitis (1-12).
Symp tom atic vulvovaginitis caused by these yeast
spe cies can not be dis tin guished from those caused 
by C. albicans in terms of clin i cal fea tures, but they
can be rec og nized by their dif fer ent re sponse to
ther apy (1). Saccharomyces cerevisiae spe cies
may col o nize vag i nal mu cus, whereas Trichospo -
ron beigelii spe cies can be isolated from the skin of
the genital region (1-7).
Typ i cal symp toms of vulvovaginal candidiasis
in clude pru ri tus and vag i nal dis charge. Other symp -
toms may in clude vag i nal sore ness, vul var burn ing
and er y thema, dyspareunia, and dysuria. Candida
vag i ni tis is as so ci ated with a nor mal vag i nal pH of
4.5 (1-3,7-12).
Al though uter ine cer vi cal in fec tion may be com -
bined with vulvovaginitis, it may also de velop in the
ab sence of such an in fec tion. Its oc cur rence is
more com mon in women tak ing oral con tra cep tives, 
with er y thema and ep i the lial ero sions as the main
signs of cervicitis, as well as in the pres ence of
mucopurulent exudate. Sev eral spe cies of bac te ria
(e.g. Neisseria gonorrhoeae or Chlamydia tracho -
ma tis) and vi ruses (e.g. her pes sim plex, hu man
papillomavirus, ad eno vi rus es, or cytomegalovirus)
are more fre quent caus ative agents of cer vi cal in -
fec tions than yeasts (1-3,6,7). Cervicitis is of ten
asymp tom atic, but in some cases it may be ac com -
pa nied by ab nor mal vag i nal dis charge and vag i nal
bleed ing (1). Yeast in fec tions of fe male gen i tal tract
have been 4.6 times (14.4%) as com mon as tricho -
moniasis (3.13%), and the pres ence of the mixed
fun gal-pro to zoan in fec tion has been shown in a
very small num ber of women (0.6%) (8,10). The
main site of trichomonadal par a sit iz ing is vag i nal
mu cus; the main sites of yeast par a sit iz ing are vag i -
nal mu cus, uter ine cer vix, and other an a tom i cal
sites of the gen i tal tract (8,10). Stud ies of the pro -
tec tive ef fect of cer vi cal mu cus in preg nant women
have shown the lo cal iza tion and spread of in fec tion
(cervicitis, endocervicitis, and colpitis) to be pri mar -
ily de pend ent on lo cal immunity disorder (local im -
mu no de fi ciency), and considerably less on the eti o -
lo g i cal agent of infection (9).
Mu cus of the gas tro in tes ti nal tract is con sid ered
the most com mon source of the yeasts col o niz ing
and/or in fect ing the mu cus of uro gen i tal tract. C.
albicans may be trans mit ted sex u ally (1-3,6,7,11).
Many stud ies have shown that less than 40% of in -
fected women had ac quired vag i nal candidiasis
through sex ual con tact (11,14). Be cause C. albic -
ans spe cies is a commensal yeast in hu man mu cus
(it has been iso lated from vag i nal smears of 45 -
-50% asymp tom atic women), it is un der stand able
that the pri mary source of Candida in fec tion is en -
dog e nous (1-3,6,7,11,14).
The first stage in the pathogenesis of fun gal uro -
gen i tal in fec tion is the ad her ence of yeast blastoco -
nidia to the ep i the lial cells of uro gen i tal sys tem (col -
o ni za tion). Ad her ing of yeast cells de pends not only 
on the sur face to which the yeast ad heres (vag i nal
mu cus or var i ous pros thetic ma te ri als, e.g. uri nary
cath e ters), but also on yeast cell prop er ties, such
as sur face hydrophobicity, growth con di tions, hor -
monal in flu ences, and im mu no logic sta tus of the
macro-or gan ism (1-3,6,7). Sur face mol e cules of
yeast cells that make ad her ence to the ep i the lial
cells of the mu cus pos si ble are called ad he sions,
and by chem i cal com po si tion, they are mannans,
mannoproteins, and chitin. The re cep tors of these
mol e cules on ep i the lial cells are glucosamine, fuco -
syl, fibronectin, and arginine-glycine-aspara gi nine
(2,6,7).
The abil ity to trans form the (monocellular) yeast
form into (multicellular) my ce lium form and the pro -
duc tion of hydrolytic en zymes (most im por tant of
which are aspartyl pro te ase and phospholipases)
are the fac tors fa cil i tat ing tis sue pen e tra tion and tis -
sue in va sion by Candida. Through the morpho -
genesis of blastoconidia into hyphae, which ex crete 
large amounts of phospholipases, this form is made 
more in va sive and helps the eva sion of phago -
cytosis by macrophages. Immunomodulational ac -
tion of fun gal sur face com po nents, es pe cially man -
nans, leads to the immunosuppression of re sponse
to fun gal in va sion (2,3,6,7). The rapid phe no typing
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abil ity of a vari a tion of C. albicans fa cil i tates the ac -
com mo da tion of this yeast to changed con di tions in
the macro-or gan ism, which is why it eas ily evades
the in fected in di vid ual’s im mune re sponse and the
ac tion of antimycotics (2,3,6,7).
MA TE RIAL AND METH ODS
The urine, vag i nal and cer vi cal swabs sam ples
were col lected from 107 pa tients (72% women and
28% men) aged 16-82 years, who were treated in
pri mary care for cys ti tis, vulvovaginitis, and cervici -
tis. The sam ples were an a lyzed with stan dard mi -
cro bi o log i cal di ag nos tic meth ods at the Mi cro bi o -
log i cal Lab o ra tory of Zagreb In sti tute of Pub lic
Health, Croatia, be tween Sep tem ber 1, 2002 and
June 31, 2003.
In oc u la tion of urine sam ples on blood agar and
McConkey’s agar was per formed within 2 h of sam -
pling, fol lowed by in cu ba tion at 35°C for 24 h and in -
cu ba tion at 25°C for the next 24 h (op ti mal tem per a -
ture for yeast conidiogenesis). The agars we in oc u -
lated with swabs of fe male gen i tal tracts were the
blood, Sabouraud’s agar (in cu ba tion at 35°C for 24
h and than at 25°C for the next 24 h) and Thayer
Mar tin agar (in cu ba tion un der microaerophilic con -
di tions at 35°C for 48 h) (2,3,6,7,11).
For the iden ti fi ca tion of C. albicans spe cies (Fig.
1) we used the ger mi na tion test, whereas for other
yeast spe cies we used their bio chem i cal prop er ties
(by means of as sim i la tion test and sugar fer men ta -
tion) and the ap pear ance of growth on maize agar
at the My col ogy Lab o ra tory of the Cro atian Na tional 
In sti tute of Public Health (2,3,6,7,15).
RE SULTS
Eight yeast spe cies be long ing to the ge nus
Candida were iso lated from both fe male and male
urine sam ples. The most com mon iso late in these
sam ples was C. albicans (61.5%), fol lowed in or der
of fre quency by C. krusei, C. kefyr, C. parapsilosis,
C. glabrata, C. tropicalis, C. famata, and C. guillier -
mondii (Ta ble 1). From vag i nal swabs we iso lated
three dif fer ent spe cies of yeasts. C. glabrata spe -
cies had the high est iso la tion fre quency (50%), C.
albicans spe cies closely fol lowed (40%), and C.
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Fig ure 1. Fre quency of iso la tion of Candida albicans spe -
cies from urine sam ples and gen i tal swabs by pa tient age
and sex. Closed bars – urine spec i mens from women;
open bars – urine spec i mens from men; grey bars – vag i -
nal swab; striped bars – uter ine cer vi cal swab.
Ta ble 1. Yeast spe cies and their fre quency in 107 sam ples of uro gen i tal sys tem with pos i tive fun gal culture
Samples (n,%)
Yeast species isolated urine vaginal swab uterine cervical swab total
Candida (C.) albicans 51 (61.5)  4 (40.0) 11 (78.6)  66 (61.7)
C. glabrata  5 (6.0)  5 (50.0)  1 (7.1)  11 (10.3)
C. krusei  8 (9.6)  1 (7.1)   9 (8.4)
C. kefyr  7 (8.4)  1 (7.1)   8 (7.5)
C. parapsilosis  7 (8.4)   7 (6.5)
C. tropicalis  2 (2.4)  1 (10.0)   3 (2.8)
C. famata  2 (2.4)   2 (1.9)
C. guilliermondii  1 (1.2)   1 (0.9)
Total 83 (100.0) 10 (100.0) 14 (100.0) 107 (100.0)
tropicalis had the low est fre quency (10%). Out of
the four yeast spe cies iso lated from cer vi cal swabs, 
C. albicans spe cies had the high est per cent age of
iso la tion (78.6%), whereas the per cent ages for
other spe cies (C. krusei, C. kefyr, and C. glabrata)
were equal – 7.1% each (Table 1).
The in ci dence of C. albicans spe cies isolations
from urine sam ples was the high est in youn ger
women (16-30 years) and men (83.3% and 100%,
re spec tively), de creas ing in both mid dle-aged (31-
 50 years) women and men (56.3% and 60%, re -
spec tively), and reach ing a low in older-age group
(51-82 years) of women and men (30.8% and
52.4%, re spec tively) (Ta ble 2, Fig. 1).
In con trast, the fre quency of other Candida iso -
lates from urine sam ples showed in creas ing in ci -
dence with age in both sexes. With ex cep tion of C.
glabrata, the per cent age of non-albicans spe cies of 
the ge nus Candida was the low est in the urines
from women and men aged up to 30 years, higher in 
mid dle-aged women and men, and the high est in
older-age women and men (Ta ble 2, Fig. 2).
C. glabrata spe cies was ab sent from all urine
sam ples ob tained from youn ger-age women and
men. The in ci dence of iso la tion of this yeast from
urine sam ples slightly in creased with age in wo -
men, reach ing 6.3% in the mid dle-aged and 7.7% in 
el derly women. In mid dle-aged men, C. glabrata
spe cies iso lates made up 20% of all yeast iso lates
from urine sam ples and 9.5% of iso lates in el derly
men (Table 2, Fig. 3).
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Ta ble 2. The fre quency of in di vid ual yeast spe cies isolations from urine sam ples in re la tion to the pa tient age 
and sex*
Age groups (n, %)
16-30 years 31-50 years 51-82 years
Yeast species F M F M F M total
Candida albicans 20 (83.3) 4 (100.0)  9 (56.3) 3 (60.0)  4 (30.8) 11 (52.4) 51 (61.5)
Non - C. albicans species  4 (16.7)  6 (37.5) 1 (20.0)  8 (61.5)  8 (38.1) 27 (32.5)
Candida glabrata  1 (6.2) 1 (20.0)  1 (7.7)  2 (9.5)  5 (6.0)
Total 24 (100.0) 4 (100.0) 16 (100.0) 5 (100.0) 13 (100.0) 21 (100.0) 83 (100.0)
*Abbreviations: F – female; M – male.
Ta ble 3. Fre quency of iso la tion of in di vid ual spe cies of yeast from vag i nal and uter ine cer vi cal swabs from
women of dif fer ent age
Age groups (n, %)












    swab
total
Candida albicans 2 (50.0) 4 (80.0) 1 (25.0) 6 (85.7) 1 (50.0) 1 (50.0) 15 (62.5)
Non-Candida albicans species 1 (25.0) 1 (20.0) 1 (50.0)  3 (12.5)
Candida glabrata 1 (25.0) 3 (75.0) 1 (14.3) 1 (50.0)  6 (25.0)






























Fig ure 2. Fre quency of iso la tion of spe cies other than
Candida albicans from urine sam ples and gen i tal swabs by 
pa tient age and sex. Closed bars – urine spec i mens from
women; open bars – urine spec i mens from men; grey bars
– vag i nal swab; striped bars – uter ine cer vi cal swab.
In vag i nal swabs from mid dle-aged and el derly
women, C. albicans iso lates amounted to a half of
all fun gal iso lates. In these iso lates, mid dle-aged
women ac counted for one fourth of all iso lates (Ta -
ble 3, Fig. 1). Non-Candida albicans spe cies were
iso lated only from vag i nal swabs of women aged
be low 30 years (25%), and in older-aged women;
such spe cies ac counted for 50% of all fun gal iso -
lates (Ta ble 3, Fig. 2). The in ci dence of iso la tion of
the C. glabrata was the high est in the vag i nal swabs 
from mid dle-aged women (75%) and the low est in
women aged be low 30 years (25%), with the in ci -
dence in el derly women in-be tween (50%) (Table 3
and Fig. 3).
Iso la tion fre quency for cer vi cal swabs of the C.
albicans spe cies was very high in youn ger (80%)
and mid dle-aged women (85.7%), and lower in
older- age women (50%) (Ta ble 3, Fig. 1). Non-
Candida albicans spe cies made up one-fifth of all
iso lates from cer vi cal swabs of youn ger-age
women, with no such iso lates from cer vi cal swabs
of mid dle-aged women. In sam ples from el derly
women, they con sti tuted one-half of all fun gal iso -
lates (Ta ble 3, Fig. 2). We could iso late C. glabrata
only from the cer vi cal swabs of mid dle-aged women 
and found the fre quency of iso la tion of this spe cies
to be very low (14.3%) (Table 3 and Fig. 3).
We iso lated yeasts from uro gen i tal sam ples in
pure cul ture (93.5%) more fre quently than in mixed
fun gal-bac te rial cul ture (from 6.5% of pos i tive sam -
ples), cul tures with gram-pos i tive cocci (enteroco -
cci and beta-haemolytic strep to cocci group B), or
gram-neg a tive spe cies of the Enterobacteriaceae
fam ily (spe cies E. coli and Klebsiella spp.). Mixed
cul tures most fre quently grew on vag i nal swabs
(30%), cer vi cal swabs (7.1%), and urine samples
(3.6%) (Table 4).
Quan ti ta tive anal y sis of fun gal cul tures showed
yeast isolations (from 57% of all sam ples) to be
more com mon in a large num ber of col ony counts.
ACTA DERMATOVENEROLOGICA CROATICA 81
Mlinariæ-Missoni et al: Acta Dermatovenerol Croat
Fun gal In fec tions of Gen i to uri nary System 2004;12(2):77-83
Ta ble 4. Fre quency of pure and mixed fun gal-bac te rial cul ture from 107 urine sam ples and gen i tal swabs
Samples (n, %)
Yeast isolations urine vaginal swab uterine cervical swab total
Pure fungal culture 80 (96.4)  7 (70.0) 13 (92.9) 100 (93.5)
Mixed fungal-bacterial culture  3 (3.6)  3 (30.0)  1 (7.1)   7 (6.5)
Total 83 (100.0) 10 (100.0) 14 (100.0) 107 (100.0)
Ta ble 5. Qual i ta tive anal y sis of fun gal isolations from 107 urine sam ples and gen i tal swabs by num ber of
col ony form ing units (CFU) grown per solid medium
No. of patients (%)
CFU (per 1 mL) urine CFU (per sample) vaginal swab uterine cervical swab total
£103 38 (45.8) £102  3 (30.0)  5 (35.7)  46 (43.0)
³104 45 (54.2) ³102  7 (70.0)  9 (64.3)  61 (57.0)






























Fig ure 3. Fre quency of Candida glabrata spe cies
isolations from urine sam ples and gen i tal swabs by pa -
tient sex and age. Closed bars – urine spec i mens from
women; open bars – urine spec i mens from men; grey
bars – vag i nal swab; striped bars – uter ine cer vi cal swab.
The col ony count ³102 grew on solid me dium from
70% of vag i nal swabs and 64.3% of cer vi cal swabs. 
Also a sig nif i cant amount of col ony form ing units
(³104) grew from 54.2% of urine sam ples (Ta ble 5).
DIS CUS SION
The fre quency of in di vid ual yeast spe cies iso la -
tion dif fers by uro gen i tal sam ple type, pa tient age
and sex. Al though very ex ten sive, the re search into
fun gal uro gen i tal in fec tions is of ten tar geted at cer -
tain pop u la tion groups, e.g. hos pi tal ized pa tients.
Yeasts were iso lated from urine sam ples from 1.4%
of hos pi tal ized adult pa tients in In dia, 9.3% hos pi -
tal ized pa tients in UK, 20% of chil dren and 25.3% of 
adult ly ing pa tients in USA, and from 60% of in pa -
tients older than 63 years in Fin land (6). Ac cord ing
to the lit er a ture, it seems that C. albicans was the
most fre quently iso lated spe cies in hos pi tal ized pa -
tients (1-3,6,7), fol lowed by C. glabrata (2,3,6,7,13), 
and C. krusei spe cies from the urine sam ples of
hos pi tal ized pa tients (2,3,6,7). Our find ings on the
fre quency of iso la tion of in di vid ual yeast spe cies
cor re spond with the pos i tive urine sam ples from pri -
mary care pa tients di ag nosed with cys ti tis. Dur ing
the 9-month-pe riod of re search a to tal of 29,997
urine spec i men from men and women was re ceived 
in the Lab o ra tory of Mi cro bi ol ogy, and yeasts were
iso lated from 83 sam ples (0.3%). In these sam ples,
C. albicans was the most fre quent iso late of fun gal
spe cies, C. krusei ranked sec ond, and isolations of
other non-C. albicans and C. glabrata were less
com mon. Our find ings on the dis tri bu tion of iso lates
of in di vid ual yeast spe cies from urine sam ples of
pri mary care pa tients with cys ti tis are in agree ment
with the re sults of other au thors in ves ti gat ing the
frequency of fungal isolates in urine samples from
the inpatients having the clinical picture of cystitis
(1-3,5-7).
Vulvovaginal candidiasis ac counts for one-third
of all vulvovaginal mu cus in fec tions (1-3,6-11). In
their life time, about 75% of women ex pe ri ence at
least one ep i sode of vulvovaginal candidiasis, and
40-50% will have two or more ep i sodes (1,8-13). A
small per cent age of women (up to 5%) ex pe ri ence
re cur rent vulvovaginal candidiasis (1). Risk fac tors
for re cur rent vulvovaginal candidiasis in clude un -
con trolled di a be tes mellitus, immunosuppression,
and corticosteroid use (6,7,16). In some women,
ep i sodes oc cur af ter re peated top i cal or sys temic
an ti bac te rial ther apy. Many women suf fer ing from
re cur rent vulvovaginal candidiasis have no ap par -
ent pre dis pos ing con di tions (1-3,6,7,11). Our re -
sults showed that C. albicans was the most com -
mon fun gal iso late from both youn ger (<30 years)
and older (³51 years) women, whereas C. glabrata
spe cies was most com mon in mid dle-aged women
with the clin i cal pic ture of vulvovaginitis. In the past
few years, many au thors obtaind sim i lar re sults
show ing in creased fre quency of iso la tion of other
non-C. albicans yeast spe cies from vag i nal swabs
(1-13). Iso lates of the C. albicans spe cies to day still
make up 35-96% of all fun gal iso lates from vag i nal
swabs of symp tom atic women. Nev er the less, the
work pub lished so far sug gests that C. glabrata or
other non-C. albicans spe cies, e.g., C. krusei, C.
kefyr, C. parapsilosis, C. tropicalis, and C. guillier -
mon dii are the cause of 1.1-33.3% of all vulvova -
ginitis cases (1-3,6-11).
In creased fre quency of fun gal uro gen i tal in fec -
tions caused by non-C. albicans spe cies may be
ex plained by the fact that these spe cies are ei ther
less sen si tive or have a pri mary, sec ond ary, or
cross-re sis tance to azole prep a ra tions (miconazo -
le, ketoconazole, fluconazole, and itraconazole)
(1-11,13,16).
Growth in pure cul ture and quan ti fi ca tion of fun -
gal iso lates are im por tant pa ram e ters for the in ter -
pre ta tion of my co log i cal find ings (2,3,6,7,11,15).
Our re sults in di cat ing a high fre quency of yeast
isolations from uro gen i tal sam ples in pure cul ture
and in a large num ber of col o nies could help in de -
ter min ing the clin i cal im por tance of iso lates as
patho genic mi cro or gan isms and causes of uro ge n i -
tal infection.
CON CLU SION
Our find ings show that C. albicans is the most
com mon fun gal iso late from cer vi cal swabs of youn -
ger and mid dle-aged women. In el derly women, the
iso la tion fre quency of C. albicans and other non-C.
albicans spe cies is the same. De spite it be ing iso -
lated in 14.3% of mid dle-aged women, C. glabrata
is not a ma jor caus ative agent of fe male cervicitis in
any age group. Ef fec tive treat ment of fun gal uro -
gen i tal in fec tions de pends on the re sults of my co -
log i cal in ves ti ga tion serv ing to es tab lish the pres -
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ence and patho ge nic ity of fun gal iso lates and their
sensitivity to antimycotics.
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IN TRO DUC TION
Atro phic acne scars of ten re main af ter acne,
hav ing neg a tive esthetical and psy cho log i cal im -
pact on the pa tient (1). In 90% cases, fa cial acne
scars are the lead ing cause of fa cial scars, and in
the re main ing 10% the scars re main af ter vi ral in -
fec tions, trau matic, and iat ro genic events (2). Al -
though type and size of the scars do not al ways cor -
re spond with the ex tent of the in flam ma tion, they
ap pear only af ter in flam ma tory acne. What pre -
cisely con trols the de vel op ment of scar ring, its
extent and type, is not known (3,4).
Com mon treat ments of atro phic acne scars in -
clude var i ous in va sive tech niques that re quire sev -
eral days for pa tient re cov ery and have var i ous un -
wanted side effects (5-10).
We used a non-in va sive method of lo cal 0.05%
tretinoin gel ap pli ca tion by iontophoresis. Tretinoin
creams have long been used suc cess fully for skin
re cov ery in cases of so lar de gen er a tion (11-14) and 
as a ther apy for other dermatological dis eases with
al tered keratinization (15). It is well known that
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SUM MARY Atro phic scars are a fre quent con se quence of acne, with a neg a -
tive esthetical and psy cho log i cal in flu ence. Treat ment of atro phic acne scars
in cludes dif fer ent in va sive meth ods. In our study, we used a noninvasive
method with lo cal ap pli ca tion of 0.05% tretinoin gel by iontophoresis. In pa -
tients with a ten dency to wards ex ac er ba tion, we per formed mild peel ing with
5% trichloroacetic acid (TCA) so lu tion 3-4 times dur ing the treat ment. Twenty-
 min ute treat ments were ap plied on 38 pa tients, 29 women and 9 men, dur ing
3.5 months on av er age. Me dian age of pa tients was 21 years (range, 16-29).
Clin i cal as sess ment in cluded an as sess ment of scars, pore size, skin mois -
ture, vascularization, and skin firm ness and elas tic ity. As con firmed by pho to -
graphs taken be fore and af ter ther apy, the treat ment proved to be clin i cally ef -
fec tive in de creas ing acne scars and per sis tence of ef fects. Flat ten ing of acne
scars was ob served in 79% of the pa tients. The re sults de pended on du ra tion
of scars per sis tence as well as on a the type of scars. The best re sults were
achieved with youn ger scars as well as with su per fi cial and ice pick scars. Side
ef fects in volved a very mild retinoid der ma ti tis and more of ten acne ex ac er ba -
tion. The ther apy was clin i cally ef fec tive and the pa tients ac cepted the treat -
ment very eas ily. Lo cal ther apy of acne scars with tretinoin by iontophoresis
can in some cases suc cess fully re place in va sive tech niques, and could also be 
com bined with those tech niques.
KEY WORDS acne scars; tretinoin; iontophoresis
tretinoin stim u lates mi totic rate of keratinocytes, in -
creases epi der mal thick ness, stim u lates col la gen
for ma tion, wid ens su per fi cial skin cap il lar ies, and
im proves elastic fiber properties (11,16-19).
Iontophoresis is sup posed to over come stra tum
corneum bar rier and to in crease drug con cen tra tion 
in all skin lay ers (5,6,20,21). Our goal was to ex am -
ine the ef fi ciency of this non-in va sive method for
atro phic acne scars treatment.
PA TIENTS AND METH ODS
Pa tients
The study in cluded 38 pa tients aged be tween 16 
and 29 years with atro phic acne scars of dif fer ent
type and age (Ta ble 1). The pa tients re ceived treat -
ment with lo cal 0.05% tretinoin gel ap pli ca tion by
iontophoresis.
Meth ods
Tretinoin gel was ap plied on the face af ter ini tial
face clean ing with 70% al co hol. Twenty-min ute
treat ments with 6-mA elec tric cur rent were per -
formed twice a week over 3.5 months on av er age.
Pa tients that showed ten dency to wards acne ex ac -
er ba tion had mild peel ing treat ment with 5% trichlo -
roacetic acid, 3-4 times over the course of the treat -
ment.
Clin i cal ef fects were eval u ated ac cord ing to the
fol low ing scale: score 1 – with out change, score 2 –
min i mal, score 3 – vis i ble, and score 4 – con sid er -
able improvement.
Skin prop er ties such as scars depth, color,
vascularization, pores size, and skin firm ness and
elas tic ity were clin i cally es ti mated. Skin mois ture,
sebum, and pH val ues were mea sured with com -
bined equip ment Sebumeter SM 810 + Corneo -
meter CM 820 + Skin-pH-Me ter pH 900 (Cour age +
Khazaka Elec tronic, Co logne, Germany). Treated
parts of the skin were pho to graphed be fore and af -
ter the treatment.
RE SULTS
Retinoid Re ac tion and Acne
Ex ac er ba tion
We ex pected that an av er age treat ment du ra tion 
of three and a half months would dis cour age pa -
tients, but it did not. Most pa tients showed high
com pli ance dur ing the whole treat ment and readi -
ness to con tinue it if even tu ally needed. This was
es pe cially no tice able for fe male pa tients who per -
ceived twice-a-week treat ments as tak ing care of
their per sonal ap pear ance. The ma jor ity of pa tients
was more pleased with fi nal re sult than the therapist 
herself.
Retinoid re ac tion in the form of mild er y thema
ap peared in 5 out of 38 pa tients and lasted one to
two days, whereas repeated ex ac er ba tion of ex ist -
ing acne ap peared in 23 pa tients (Ta ble 2). There
was ap pear ance of papules and papulopustules in
pa tients who pre vi ously did not have acne at all.
Scars Flat ten ing 
Con sid er able im prove ment with re spect to scars 
flat ten ing was achieved in 10 out of 38 pa tients, vis i -
ble im prove ment in 15, min i mal but still no tice able
by both the pa tient and the ther a pist in 5 pa tients,
whereas no scar flat ten ing was the re sult of the
ther apy in 8 pa tients (Ta ble 2; Figs. 1-3).
Re la tion ship be tween re sults and scar type was
vary ing. Scars with small di am e ter (su per fi cial and
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Ta ble 1. Char ac ter is tics of 38 pa tients with acne
and acne scars
Characteristic No. of patients
Men/women  9/29
Age (years, median, range) 21 (16-29)
Acne type:













ice pick) showed best re sults, whereas big ger scars 
(macula atro phic and de pressed-fibrotic) did not re -
act as well to the ther apy. The worst re sults were
ob tained in pa tients 3with de pressed fibrotic scars
(Fig. 4).
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Ta ble 2. Skin reactions to and re sult of lo cal 0.05%
tretinoin gel ap pli ca tion by iontophoresis
Type of reaction/result Onset No. of patients (N=38)
Retinoid dermatitis:
immediately  1
after 2 weeks  3
after 8 weeks  1
without dermatitis 33
Acne exacerbation:
after 2 weeks 10
after 4 weeks  9
after 8 weeks  4
no exacerbation 15
Scar flattening:
none (score 1)  8
minimum (score 2)  5
visible(score 3) 15
considerable (score 4) 10
 
 
Fig ure 1. Pa tient XX be fore (A) and af ter (B) the treat -






Fig ure 2. Pa tient YY be fore (A) and af ter (B) the treat -





Fig ure 3. Pa tient XY be fore (A) and af ter (B) the treat -
ment with 0.05% tretinoin gel ap pli ca tion by iontopho -
resis. De tail of the right cheek.
BA
There was also a cor re la tion be tween re sults
and scars age, with older scars be ing more dif fi cult
to flat ten. Im prove ment of the treat ment re sult was
get ting worse as the age of scars was in creas ing
(Fig. 5).
Clin i cal Eval u a tion of Skin Prop er ties 
Treat ment im proved all clin i cally es ti mated skin
prop er ties (Fig. 6). Skin color was im proved in all
pa tients. Pig men ta tion was light ened and in most
cases it be come sim i lar to the sur round ing area.
Skin vascularization was also im proved in all pa -
tients. Skin got health ier look and more nat u ral
color. Pores also got smaller in al most all patients
(Fig. 7).
Me chan i cal skin char ac ter is tics were also im -
proved by the treat ment. Skin firm ness im prove -
ments con sisted of in creased firm ness of scar tis -
sue of atro phic macula and ice pick scars. With
superficial scars, tis sue con sis tency slightly im -
proved, but even be fore the treat ment those prop er -
ties were not very ad verse. Indurated scar tis sue in
de pressed fibrotic scars be came re laxed (Fig. 8).
Skin elas tic ity im proved in al most all pa tients, both of 
the scar tis sue and of treated skin be tween scars
(Fig. 8).
Pa ram e ters of Skin’s Hydrolipidic Film
At the be gin ning of the treat ment cheek skin
mois ture was low. Sig nif i cant (p=0.005) im prove -
ment of skin mois ture in the treated ar eas prob a bly
re sulted from the skin rep a ra tion af ter tretinoin
treat ment (Fig. 9). Amount of sebum fell af ter one-
 third of the ther apy du ra tion, and then re stored to
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Fig ure 4. Im prove ment of dif fer ent types of scars.
 
Fig ure 5. Scars flat ten ing ver sus scars age.
 
Fig ure 6. Im prove ment of skin color and vascularization.
 
Fig ure 7. Im prove ment of pore size.
 
Fig ure 8. Skin firm ness and elas tic ity.
 
Fig ure 9. Skin mois ture changes dur ing treat ment.
the initial level, at which it re mained un til the end of
the treat ment (Fig. 10). Skin pH value was mea -
sured both be fore and af ter ev ery treat ment dur ing
the whole ther apy. The treat ment caused in creased 
acid ity for ap prox i mately 1,8 units. Dur ing the ther -
apy, pH value did not change (Fig. 11).
DIS CUS SION
Scars Flat ten ing
The lo cal ef fect of tretinoin on acne and photo -
aging is well known. The ben e fi cial ef fect on striae
distensae, which is histologically and by the na ture
equiv a lent to the atro phic scars, has also been de -
scribed (22). Tretinoin cream and tretinoin so lu tion
have a ben e fi cial ef fect on acne scars as well
(23,24).
The loss of col la gen tis sue and deg ra da tion of
elas tic tis sue pres ent in photoaging can be, to some 
ex tent, com pared with re sults of histological ex am i -
na tion of atro phic scars and striae distensae.
Tretinoin stimulatory ef fect on the pro duc tion of col -
la gen and the im prove ment of elas tic tis sue’s prop -
er ties can ex plain its pos i tive ef fect in such con di -
tions. In the epi der mis, it acts as an ac cel er a tor of
the mi totic ac tiv ity of keratinocytes, which re sults in
the ex cre tion of ex ist ing and pre ven tion the for ma -
tion of new comedones. A de po si tion of mucinous
sub stances in the voids be tween stra tum corneum
and stra tum spinosum cells takes place dur ing the
ini tial weeks of the treat ment. How ever, the histo -
logic con di tion in the epi der mis re turns af ter 3-4
months of treat ment to the pre treat ment stage while 
the clin i cal ap pear ance of the skin keeps im prov ing; 
this im plies that the dermis is the fi nal goal of the
ther apy (16,25,26). An im proved com pact ness of
the stra tum corneum con trib utes to the flat ten ing of
the skin.
Lo cal ap pli ca tion of retinoids is lim ited by the
bar rier func tion of the skin. Iontophoresis is a
method known to spe cial ists in phys i cal med i cine;
in der ma tol ogy, it is used to cure hyperhidrosis. The
use of gal vanic cur rent con sid er ably in creases the
con cen tra tion of a drug in the skin (27). The elec tric
po ten tial used in iontophoresis can change the per -
me abil ity of the skin, caus ing changes in the dis tri -
bu tion of lipids, pro teins, and wa ter mol e cules in
stra tum corneum. Trans port of the drug in ionic form 
takes place along the sweat glands and dis crete
pores in the skin. These pores are cre ated by the
flow of elec tric cur rent in the pro cess of iontopho -
resis and one of the pre mises for the mech a nism of
their mak ing is a so-called “flip-flop” model of the
gate. Ac cord ing to this the ory, the elec tric po ten tial
in the stra tum corneum causes re ori en ta tion of
polypeptide mol e cules of al pha-he lix ker a tin into a
par al lel or der ing. Pores are cre ated be tween non -
adjacent ker a tin he lixes as the re sult of mo lec u lar
re ori en ta tion and re pul sion of nonadjacent di poles
(21,28,29).
Al though a pre cise mech a nism of the tretinoin
ac tion at mo lec u lar level is not ex plained, the cause
of atro phic scars cor rec tion is pro lif er a tion of col la -
gen and the con se quen tial in cre ment of the thick -
ness of dermis layer. The drug re sults in an in -
creased con cen tra tion of type III col la gen (6).
It is as sumed that the stim u la tion col la gen syn -
the sis by lo cal ap pli ca tion of tretinoin is achieved
through at least two mech a nisms: first, the in cre -
ment of mes sen ger ri bo nu cleic acid (mRNA) for
col la gen type I and II; and sec ond, the stim u la tion of 
the fibroblasts to in duce tis sue in hib i tor of ma trix
metalloproteinases (MMPs), which in hib its col la -
gen ase, i.e. pre vents the de struc tion of col la gen
(30-32). MMPs ac tiv ity is of out most im por tance
dur ing the rep a ra tion of the dam aged tis sue. MMPs
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Fig ure 10. Sebum changes dur ing treat ment.
 
Fig ure 11. Mean pH val ues dur ing ther apy, mea sured
both be fore and af ter the treat ment with 0.05% tretinoin
gel ap pli ca tion by iontophoresis.
be fore after
func tion is reg u lated by the pro tein tran scrip tion fac -
tor, the so-called ac ti va tor pro tein-1 (AP-1). The im -
proved ac tiv ity of tran scrip tion fac tor AP-1 leads to
the in creased MMPs ac tiv ity and to aug mented de -
struc tion of col la gen (16,32). Be cause of that it is
as sumed that tretinoin treat ment can pre vent for -
ma tion of scars (33).
We achieved com plete or par tial flat ten ing of
scars in 79% of the cases. Schmidt et al (5,6)
quoted in two stud ies that scars flat ten ing was
achieved in 93% and 94% of the cases by ap pli ca -
tion of tretinoin 0.025% gel by iontophoresis. The
de gree of scars flat ten ing was not defined.
Fernandes (34) treated two pa tients af fected by
varicella scars with tretinoin 0.05% gel. One of them 
had 4 months, the other 40 years old scars. Better
re sults were achieved in a pa tient with youn ger
scars that dis ap peared al most com pletely af ter 24
treat ments. The older scars were less vis i ble and
shal lower (34).
Retinoid Re ac tion and Acne
Ex ac er ba tion
Dur ing the ther apy, retinoid re ac tion oc curred as 
a mild er y thema in only 5 pa tients and lasted only
1-2 days. All pa tients had a mild des qua ma tion in
the form of a min i mal pityriasiform peel ing. This was 
not an es ti mated retinoid re ac tion. Schmidt et al
(5,6) did not pro vide any in for ma tion on retinoid re -
ac tion in their patients.
There is a large num ber of stud ies on the
retinoid re ac tion of dif fer ent tretinoin for mu la tions
and al ter na tive A vi ta min an a logues, first adapale -
ne and tazarotene re cently, at lo cal ap pli ca tion with -
out iontophoresis. These stud ies com pared tol er -
ance and ef fec tive ness of these drugs and found
that the treat ment caused a retinoid re ac tion in
about 30% of the cases (35,36).
We had acne ex ac er ba tion in a high per cent age
of pa tients. It is well known that, dur ing the first
weeks of retinoid ap pli ca tion with out iontophoresis,
an ag gra va tion of ex ist ing acne le sions can hap -
pen. Due to an in creased con cen tra tion of drugs in
the skin when iontophoresis is ap plied, the pro cess
can be ac cel er ated, as it was in our study. We
solved the prob lem by a mild peel ing with 5%
trichloroacetic acid. Schmidt et al (5,6) did not
mention this phe nom e non.
Skin’s Prop er ties
Our study has dem on strated that the tretinoin
ther apy im proves vascularization, de creases skin
pig men ta tion, re duces pore size, im proves skin
elas tic ity and firm ness. Those re sults cor re spond
with find ings of other stud ies (5,6,11,34).
Hydrolipidic Film of the Skin
The mois ture of the skin on the treated spots sig -
nif i cantly in creased and ap proached the nor mal
val ues dur ing ther apy. We as sumed that the low
mois ture of the skin on the cheeks be fore the treat -
ment was the con se quence of the skin dam age
caused by scars. Im prove ment of the skin mois ture
at these spots prob a bly oc curred as the con se -
quence of skin tis sue heal ing due the tretinoin
treatment.
Fernandes (34) con cluded that the treat ment of
dam aged skin by iontophoresis led to in cre ments of 
glycosaminoglycans and other nat u ral fac tors that
im prove the skin mois ture.
Sebum mea sure ments proved that tretinoin
treat ment does not in flu ence these val ues, which is
in com pli ance with var i ous au thors find ings (37-39).
The pH-val ues mea sured dur ing the treat ment
proved that our pa tients had a less acid skin than
nor mal. This can be ex plained by a reg u lar use of
the toilette be fore treat ment (pH-value of Sarajevo
tap wa ter is ap prox i mately 8, soap used ap prox i -
mately 9,5) as well as by the skin dam age caused
due to acne.
CON CLU SION
Top i cal ther apy of atro phic acne scars with
retinoids by iontophoresis im proved scars in most
pa tients. This ther apy also im proved vascu la rizati -
on, de creased skin pig men ta tion, re duced pore
size, and im proved skin elas tic ity and firm ness.
This ther apy was well ac cepted by pa tients, it
im proved their psy cho log i cal state, was easy to go
through, and in creased the in ter est in con tin u a tion
and/or rep e ti tion of its ap pli ca tion. This tech nique
could be in ter est ing as a com ple men tary method to
in va sive tech niques for acne scars reparation.
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IN TRO DUC TION
Cat-scratch dis ease (CSD) is a be nign self-lim -
ited dis ease char ac ter ized by pri mary cu ta ne ous
papule or pus tule and dis tal re gional lymphadeno -
pathy oc cur ring af ter a cat scratch or bite. In some
cases, pri mary cu ta ne ous changes can not be seen. 
Bartonella henselae is the pri mary agent caus ing
cat-scratch dis ease (1). The ma jor ity of af fected pa -
tients have a his tory of ex po sure to cats, whereas in 
some cases the dis ease de vel ops af ter a dog
scratch (2). Cat-scratch dis ease oc curs pri mar ily in
chil dren and young adults, ie, 55% of pa tients are
youn ger than 18 years (3). Un com pli cated cat-
 scratch dis ease is most of ten man i fested by re -
gional lymphadenopathy, which usu ally re solves
spon ta ne ously within 2-6 months with out the need
for an ti bi otic ther apy. An ti bi otic ther apy, how ever,
can be con sid ered for pa tients with se vere form of
cat-scratch dis ease, which is seen in up to 25% of
cases (4,5). This form in cludes osteomyelitis, oc u -
lar in volve ment, encephalopathy, granulomatous
hep a ti tis, hepatosplenic in fec tion, endocarditis or
intra-ab dom i nal lymphadenitis (5). Osteomyelitis
usu ally pres ents as osteolytic le sion and can be
caused by lymphogenous or hematogenous spread 
of the bac te ria or by in fec tion pro gress ing per
continuitatem. Clin i cal pre sen ta tion of cat-scratch
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SUM MARY We pres ent a case of a 22-month-old child with swol len up -
per part of the right arm and osteolytic le sion of the right hu merus, which
re sem bled a neo plas tic pro cess. Ep i de mi o log i cal his tory re vealed no
scratch marks on the skin or cu ta ne ous papule or pus tule. Pre sump tive
di ag no sis of hematogenous osteomyelitis was es tab lished, but treat -
ment with fusidic acid was un suc cess ful. Histological ex am i na tion of the
bioptic spec i men of the soft tis sue swell ing showed a lymph node mor -
phol ogy, with nu mer ous granulomas with cen tral stellate ne cro sis. In di -
rect immunofluorescence as say for Bartonella henselae yielded pos i tive
re sults. New treat ment in cluded 15 days of trimetoprime and sulfametho -
xazole, fol lowed by azithromycin for 5 days. Four months later, swell ing
re solved and osteolytic le sion al most com pletely healed with for ma tion of 
sur round ing scle ro sis. In con clu sion, cat-scratch dis ease with out pos i -
tive ep i de mi o log i cal his tory and pri mary cu ta ne ous papule or pus tule
may be a se ri ous di ag nos tic prob lem, but can be solved by serological
and histological ex am i na tion.
KEY WORDS Bartonella henselae; cat-scratch dis ease; child; flu o res -
cent an ti body tech nique, in di rect; osteomyelitis
dis ease in the form of lymphadenopathy and osteo -
lytic bone le sion with out a skin le sion can raise the
sus pi cion of neo plasm (6). In such cases, it is of
par tic u lar im por tance to perform less invasive di a g -
nos tic procedures, such as lymph node needle bi -
op sy, to avoid major surgeries.
CASE RE PORT
A 22-month-old fe male child with swell ing of the
right shoul der was ad mit ted to the De part ment of
Pe di at rics, Split Uni ver sity Hos pi tal. She was the
third child of healthy non-con san guin e ous par ents.
Her med i cal his tory was un re mark able, but ep i de -
mi o log i cal his tory re vealed that she fre quently
played with her kit ten. On ad mis sion she was fe brile 
up to 37.2°C and appeared as a mildly ill child.
Lymph nodes of ap prox i mately 1 cm in di am e ter
were pal pa ble on the right side of the neck. A sub -
cu ta ne ous pain ful swell ing of 3.5 cm in di am e ter
was found on the tip of the right up per arm. Phys i cal 
ex am i na tion of car diac and pul mo nary func tion
showed no clin i cally sig nif i cant ab nor mal i ties. He -
pa to megaly and splenomegaly were not noted.
Scratch marks were not found on the skin. Lab o ra -
tory tests re vealed the Westergren eryth ro cyte sed -
i men ta tion rate of 16 mm/h. The pe riph eral leu ko -
cyte count was 7.4×109 cells/L (2% eosinophils,
36% seg mented neu tro phils, 0% band forms, 58%
lym pho cytes, and 4% monocytes). He mo glo bin
con cen tra tion was 11.7 g/dL and the platelet count
was 263x109 plate lets/L. There were 52% of T-lym -
pho cytes and 10% of B-lym pho cytes. Blood chem -
is try val ues (creatinine, blood urea ni tro gen, to tal
pro tein, al bu men, glob u lin, im mu no glob u lin, am y -
lase, se rum aspartate aminotransferase, alanine
aminotransferase, bil i ru bin, creatinine phosphoki -
nase, glu cose, cal cium, and al ka line phosphatase)
were in the ranges of ref er ence val ues. C-re ac tive
pro tein con cen tra tion was 31.5 mg/L (nor mal, <5
mg/L). Re sults of rou tine uri nal y sis were un re mark -
able. Ini tial ul tra sound of ab dom i nal or gans re -
vealed no en large ment of liver, spleen, or intra-ab -
dom i nal lymph nodes. The re sults of mul ti ple blood
and urine bac te rial cul tures were neg a tive. X-ray of
the right hu merus showed a de struc tive, osteolytic
le sion in the epiphysial area that ex panded into the
metaphysial area (Fig. 1). Treat ment with fusidic
acid was started (18 mg/kg/day) and dis con tin ued
af ter 3 weeks be cause there were no changes in
clin i cal con di tion of the child. On day 10 of hos pi tal -
iza tion, bioptic sam ples of the soft tis sue swell ing of
the right shoul der and bone frag ments from the
osteolytic metaphysial le sion of the hu merus were
taken. Histological ex am i na tion of the soft tis sue re -
vealed lymph-node mor phol ogy, with nu mer ous
granulomas with cen tral stellate ne cro sis. Warthin-
 Starry sil ver stains were neg a tive for mi cro or gan -
isms. Gigantocellular granulomas with out ne cro sis
were found in the spec i men of the metaphysial
osteolytic le sion. No ma lig nant changes were iden -
ti fied. Bac te rial cul tures of lymph nodes and bone
were neg a tive. In di rect immunofluorescence as say
(IFA) for Bartonella henselae yielded pos i tive re -
sults. Con cen tra tion of IgM and IgG were 1:64 and
1:128, re spec tively. IFA for Bartonella quintana was
IgM-neg a tive. Ag glu ti na tion test for Francisella tula -
rensis was also neg a tive, as well as en zyme-linked
immunosorbent as says (ELISA) for Ep stein-Barr vi -
rus, cytomegalovirus, hu man im mu no de fi ciency vi -
rus (HIV), and Toxoplasma gondii. Tu ber cu lin skin
test re sult was also neg a tive. The child was dis -
charged from the hos pi tal af ter 25 days. Upon dis -
charge from the De part ment of Pe di at rics, out pa -
tient treat ment was con tin ued by a spe cial ist in in -
fec tious dis eases. New treat ment in cluded 15 days
of oral sus pen sion of trimetoprime (10 mg/kg) and
sulfamethoxazole (50 mg/kg/day), fol lowed by
azithromycin for 5 days (20 mg/kg on day 1, and 10
mg/kg on days 2-5). Af ter this an ti bi otic reg i men,
no ta ble re duc tion of the swell ing and slow res o lu -
tion of the osteolytic le sion en sued. Three months
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Fig ure 1. X-ray in a 22-month-old child with cat-scratch
dis ease re vealed de struc tive osteolytic le sion (ar row) of 2 
×1.5 cm in di am e ter in the epiphysial area, ex pand ing into 
the metaphysial area of right humerus.
later X-ray ex am i na tion showed con sid er able re -
duc tion of the osteolytic le sion. Six months af ter eti -
o log i cal di ag no sis had been es tab lished, X-ray im -
ag ing re vealed al most com plete heal ing of the
osteolytic le sion with for ma tion of surrounding scl e -
ro sis.
DIS CUS SION
This is the first case re port of cat-scratch dis -
ease with osteomyelitis in Croatia. Osteomyelitis is
a rare com pli ca tion of cat-scratch dis ease (2), and
in case of a lack of no ta ble symp toms of in fec tious
dis ease, phy si cians usu ally sus pect ma lig nant pro -
cesses (7). Lit er a ture re view showed no case re -
port of cat-scratch dis ease with osteomyelitis in
chil dren youn ger than our pa tient (8). Be cause of
the pain ful swell ing on the right up per arm and
young age of the child, pre sump tive di ag no sis of
hematogenous osteomyelitis was es tab lished.
Since the treat ment with fusidic acid was un suc -
cess ful, fur ther di ag nos tic tests were car ried out. Al -
though methicillin is usu ally the an ti bi otic of first
choice, treat ment with fusidic acid was ad min is -
trated be cause caus ative agent of osteomyelitis,
among oth ers, could be methicillin re sis tant Staph -
y lo coc cus aureus. Since neo plasm was sus pected,
a bi opsy was per formed and a small sam ple of the
swol len tis sue, a lymph node, and piece of bone
was ob tained. Histological find ings, along with
X-ray and his tory of ex po sure to the cat, sug gested
the di ag no sis of cat-scratch dis ease. IFA is to day
used for es tab lish ing the di ag no sis of cat-scratch
dis ease, with sen si tiv ity of 84% and spec i fic ity of
96% (9). Histopathologic ex am i na tion by light mi -
cros copy may be used to con firm the di ag no sis (1).
The histopathologic find ings of af fected lymph
nodes from pa tients with cat-scratch dis ease in -
clude stellate granulomas, microabscesses and
follicular hy per pla sia (2). Al though Bartonella hen -
selae may be iden ti fied by Warthin-Starry sil ver
stain ing (1), in our pa tient the di ag no sis of cat-
 scratch dis ease was based on ep i de mi o log i cal data 
(cats or kit tens in the fam ily), histological find ings,
and in di rect immunofluorescence as say. Al though
there are re ports of hematogenous spread of
Bartonella henselae from the lymph node to the
bone (10), be cause of their con ti gu ity, we be lieve
that bone in volve ment in our pa tient could have
been the re sult of di rect non-hematogenous ex pan -
sion. Osteolytic le sion of the right hu merus was ob -
served by ra dio graphic ex am i na tions, which re -
vealed slow res o lu tion of the osteolytic le sion.
There are no pro spec tive con trolled clin i cal tri als on 
the ef fec tive ness of antimicrobial ther apy for dis -
sem i nated cat-scratch disease, but there are
reports that recommend trimethoprime-sulfametho -
xazole, ciprofloxacin or azithromycin in complicated 
cat-scratch disease (11).
We can not be cer tain in the ef fi ciency of the ap -
plied antimicrobial treat ment be cause cat-scratch
dis ease usu ally re solves with out antimicrobial ther -
apy (12), even in cases with atyp i cal man i fes ta -
tions. Our case sug gests that cat-scratch dis ease in 
its typ i cal and atyp i cal form should be con sid ered
even at a rel a tively young age of the pa tient. Me tic -
u lous ep i de mi o log i cal his tory is of es sen tial im por -
tance (skin scratch, papule or pus tule) even in very
small chil dren. Serological ex am i na tions should be
per formed as early as pos si ble, and histological
find ings should support the diagnosis of cat-scratch 
disease.
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IN TRO DUC TION
Mas tur ba tion is de fined as erotic stim u la tion in -
volv ing the gen i tal or gans, com monly re sult ing in
or gasm. It is achieved by man ual or other bodily
fric tion, ex clu sive of sex ual in ter course. In stru men -
tal ma nip u la tion, sex ual fan ta sies, or var i ous com -
bi na tions can aug ment the pro cess (1). There are
over 300 slang terms in the Eng lish lan guage for
male mas tur ba tion, ac cord ing to an Internet search, 
while only four syn onyms ap pear reg u larly in the
med i cal lit er a ture (self-pol lu tion, Onansism, sem i -
nal pol lu tion, and self-abuse) Some of these terms
are eu phe mis tic, others diminutive, and still others
plain silly.
The Bi ble, in Gen e sis 38:9. im plies that Onan’s
sin was his prac tice of co itus in ter rup tus and not
mas tur ba tion. He spilled his seed on the ground
rather than in sem i nate his older brother’s child less
widow. The el dest son of such a un ion would in herit
his dead brother’s name, as well as his birth right.
As the el dest sur viv ing brother, he then would not
in herit his father’s fortune.
Prior to 1700, there is lit tle ev i dence in West ern
med i cal lit er a ture that mas tur ba tion causes dis -
ease. By the early part of the 18th cen tury, both lay
and med i cal pub li ca tions be gan to as cribe a va ri ety
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SUM MARY A 33-year-old man pre sented with a his tory of a penile ul cer of four days’ du -
ra tion. He was im me di ately treated with 2.4 mil lion IU of benzathine pen i cil lin IM and
tested for syph i lis, but sub se quently proved non-re ac tive. He was al ready re ceiv ing
doxycycline BID from an other phy si cian for this non spe cific gen i tal ul cer and
minocycline for acne. Past med i cal his tory re vealed pe ri odic flares of hidradenitis
suppurativa, lim ited to the but tocks and in gui nal re gion; acne, in volv ing the face and
back; and angiokeratoma of the scro tum. He had no known drug al ler gies, nor had he
ad mit ted to tak ing any other me di ca ments. Ex am i na tion re vealed an 8x15 mm ir reg u -
larly shaped, shal low, ten der ul cer over a larger purpuric base and in volv ing part of the
co rona and the dis tal por tion of the shaft. No in gui nal adenopathy or buboes could be
found on pal pa tion. The pa tient was placed on a cream con tain ing 3% iodochlo -
rhydroxyquin 1% hy dro cor ti sone. By the end of two weeks of ther apy, the le sion had
healed with no re sid ual dis col or ation. Sub se quently, the pa tient re vealed that he mas tur -
bated daily, rub bing his pe nis back and forth on the bed sheet while ly ing prone on the
bed. Eleven months later, he con sulted us again for a new purpuric penile ul cer, be cause 
he had be gun to masturabate in his usual fash ion. The ul cer healed within sev eral days,
and there were no sequellae.
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of phys i cal and es pe cially men tal ill nesses to
self-pol lu tion. Mas tur ba tion, there af ter, cre ated
health con se quences. Hardly a dis ease was not
caused by so-called self-abuse. If an ad o les cent or
young man in dulged in such ac tiv ity, he would un -
doubt edly be af flicted with acne, hair loss, ep i lepsy,
pros tate en large ment, pre ma ture ejac u la tion, se -
men leak age, ste ril ity, al co hol ism, tu ber cu lo sis, im -
paired mem ory and con cen tra tion, hypochondria -
sis, in som nia, anx i ety, ag o ra pho bia, para noia, ho -
mi cidal in san ity, mas tur ba tion in san ity, and de men -
tia, to men tion only a few of the dread ill nesses he
could in flict upon him self. With the changes in med i -
cal thought brought about by the First World War,
phy si cians, and sub se quently the la ity, rec og nized
that mas tur ba tion was the symp tom of an unrelated
disease and not the cause of a multitude of
illnesses, both organic and psychiatric (2,3).
CASE RE PORT
A 33-year-old man pre sented with a his tory of a
penile ul cer of four days’ du ra tion. Due to con cern
over sev eral sex u ally trans mit ted dis eases, his
fam ily phy si cian im me di ately treated him with 2.4
mil lion IU of benzathine pen i cil lin IM and drew a se -
ro logic test for syph i lis that sub se quently proved to
be non-re ac tive. He was al ready re ceiv ing doxyc -
ycline BID from an other phy si cian for this non spe -
cific gen i tal ul cer and minocycline for acne, un be -
known to the var i ous phy si cians in volved. Past
med i cal his tory re vealed pe ri odic flares of hidrade -
ni tis suppurativa, lim ited to the but tocks and in gui -
nal re gion; acne, in volv ing the face and back; and
angiokeratoma of the scro tum. He had no known
drug al ler gies, nor had he ad mit ted to tak ing any
other me di ca ments. Ex am i na tion re vealed an 8x15
mm ir reg u larly shaped, shal low, ten der ul cer over a
larger purpuric base and in volv ing part of the co -
rona and the dis tal por tion of the shaft (Fig. 1). No
in gui nal adenopathy or buboes could be found on
pal pa tion.
We made a pro vi sional di ag no sis of a trau matic
ul cer or pos si bly, even a fixed drug erup tion. The
pa tient was placed on a cream con tain ing 3%
iodochlorhydroxyquin 1% hy dro cor ti sone. By the
end of two weeks of ther apy, the le sion had healed
with no re sid ual discoloration.
Sub se quently, the pa tient re vealed that he mas -
tur bated daily in the be lief that this gen i tal ma nip u -
la tion would be ben e fi cial to his pros tate. His form of 
mas tur ba tion in volved first ob tain ing an erec tion
and then rub bing his pe nis back and forth on the
bed sheet while lying prone on the bed.
Eleven months later, he con sulted us again for a
new purpuric penile ul cer. Al though he had fre quent 
het ero sex ual in ter course dur ing this pe riod, he had
be gun to masturabate in his usual fash ion. The ul -
cer healed within sev eral days, and there were no
sequellae.
DIS CUS SION
The dif fer en tial di ag no sis could in clude any of
the sex u ally trans mit ted dis eases that have ul cer -
ations, such as syph i lis, chancroid, lymphogranu -
loma venereum, granuloma inguinale, and her pes
progenitalis. While a syph i litic chan cre would be
pain less and indurated, our pa tient had none of
these man i fes ta tions. The non-re ac tive se rol ogy, in
re al ity, was not help ful but did ex clude pre vi ous
syph i litic dis ease. The mor phol ogy of the le sion
also helped to ex clude chancroid, as there were no
rag ged or pain ful edges. Sim i larly, lymphogranu -
loma venereum and granuloma inguinale were
elim i nated from the dif fer en tial di ag no sis, as there
were no pal pa ble lymph nodes. While a herpetic in -
fec tion could be a good di ag nos tic pos si bil ity, there
was no his tory of re cur rent penile le sions. A fixed
drug erup tion was sug gested due to the purpura but 
was dis missed from the di ag nos tic con sid er ations,
as the ul cer healed on both oc ca sions, de spite con -
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Fig ure 1.  An 8x15 mm ir reg u larly shaped, shal low, ten -
der ul cer over a larger purpuric base and in volv ing part of
the co rona and the dis tal por tion of the shaft.
tin u a tion of sev eral me di ca ments; more over, he
has con tin ued to take a mul ti tude of sim i lar agents,
in clud ing tet ra cy cline, doxycycline, and minocycli -
ne with no un wanted side ef fects. The ulcer most
likely healed by itself, with little, if any, assistance
from the prescribed therapy.
Mas tur ba tion can cause or ag gra vate a num ber
of dermatologic and uro logic con di tions, rang ing
from penile edema (4) to ec zema (5) and non-ve ne -
real sclerosing lymphangitis (6) to penile frac ture
(7), as well as stran gu la tion of the pe nis (7). Not
sur pris ingly, for eign bod ies, in tro duced to the gen i -
ta lia dur ing ex ces sive ma nip u la tion, have been ex -
tracted from the penile shaft and the lower por tion of 
the urinary tract (7). 
To our knowl edge, this is the first re ported in -
stance of penile ul cer ation, with ac com pa ny ing
purpura, as so ci ated with mas tur ba tion. Al though
most penile ul cers are as so ci ated with sex u ally
trans mit ted dis eases, mas tur ba tion should be con -
sid ered in the differential diagnosis.
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INTRODUCTION
Erythromelalgia is a rare, poorly un der stood
clin i cal con di tion char ac ter ized with in tense burn ing 
pain, marked er y thema, and in creased skin tem per -
a ture (1). Some au thors be lieve that it is not a sep a -
rate en tity but a pathophysiological re sponse of the
skin microcirculation (2). The name of the dis ease,
first de scribed by Mitch ell in 1878, was de rived from 
three Greek words – erythros (red), melos (ex trem i -
ties), and algos (pain) (3-5). The in ci dence in Nor -
we gian pop u la tion has been es ti mated at 2.5-3.3
per mil lion in hab it ants per year (6,7), and the dis -
ease affects twice as many women as men (2).
CLASSIFICATION
Drenth (8) and Michiels (9) di vided erythromel -
algia ac cord ing to the pa tient’s re spon sive ness to
as pi rin into three cat e go ries: platelet-me di ated and
as pi rin-sen si tive, pri mary erythermalgia, and sec -
ond ary erythermalgia (8). Erythromelalgia seemed
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SUM MARY Erythromelalgia is a rare poorly un der stood clin i cal con di tion
char ac ter ized by in tense burn ing pain, pro nounced er y thema, and in -
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tive dis or ders-re lated thrombocythemia, polycythemia, col la gen-vas cu lar
dis eases, di a be tes mellitus, pe riph eral neu rop a thy, au to im mune and in fec -
tious dis eases, and use of cer tain me di ca ments. A wide va ri ety of eti o log i -
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pathogenetic mech a nism – microvascular arteriovenous shunt ing. The
dis ease is char ac ter ized by se vere pain as so ci ated with red ness and hot -
ness in ex trem i ties. The di ag no sis is based on the med i cal his tory and clin -
i cal find ings. The most use ful oral med i ca tions for erythromelalgia seem to
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ease and get better, or even ex pe ri ence full res o lu tion of the dis ease, with
time. This re view ar ti cle pres ents the eti o log i cal ba sis, di ag nos tics, and
ther apy of erythromelalgia.
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to dif fer from erythermalgia (10). Ac cord ing to
Drenth and Michiels (11), erythromelalgia was re -
stricted to thrombocythemia of var i ous myelopro -
life rative dis or ders. Pri mary erythermalgia was a
mys te ri ous con gen i tal dis or der, whereas sec ond -
ary erythermalgia was as so ci ated with a de tect able
un der ly ing dis or der, or ap pears as a side effect of
vasoactive drugs (11).
Kurzrock and Co hen (12) dis cerned be tween
erythromelalgia of adult on set with id io pathic and
sec ond ary forms, and erythromelalgia of early on -
set, which was id io pathic and oc curred in child -
hood. They clas si fied erythromelalgia as pri mary or
id io pathic if there was no ac com pa ny ing dis ease, or 
as autosomal-dom i nant he red i tary dis or der with
symp toms be gin ning in child hood (13). Sec ond ary
erythromelalgia was most com monly as so ci ated
with myeloproliferative dis or ders-re lated thrombo -
cy themia, polycythemia, col la gen-vas cu lar dis ea -
ses, di a be tes mellitus, pe riph eral neu rop a thy, au to -
im mune and in fec tious dis eases, and use of cer tain
me di ca ments (Ta ble 1). Blech (14) rec og nized
three sub types of erythromelalgia: one as so ci ated
with thrombocytosis/hyperviscosity, the other ac -
com pa ny ing microvascular ischemia (vasoconstric -
ti ve), and the third a vasodilatory erythromelalgia.
Mark et al (15) pro posed a new clas si fi ca tion based
on the eti ol ogy and clin i cal find ings. They di vided
erythromelalgia into a syn drome and a phe nom e -
non, with each of them hav ing an acute and chronic
from. “Syn drome” was used when symp toms were
re stricted to the feet and legs, and ap peared in
child hood or ad o les cence. “Phe nom e non” was
used for all other cases. It could be pri mary or sec -
ond ary. Pri mary phe nom e non was a con di tion
when erythromelalgia was id io pathic, and sec ond -
ary when it was as so ci ated with pri mary dis ease,
such as he ma to log i cal, met a bolic, con nec tive tis -
sue, musculoskeletal, in fec tive, or drug-in duced
dis ease, or caused by paraneoplastic symptoms.
The term “acute” was used when symptoms
reached maximum strength within 1 month from the 
onset (15).
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Ta ble 1. Dis or ders as so ci ated with erythromelagia (adopted from ref. 1)
Hematologic disorders: Infectious diseases:
 polycythemia, trombocythemia  AIDS
 leukemia (particularly chronic myeloid leukemia)  recurrent bacterial infections
 hereditary spherocytosis  viral infections
 pernicious anemia  syphilis
 thrombotic trombocytopenic purpura Musculoskeletal disorders:
Cardiovascular disorders:  sciatica
 atherosclerosis  carpal tunnel syndrome
 hypertension  back tunnel syndrome, peritendinitis
 venous insufficiency  neck and other trauma
Embolic disease: Neurological disorders:
 cholesterol crystal emboli syndrome  neuropathies 
Metabolic disorders:  multiple sclerosis
 diabetes mellitus, types 1&2  spinal cord disease, sciatica
 hypercholesterolemia Drug induced:
 gout  iodide contrast injection
 familial nephritis  oral medications (nifedipine, felodipine, nicardipine, bromocriptine,
 norephedrine, pergolide, and ticlopidine)
Connective tissue disorders:  vaccines: influenza, hepatitis
 rheumatoid arthritis Other conditions:
 systemic lupus erythematosus  cancer (abdominal, colon, thymoma, or astrocytoma)
 mixed connective tissue disorder  frostbite
 Sjogren's syndrome  conversion disorder
 vasculitis  mercury poisoning
PATHOGENESIS
A wide va ri ety of eti o log i cal fac tors can cause
erythromelalgia. However, there is only one com -
mon pathogenetic mech a nism sus pected –
microvascu lar arteriovenous shunt ing (16). The pa -
thol ogy un der ly ing erythromelalgia seems to in -
volve re duced nu tri tive blood flow cou pled with
arteriovenous shunt ing. Ac cord ing to shunt ing hy -
poth e sis, symp toms are caused by tis sue hypoxia,
in duced by misdistribution of skin microvascular
blood flow, with in creased thermoregulatory flow
and in ad e quate nu tri tive per fu sion (15). The skin
tem per a ture of pa tients with erythromelalgia, when
not flar ing, is lower then that of con trol sub jects
(17). This sug gests a subclinical vasoconstriction
dur ing the day with sub se quent re ac tive hy per emia
at night. In erythromelalgia, some precapillary
sphin cters may be con stricted while the arteriove -
nous shunts are open, cre at ing an im bal ance of in -
creased to tal per fu sion, yet de fi cient nu tri tive per fu -
sion (2,18). The re sult is the co ex is tence of hypoxia
and hy per emia of the skin. The prod ucts of tis sue
hypoxia trig ger in creased lo cal blood flow, wors en -
ing the red ness, warmth, and pain. Kazemi et al
(19) per formed sym pa thetic skin re sponse test and
con cluded that sym pa thetic pe riph eral fi bers (C
fibers) were in volv ed in erythromelalgia. Activated
C fibers could cause vasodilatation.
Sec ond ary erythromelalgia may re sult from
humoral fac tors re leased from plate lets of ischemic
tis sues or from C-fi ber in jury in some cases of neu -
rop a thy, whereas pri mary erythromelalgia could be
due to a mu ta tion of capsaicin re cep tor (13). Da vis
et al (20) con firmed that, in ad di tion to other forms
of neu rop a thy, ma jor ity of their 67 pa tients with
erythromelalgia had small-fi ber neu rop a thy. Their
anal y sis of au to nomic and neurophysiologic stud -
ies re vealed two ma jor find ings. First, most pa tients
with EM had ev i dence of postganglionic sudomotor
fail ure, of ten with se vere def i cit. The find ing of pe -
riph eral, es pe cially dis tal, denervation sug gested
the pres ence of a dis tal small fi ber neu rop a thy (20).
Sec ond, ev i dence from nerve con duc tion stud ies
and electromyography of large fiber neuropathy
was relatively common (20).
Al though erythromelalgia is a het er o ge neous
con di tion, neu rop a thy and vasculopathy are the
most likely mech a nisms of cau sa tion (16-20). Vas -
cu lopathy and neu rop a thy co ex ist be cause vascu -
lo pathy with hypoxia may cause neuropathy (20).
CLINICAL PICTURE
Soles, toes, palms, feet, or fin ger tips are red,
warm, and pain ful. Lower ex trem i ties are af fected
more fre quently than up per ex trem i ties (Figs. 1 and
2). Most pa tients ex pe ri ence erythromelalgia in the
feet, al though se vere erythromelalgia may spread
up the legs or arms. There are in ten sive sen sa tions
of burn ing, itch ing, and prick ling. The swell ing is
usu ally bi lat eral, al though it may be uni lat eral, es -
pe cially in sec ond ary cases (1). All those symp toms 
are pro voked or wors ened by ex er cis ing, in some
cases even by walk ing. Ex po sure to heat wors ens
the con di tion im me di ately, whereas cool ing of the
af fected feet brings re lief. The du ra tion of at tacks
may last from a few min utes to sev eral days. Re lief
of pain with ice wa ter im mer sion is so com mon that
is al most pathognomonic (1). The se ver ity and fre -
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Fig ure 1. Swell ing of the dis tal limbs dur ing an ep i sode of
erythromelalgia.
quency of at tacks of erythromelalgia in some pa ti -
ents are increased during the summer (15).
Many pa tients have prodromal symp toms of
burn ing, pain, heat in tol er ance, or flush ing for many 
months or years be fore the ap pear ance of char ac -
ter is tic va so mo tor symptoms.
Sec ond ary tis sue dam age and re ac tive hy per -
emia may be the re sult of the ex ces sive cool ing
(15). Dig i tal ne cro sis or skin ul cer ation with sec ond -
ary in fec tion can lead to am pu ta tion. If erythro -
melalgia is left un treated, it may prog ress to pain ful
acrocyanosis and even pe riph eral gan grene (21).
In some pa tients, spon ta ne ous ul cer ous with slow
heal ing and gan grene on the ex trem i ties may lead
to am pu ta tion (15). How ever, once re versed, re mis -
sions may last months, years, or indefinitely (1).
DIAGNOSIS
As no ob jec tive lab o ra tory cri te ria are avail able,
the di ag no sis is based on the med i cal his tory and
clin i cal find ings (15). Pa tients with erythromelalgia
can usu ally pro vide good de scrip tion of their symp -
toms, from which a ten ta tive di ag no sis may be
made. Typ i cally, symp toms ap pear late in the day.
The pa tient can pres ent with nor mal skin dur ing the
reg u lar day time ex am i na tion. If doubt re mains, im -
mer sion of an af fected area into hot wa ter for 10-30
min utes some times (but not al ways) pro vokes flar -
ing. Di ag nos tic cri te ria dif fer from au thor to au thor.
Da vis et al (22) used 3 in clu sion cri te ria – red, hot,
and burn ing ex trem i ties. Thomp son et al (23) pro -
posed 5 cri te ria – burn ing ex trem ity pain, pain ag -
gra vated by warm ing, pain re lieved by cool ing, er y -
thema of affected skin, and increased temperature
of the affected skin.
Electromyographic stud ies are usu ally nor mal.
Termography re veals in creased skin tem per a tures
in the af fected area, but it is not nec es sary to es tab -
lish di ag no sis. X-ray of the feet and hands usu ally
pro vides no spe cific findings.
DIFFERENTIAL DIAGNOSIS
The di ag no sis of erythromelalgia is eas ily made
on the ba sis of well-taken med i cal his tory and clas -
si cal find ings. Dif fer en tial di ag no sis in cludes Ray -
na ud syn drome, “burn ing feet syn drome” (24), re -
flex sym pa thetic dys tro phy (com plex re gional pain
syn drome) (1), neu rop a thy, cellulitis, and frost bite.
Meno pausal symp toms and med i ca tion re ac tions
may pro duce flush ing or sen sa tion of in tense heat
with out pro found, lo cal ized red ness and pain
characteristic of erythromelalgia (1).
Raynaud syn drome is of ten mis taken for ery -
thro melalgia, but it is usu ally trig gered by cold and
has cy clic pro gres sion with ini tial vasospasm. Burn -
ing feet syn drome (24) has sim i lar symp toms, but
dif fer ent phys i cal find ings – there is no lo cal ten der -
ness of af fected parts, the over ly ing skin and blood
ves sels are nor mal in most pa tients, whereas in
some cases there may be ac com pa ny ing er y thema
of the feet with warm skin, as in erythromelalgia.
Re flex sym pa thetic dys tro phy oc curs un der dif fer -
ent cir cum stances (at the site of an in jury); it is a
per ma nent chronic con di tion char ac ter ized by se -
vere burn ing pain, patho log i cal changes in bone
and skin, ex ces sive sweat ing, tissue swelling, and
extreme sensitivity to touch.
TREATMENT
There is no con sis tently ef fec tive treat ment for
erythromelalgia. The rea sons could be low prev a -
lence of the dis ease and no char ac ter is tic lab o ra -
tory find ings. The man age ment of erythromelalgia
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Fig ure 2. Swell ing of the dis tal limbs dur ing an ep i sode of 
erythromelalgia (de tail).
is dif fi cult and fre quently in volves multidisciplinary
ap proach. Var i ous treat ment mo dal i ties have been
tested, but none proved suc cess ful, es pe cially for
the id io pathic type (Ta ble 2). There is still no treat -
ment of pri mary erythromelalgia, whereas the treat -
ment of the sec ond ary form con sists of ces sa tion of
caus ative drugs or treatment of the underlying dis -
or ders (4).
The symp toms are re lived upon cool ing. Pain re -
lief by cool ing could be ex plained by the low ered
met a bolic rate and con se quently re duced need for
ox y gen supply (15).
The most use ful oral med i ca tions for erythrome -
lalgia seem to be as pi rin, propranolol, clonazepam,
cyproheptadine, drugs in hib it ing se ro to nin reuptake 
(venlafaxine and sertraline), tricyclic an ti de pres -
sants (amitriptyline, imipramine), anticonvulsants
(gabapentin), cal cium an tag o nists (nifedipine, dil -
tia zem), and prostaglandins (micoprostol) (1).
Smith and Allen (25) were the first to dis cover
that a sin gle dose of as pi rin pro duces re mark able
re lief of burn ing pain, per sist ing for few days. As pi -
rin is ef fec tive in pa tients with thrombocythemia and 
polycythemia, al though most cases are very re sis -
tant to treat ment (1). As pi rin is usu ally a treat ment
of choice, as it in hib its pros ta glan din syn the sis and
thus pre vents for ma tion of platelet-ag gre ga tion
tromboxane A2.
Suc cess ful treat ment was achieved with nitro -
prusside in fu sions in chil dren and ad o les cents, and
pros ta glan din and lidocaine in fu sions, 10% top i cal
capsaicin, or bi lat eral sympathectomies in adults.
Nitroprusside is a valu able al ter na tive for erythro -
melalgia re sis tant to as pi rin ther apy, es pe cially in
chil dren (26). It seems that capsaicin ac cen tu ates
the re lease of sub stance P from sen sory nerves fi -
bers and, af ter re peated ap pli ca tions, de pletes the
neu rons of sub stance P (27). The un der ly ing mech -
a nism of pain in erythromelalgia is still unclear, but it 
could involve substance P (28).
Uchida et al (29) ad min is tered in tra ve nously a
low dose of ketamine, a drug con sid ered to be ef -
fec tive for in trac ta ble pain, and pain sub sided sig -
nif i cantly and be come com pletely con trol la ble in
com bi na tion with oral med i ca tions. Treat ment of
erythromelalgia can also be achieved with high-
 dose oral mag ne sium (30). Ad min is tra tion of intra -
thecal opioid and an a2-ag o nist can be ef fec tive in
the treat ment of the pain (31).
Sano et al (32) treated a 28-year-old woman
with cyclosporine. Ini tial dose was 5 mg/kg/day, and 
over three-month pe riod dose was re duced to 3
mg/kg/day, be cause the er y thema and pain in her
legs grad u ally sub sided. Eigh teen months later, the
red ness of her feet, calves, and thighs sub sided,
the sur face tem per a ture nor mal ized and the qual ity
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Ta ble 2. Treat ment mo dal i ties
Cooling or elevating the extremity
Aspirin
Nonsteroidal anti-inflammatory drugs (ibuprophen,
 indomethacin, nabumetone, neproxen, or sulindac)
Chemotherapy (in myeloproliferative disorders)
Phlebotomy (in patients with polycythemia vera)
Surgery (in rare complication of gangrene)
surgical sympathectomy
Platelet inhibition (in patients with thrombocytosis)
Propranol
Epinephrine No randomized
Biofeedback trials of 
Sodium nitroprusside therapy
Methysergide











Methysergide (serotonin reuptake inhibitor)











of her life re mark ably im proved (32). The ex act
mech a nism of ac tion of cyclosporine in ame lio ra -
tion of erythromelalgia is not known (32). It may re -
duce ni tric ox ide pro duc tion in vas cu lar smooth-
 mus cle and en do the lial cells through down-reg u la -
tion of in duc ible ni tric ox ide synthase (33), and stim -
u late endothelin-1 pro duc tion (34), re sult ing in an
ame lio ra tion of the microvascular ab nor mal i ties.
Sur gi cal sympathectomy has been at tempted, with
dif fer ent re sults (35,36). In ad di tion, it is im por tant to 
ed u cate pa tients how to avoid ep i sodes of erythro -
me lalgia, re lieve dis com fort during the episodes,
and control secondary and underlying factors.
PROGNOSIS
Al though spon ta ne ous re mis sions do oc cur,
erythromelalgia may last for many years and be
com pli cated by at tempts to re lieve the pain. The
dis ease usu ally has a chronic, some times pro gres -
sive and dis abling course. The on set of erythrome -
lalgia may be grad ual, with some cases re main ing
mild and un changed for de cades, or it can be gin
acutely, spread ing quickly and dis abling the patient
within weeks.
CONCLUSION
Erythromelalgia is usu ally a chronic, some times
pro gres sive and dis abling dis ease, which can
strongly af fect the qual ity of life. De spite re cent
prog ress in un der stand ing and treat ing erythrome -
lalgia, this vas cu lar dis or der re mains a pain ful and
life-al ter ing con di tion for many pa tients. No sin gle
ther apy has been con sis tently ef fec tive. The out -
come is dif fi cult to pre dict and de pends on the pri -
mary con di tion. In some pa tients, the dis ease is sta -
ble and im proves with time, or even fully resolves.
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WEL COME AD DRESS
On be half of the Or ga niz ing and Sci en tific Com -
mit tee of the In ter na tional Sym po sium “Up date on
atopic ec zema/der ma ti tis syn drome” and Cro atian
Dermatovenerological So ci ety Board, I cor dially
wel come you to Cavtat/Dubrovnik. I wish you a suc -
cess ful sci en tific meet ing and hope you find the so -
cial pro gram equally en joy able.
I am very happy and proud to have the op por tu -
nity to or ga nize this In ter na tional Sym po sium. Here
are again our friends and world known pro fes sors
from 16 coun tries, such as Prof. Ring, Prof. Marks,
Prof. Nakayama, Prof. Kapp, Prof. Stingl, Prof.
Wolf, Prof. Turjanmaa, Prof. Ruzicka, and Prof.
Berardesca.
I am also pleased to wel come Prof. Luger, who is
for the first time in Croatia, as well as Prof. Seidenari, 
Prof. Deleuran, Prof. Fedenko, Prof. Diepgen, Prof.
Wüttrich, Prof. Zuberbier, Prof. Werfel, Prof.
Sziepetowski, Prof. Darsow, Prof. Vena, Prof. Silny,
and Prof. Kaznacheeva.
We are especially proud to wel come Prof.
Marks, Pres i dent of the In ter na tional League of
Der ma tol ogy, Prof. Stingl, Sec re tary Gen eral, and
Prof. Ring as EADV elected pres i dent.
We have pre pared 55 oral pre sen ta tions, 5 sat -
el lite sym po sia with 11 oral pre sen ta tions, two
spon sored lec tures, and 11 post ers.
We re gret that Prof. Trevisan (It aly), Dr. Law -
rence (USA), Prof. Girolomoni, Prof. Bieber, Sec re -
tary of Der ma tol ogy Sec tion of EAACI, Prof.
Therstrun-Pederson were not able to par tic i pate
this Sym po sium.
We also want to thank our spon sors and ex hib i -
tors on help they pro vided with the or ga ni za tion of
this meet ing.
The last meet ing at Plitvice in 2003 of fered many 
up-to-date pre sen ta tions on the main topic. I hope
that this year’s Sym po sium on atopic ec zema/der -
ma ti tis syn drome, which is a great sci en tific trig ger,
is go ing to be equally in ter est ing, in for ma tive, and
ex cit ing.
The Sym po sium is at tended by par tic i pants from 
16 dif fer ent coun tries all over the world.
My ob li ga tion, as a new Board mem ber of the
Sec tion Der ma tol ogy of the Eu ro pean Acad emy of
Allergology and Clin i cal Im mu nol ogy, is to ful fill the
prom ise I made in Paris on June 7, 2003, and or ga -
nize the meet ing on atopic der ma ti tis un der the
spon sor ship of EAACI.
Cavtat venue of the Sym po sium, near Dubrov -
nik, which is unique world cen tral her i tage un der the 
aus pices of UNESCO, gives your op por tu nity to ful -
fill your sci en tific and so cial ex pec ta tions.
Prof. Jasna Lipozenèiæ, MD, PhD
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De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver sity Hos pi tal Cen ter,
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Slobodna Murat-Sušiæ e-mail: slosusic@vef.hr
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Tar get Au di ence
Der ma tol o gists, pe di a tri cians, al ler gists, and im mu nol o gist are in vited along with their col leagues from
ba sic and clin i cal re search and phar ma ceu ti cal in dus try to par tic i pate in the dis cus sion fo rum on early di -
ag no sis of atopic ec zema/der ma ti tis syn drome, with an em pha sis on fu ture de vel op ments in di ag no sis,
man age ment, and pre ven tion of the syn drome.
Atopic ec zema/der ma ti tis syn drome strat e gies: The rel e vance of the di ag no sis of al lergy in atopic der ma -
ti tis and re search in the pe di at ric al lergy/der ma tol ogy will be pre sented by prom i nent lec tur ers.
Dear Col leagues,
Sec tion Der ma tol ogy of the Eu ro pean Acad emy of Allergology and Clin i cal Im mu nol ogy (EAACI) in co op -
er a tion with Cro atian Dermatovenerological So ci ety of the Cro atian Med i cal As so ci a tion and spon sored
by the In ter na tional League of Dermatological So ci et ies or ga nizes an In ter na tional Sym po sium on Up -
date on Atopic Ec zema/Der ma ti tis Syn drome, which will take place in Cavtat. The city of Cavtat, near
Dubrovnik, is the pearl of south Adri atic coast, con sid ered one of the sun ni est places in Eu rope, with
unique world cul tural her i tage un der the aus pices of UNESCO. The sci en tific pro gram of the Sym po sium
is well bal anced and tai lored to the cur rent needs of cli ni cians and ba sic sci en tists with a spe cial in ter est
in atopic ec zema/der ma ti tis syn drome.
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BOOK OF AB STRACTS
ORAL PRE SEN TA TIONS 
PLE NARY LEC TURES
O 1
THE ATOPIC EC ZEMA/DER MA TI TIS
SYN DROME: CLAS SI FI CA TION, NAT U RAL
COURSE AND IM MU NO LOGIC
DIF FER ENCES BE TWEEN THE
IgE-AS SO CI ATED (“EX TRIN SIC”) AND THE 
NON-IgE-AS SO CI ATED (“INTRINSIC”)
TYPE
B. Wüthrich, P. Schmid-Grendelmeier1
Hos pi tal Zollikerberg; and 1Al lergy Unit, De part ment of Der -
ma tol ogy, Uni ver sity Hos pi tal, Zu rich, Swit zer land
Ac cord ing to the Po si tion Pa per from the Eu ro -
pean Acad emy of Allergology and Clin i cal Im mu -
nol ogy (EAACI) no men cla ture task force,* the term
“atopic ec zema/der ma ti tis syn drome” (AEDS)
should be used as the “um brella” term to cover the
dif fer ent sub types of atopic der ma ti tis (AD). The
new no men cla ture un der lines the fact that AD is not 
one, sin gle dis ease but rather an ag gre ga tion of
sev eral dis eases with cer tain clin i cal char ac ter is tics 
in com mon. The so-called “in trin sic” type of AD
(now nonallergic or non-IgE-as so ci ated AEDS) ful -
fils the most com monly used di ag nos tic cri te ria for
AD. These pa tients have no as so ci ated re spi ra tory
dis eases, such as bron chial asthma (BA) or al ler gic
rhi ni tis (AR), show nor mal to tal se rum IgE lev els, no 
spe cific IgE, and neg a tive skin prick tests to
aeroallergens or foods. Im mu no logic dif fer ences
be tween the IgE-as so ci ated type of AD and the
non-IgE-as so ci ated type can be found in cell and
cytokine pat tern in pe riph eral blood and in the af -
fected skin, and also by phenotyping char ac ter iza -
tion of epi der mal den dritic cells. The cur rent ex pla -
na tion of this dis tinc tion is based on dif fer ences in
ge net ics and/or en vi ron men tal con di tions (mi cro
mi lieu). How ever, the non-IgE-as so ci ated type may
switch to an IgE-as so ci ated one dur ing the course
of the time what un der lines the ne ces sity of re -
peated allergological in ves ti ga tions over the years.
How ever, chil dren suf fer ing from a non-IgE-as so ci -
ated type rarely de velop BA and AR, con trary to the
early atopic chil dren with AEDS. The ques tion
arises whether we are miss ing some rel e vant al ler -
gens or an ti gens in the non-IgE-as so ci ated type,
such as Coprinus comatus (shaggy cap) or Malas -
sezia furfur/sympodialis. On the other side, by per -
form ing the so-called “atopy patch tests” with
aeroallergens, foods and Malassezia furfur, a sub -
group of non-IgE-as so ci ated type with a T-cell-as -
so ci ated AEDS in the ab sence of a IgE sen si ti za tion 
could be iden ti fied. An other pathogenetic fac tor,
which has been dem on strated in both types of
AEDS, is IgE an ti body re ac tiv ity against hu man pro -
teins. The sen si ti za tion against Hom S 1 has been
sus pected as the ba sis of the nonallergic AEDS.
But this may rather sup port the hy poth e sis that
autoantigens, such as Hom S 1, may play a part in
the chronicity of AEDS in the ab sence of ac tual ex -
og e nous al ler gens. In the fu ture, all the sub groups
of AEDS should be better de fined, as by an ex ten -
sive allergological work-up by in vi tro and in vivo
test ing, in clud ing atopy patch tests to aeroaller -
gens, foods and fungi, and by deep im mu no logic in -
ves ti ga tions, mainly in skin bi op sies.
*Al lergy 2001;56:813-24.
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O 2
IgE – A PATHOGENETIC FAC TOR IN
ATOPIC DER MA TI TIS?
G. Stingl
Di vi sion of Im mu nol ogy, Al lergy and In fec tious Dis eases,
De part ment of Der ma tol ogy, Uni ver sity of Vi enna Med i cal
School, Vi enna, Aus tria
Ab stract not re ceived.
O 3
IgE vs NON-IgE-RE LATED ATOPIC
EC ZEMA
J. Ring, S. Weidinger, U. Darsow, H. Behrendt
De part ment of Der ma tol ogy and Al lergy Biederstein, Tech ni -
cal Uni ver sity Mu nich; and Di vi sion of En vi ron men tal Der -
ma tol ogy and Al lergy GSF/TUM, Municg, Germany
Atopic ec zema (AE) is the most com mon
non-con ta gious in flam ma tory skin dis ease in child -
hood and also in creas ingly more prev a lent in the
adult pop u la tion. The role of al lergy in atopic ec -
zema has been de bated in the past; now there is
clear-cut ev i dence that aeroallergens and food al -
ler gens play a dis tinct and clin i cally rel e vant role in
at least a subpopulation of AE pa tients, as can be
shown by the atopy patch test and oral prov o ca tion
tests. Com pared with skin prick test and ra -
dio-allergo-sorbent test (RAST,) the atopy patch
test has a lower sen si tiv ity but much higher spec i fic -
ity (60-90%). In skin bi op sies the high-af fin ity IgE
re cep tor (FceR1) can be dem on strated on epi der -
mal Langerhans cells and es pe cially in AE lesional
skin, as well as in some pa tients with neg a tive skin
prick test and RAST. In an ep i de mi o log i cal study
among school chil dren, it has been shown that in -
creased pol len counts are sig nif i cantly as so ci ated
with ec zema flares dur ing sum mer months in sen si -
tized chil dren. A cer tain num ber of pa tients with
clin i cally typ i cal AE does not show pos i tive on skin
prick test or RAST; this pa tient group has been
called, ac cord ing to B. Wüthrich, the “in trin sic type”
of AE, in anal ogy with the com mon dis tinc tion “ex -
trin sic vs. in trin sic” in bron chial asthma. “In trin sic” is 
a neg a tive def i ni tion reached only by ex clu sion.
Maybe we are look ing for too few or for the wrong
al ler gens in screen ing for IgE an ti bod ies. It may
also be pos si ble that un der the “in trin sic” vari ant, in -
di vid u als with al lergy are hid den, and ei ther IgE an -
ti bod ies are only bound lo cally in the skin or other
effector mech a nisms (T cells or eosinophils) play
the crit i cal role. Re cently, a task force “no men cla -
ture” of the World Al lergy Or ga ni za tion has pro -
posed new def i ni tions in the clas si fi ca tion of al ler gic 
dis eases, re strict ing “atopy” to IgE-as so ci ated dis -
eases. In this ter mi nol ogy, an “in trin sic” vari ant can
no lon ger be called “atopic”. There fore, a new clas -
si fi ca tion for ec zem a tous/dermatitic skin dis eases
has been pro posed, whereby the term “ec zema” is
to re place the term “atopic ec zema” or “atopic der -
ma ti tis”. Only the IgE-as so ci ated vari ants of ec -
zema should be called “atopic ec zema”, while the
“in trin sic” vari ants are then clas si fied un der “non-
 atopic ec zema”. The con tro ver sies in ter mi nol ogy
re flect dif fer ent opin ions on pathophysiology and
arise from the lack of solid knowl edge re gard ing the 
com plex pathophysiology of AE. We hope that by
fu ture re search, es pe cially into the pathomecha -
nisms of the “intrinsic” variant, a better un der stand -
ing will be possible, giving rise not only to a more
logical classification, but also to new strategies for
diagnosis, therapy, and prevention of this disease.
O 4
STUD IES ON THE FRE QUENCY AND
CAU SA TION OF ATOPIC EC ZEMA IN
AUS TRA LIA
R. Marks
Uni ver sity of Mel bourne De part ment of Med i cine (Der ma tol -
ogy), St. Vin cent’s Hos pi tal Mel bourne; Skin and Can cer
Foun da tion, Vic to ria, Aus tra lia
Re cent pa pers de scrib ing the fre quency of
atopic der ma ti tis in di cate that the prev a lence of the
dis ease in the com mu nity may be in creas ing. Pop u -
la tion-based sam pling sur veys by der ma tol o gists
us ing stan dard ized cri te ria are the gold stan dard for 
de ter min ing the true fre quency in the com mu nity. A
se ries of pop u la tion-based stud ies were car ried out
in the State of Vic to ria, Aus tra lia, aim ing to de ter -
mine the true prev a lence of atopic der ma ti tis. They
looked at the fre quency of atopic der ma ti tis in (1)
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Ma ter nal and Child Health Cen ters for chil dren up
to the age of four; (2) Pri mary Schools with chil dren
aged 4-12 years; (3) Sec ond ary Schools with chil -
dren aged 12-18 years; and (4) com mu nity-based
sur vey of adults aged 18 and over. Data col lected
in cluded whether the par tic i pants knew if they had
the dis ease; what treat ment, if any, they had re -
ceived; and who pre scribed it. A lon gi tu di nal study
was also done on the 12-month in ci dence of atopic
der ma ti tis in three sep a rate co horts of new born ba -
bies (Cau ca sians, eth nic Chi nese and eth nic Viet -
nam ese) in Aus tra lia. The re sults showed that the
prev a lence of atopic der ma ti tis was most com mon
in the first 12 months, de ceas ing in fre quency with
in creas ing age, but still be ing pres ent well into
adult hood in a small pro por tion of the com mu nity.
Par ents of chil dren with min i mal to mild atopic der -
ma ti tis were fre quently not aware that the child had
some ab nor mal ity in their skin. In the lon gi tu di nal
study on the three co horts of in fants, 21% of Cau ca -
sians, 44% of Chi nese and 17% of Viet nam ese in -
fants de vel oped atopic der ma ti tis in the first 12
months. Par ents of Chi nese and Cau ca sian in fants
had sim i lar socio-eco nomic and hous ing con di tions
com pared with the par ents of Viet nam ese in fants,
who tended to be of low socio-eco nomic sta tus with
com mu nal hous ing and lack of plush pile car pet ing.
The high in ci dence of atopic der ma ti tis in Chi nese
com pared with Cau ca sian in fants may re flect ge -
netic dif fer ences between the two populations,
whereas the difference in incidence between the
Chinese and Vietnamese infants possibly reflects
more the environmental contribution to disease
expression.
1. PRO GRES SION IN ATOPIC
DER MA TI TIS
O 5
T CELLS IN ATOPIC DER MA TI TIS
M. Deleuran
De part ment of Der ma tol ogy, Aarhus Uni ver sity Hos pi tal,
Aarhus, Den mark
The ev i dence for T-cells par tic i pat ing in the in -
flam ma tory pro cess in atopic der ma ti tis (AD) is in -
creas ing. We dem on strated that adults with mod er -
ate AD have dou ble the num ber of T-cells in the skin 
com pared with their num ber in the pe riph eral blood
com part ment. There was also a sig nif i cant re duc -
tion in the telomere length of both CD4+ and CD8+
T-cells in blood, as well as skin-hom ing T cells.
These re sults pointed to wards an in creased turn -
over in the pe riph eral T-cell sys tem. Treat ments,
which spe cif i cally in hibit T-cells, are very ef fec tive in 
con trol ling AD, sup port ing the view that T cells play
a cen tral role in the pathogenesis of AD. Many
chemotactic fac tors are pro duced in the skin in pa -
tients with AD, in duc ing an in va sion of T-cells into
the skin. We shoed that T-cells in AD skin ex -
pressed the chemokine re cep tors CCR4 and
CCR10 and that their lig ands, TARC and CTACK,
were un reg u lated. We ob served three subpopulati -
ons of T helper cells in AD: CCR4+/CCR10+,
CCR4+/CCR10–, and CCR4-/CCR10+. This show -
ed the het er o ge ne ity of the T-cell pop u la tion in the
skin and sup ported the hy poth e sis that TARC and
CTACK were in de pend ent lym pho cyte-at tract ing
chemokines in AD. We fur ther showed that intrader -
mal in jec tion of TARC into the skin of BALB/c mice
did re sult in ac cu mu la tion of CD4+ lym pho cytes in
the skin. Ob ser va tions in di cated that CCR4+ cells
were pre dom i nantly of the Th2 type, whereas the
CCR10+ cells were of both Th1 and Th2 sub set.
TARC could en hance tu mor necrotizing fac tor-a-in -
duced CTACK pro duc tion, which suggested a pos -
si ble mech a nism for the shift from a Th2 re sponse
in the acute phase in AD to a mixed Th1/Th2 re s -
ponse in the more chronic phase of AD.
O 6
KERATINOCYTES CON TRIB UTE TO
IN FLAM MA TORY CIR CUITS IN ATOPIC
DER MA TI TIS
S. Pastore, G. Girolomoni
Lab o ra tory of Im mu nol ogy, Istituto Dermopatico
dell’Immacolata, IRCCS, Rome, It aly
Atopic der ma ti tis (AD) re sults from a com plex in -
ter play of en vi ron men tal, ge netic, im mu no logic,
and bio chem i cal fac tors. Rel e vant to the am pli fi ca -
tion and per sis tence of in flam ma tory and im mune
re sponses in AD skin is the con tri bu tion of kera tino -
cytes, which can be in duced to se crete pro-in flam -
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ma tory me di a tors in re sponse to trig ger ing fac tors
in clud ing the epi der mal bar rier per tur ba tion char ac -
ter iz ing this dis ease and the po tent cytokines re -
leased by in fil trat ing leu ko cytes. More over, kerati -
no cytes from AD pa tients syn the size ex ag ger ated
amounts of me di a tors in volved in the en hanced re -
cruit ment as well as sus tained sur vival and ac ti va -
tion of den dritic cells and T cells. A dysregulated
cytokine pro duc tion by ep i the lial cells can be pri -
mar ily in volved in the pathophysiology of atopic dis -
eases. The bio chem i cal mech a nisms un der ly ing
ex ces sive pro duc tion of pro-in flam ma tory me di a -
tors by ep i the lial cells are prob a bly mul ti ple. Ex per i -
men tal ev i dence in di cates that AD keratinocytes
have a con sti tu tive dysregulated ac tiv ity of spe cific
con stit u ents of AP-1 com plex, crit i cally im pli cated
in the con trol of the ex pres sion of nu mer ous in flam -
ma tory genes, sug gest ing the ex is tence of ge net i -
cally pre de ter mined mech a nisms tar get ing atopic
in flam ma tion to the skin. Data ob tained by microar -
ray tech nol ogy are cur rently un der in ves ti ga tion
aim ing to de tect rel e vant keratinocyte-spe cific mo -
lec u lar mark ers of the dis ease. In as much as ep i the -
lial cells are an eas ily ac ces si ble target for ther a -
peu tic intervention, studies on the mechanisms that 
regulate expression of inflammatory genes in
epithelial cells may ultimately afford new strategies
for the control of AD.
O 7
THE ROLE OF DEN DRITIC CELLS IN
ATOPIC DER MA TI TIS
N. Novak, T. Bieber
De part ment of Der ma tol ogy, Uni ver sity of Bonn, Ger many
Atopic der ma ti tis (AD) pres ents as a chronic re -
laps ing skin dis ease with a char ac ter is tic phe no -
type and typ i cally dis trib uted skin le sions, which of -
ten make the di ag no sis of AD very sim ple and
clear-cut. In con trast, the un der ly ing pathophysiolo -
gi cal and ge netic mech a nisms lead ing to the man i -
fes ta tion of AD are of ten not ob vi ous. Chal lenged
by this puz zle, sci en tific ap proaches of the last
years have made con sid er able prog ress in gain ing
in sights into the com plex ity of the mech a nisms
caus ing AD. This biphasic in flam ma tory skin dis -
ease is char ac ter ized by an ini tial phase pre dom i -
nated by Th2 cytokines and a sec ond and more
chronic ec zem a tous phase dom i nated by Th1. Two
dif fer ent den dritic cell sub types bear ing high-af fin ity 
re cep tors for IgE (FceRI) have been iden ti fied in the
skin of AD pa tients: FceRI-high Langerhans cells
(LC) and FceRI high-in flam ma tory den dritic epi der -
mal cells (IDEC). These two den dritic cell sub types
are sup posed to con trib ute dis tinctly to the biphasic
na ture and the out come of T-cell re sponses in AD.
In con trast, plasmacytoid den dritic cells, which
have only re cently been shown to bear the high-af -
fin ity re cep tor for IgE and which play an im por tant
role in the de fense against vi ral in fec tions, are
nearly ab sent from the skin le sions of AD pa tients.
At pres ent, it seems that dif fer ent IgE-re cep tor
bear ing den dritic cell sub types in the blood and the
skin of AD pa tients play a piv otal role in the com plex 
pathophysiological net work of AD.
O 8
ATOPIC DER MA TI TIS CAN BE AL LER GIC –
BUT WHEN?
C. Bindslev-Jensen
Al lergy Cen ter, De part ment of Der ma tol ogy, Odense Uni ver -
sity Hos pi tal, Odense, Den mark
Ab stract not re ceived.
O 9
THE NAT U RAL HIS TORY OF ATOPIC
DER MA TI TIS
T. Diepgen
De part ment of Clin i cal So cial Med i cine, Oc cu pa tional and
En vi ron men tal Der ma tol ogy, Uni ver sity Hos pi tal of Hei del -
berg, Hei del berg, Ger many
Ab stract not re ceived.
O 10
IN TRIN SIC VS. EX TRIN SIC ATOPIC
DER MA TI TIS: DI AG NOS TIC DEF I NI TION
AND PREV A LENCE
S. Seidenari, F. Giusti
De part ment of Der ma tol ogy, Uni ver sity of Modena and
Reggio Emilia, It aly
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Our aim was to in ves ti gate the cri te ria for clas si -
fi ca tion of pa tients with atopic der ma ti tis (AD) into
those with the “in trin sic” vs. “ex trin sic” form, and to
eval u ate the fre quency of these to AD types among
our pop u la tion. We per formed skin prick tests in
282 pa tients with AD, 117 men and 165 women.
The skin prick tests con sisted of 2 pan els of al ler -
gens: panel 1 with 11 and panel 2 with 66 sub -
stances, re spec tively. We ob served 171 (61%) pos -
i tive re sponses to panel 1 and 189 (67%) pos i tive
re ac tions to panel 2, im ply ing that a dif fer ent per -
cent age of our pa tients could be con sid ered af -
fected by an ex trin sic form of AD, ac cord ing to the
num ber of tested al ler gens. More over, atopy patch
tests with 20 aeroallergens and food al ler gens were 
per formed in all pa tients. Among the sub jects with
neg a tive prick tests (93 “in trin sic” cases), 68 re -
acted to atopy patch tests in di cat ing a de layed “ex -
trin sic” in flu ence of al ler gens on the der ma ti tis.
Thus, only 9% of our study pop u la tion could be
clas si fied as af fected by in trin sic AD on the ba sis of
skin test re sults. Fi nally, in 18 sub jects from the in -
trin sic group, we per formed oral chal lenges with
pea nut, cow’s milk, and egg, and ob served a pos i -
tive re sponse to egg in a sin gle case – it was one
more pa tient that shifted from the in trin sic to the ex -
trin sic group. In con clu sion, our data proved that the 
prev a lence of the in trin sic form of AD might be
overestimated in case of in ad e quate di ag nos tic
work-up.
O 11
THE ROLE OF MAST CELLS IN ATOPIC
DER MA TI TIS
T. Zuberbier
De part ment of Der ma tol ogy and Al lergy, Charité Uni ver sity
Hos pi tal – Humbolt Uni ver sity, Berlin, Ger many
For a long time mast cells have been sus pected
to play a role in atopic der ma ti tis (AD), es pe cially
be cause ap prox i mately 80% of AD pa tients show
in creased con cen tra tions of IgE and spe cific sen si -
ti za tion against food or aeroallergens. How ever,
their role has been dis puted since older an ti his ta -
mines showed lit tle ef fect on pru ri tus and skin sym -
p toms of ec zema in AD pa tients. Re search then fo -
cused on the role of T-cells in the patho genesis of
AD, and in the last years cross-links be tween
T-cells and mast cells have been de scribed. It has
been shown that mast cells pro duce a num ber of
pro-in flam ma tory cytokines, such as interleukin-13,
in skin le sions of AD pa tients. The se cre tion of
these non-his ta mine me di a tors can be in duced not
only by IgE-cross-link ing, but also by other non-IgE
de pend ent stim uli. Fur ther more, the close in ter ac -
tion of mast cells and sen sory nerves has been de -
scribed re peat edly. In con clu sion, new ev i dence
suggests that mast cells may play a sig nif i cant role
as one of the pathogenetic fac tors in atopic ec zema.
2. CUR RENT AP PROACH TO AL LERGY
O 12
NEUROIMMUNOLOGICAL IN TER AC TIONS 
IN ATOPIC DER MA TI TIS – EV I DENCE FOR
NEURODERMATITIS?
A. Kapp, U. Raap
De part ment of Der ma tol ogy and Allergology, Hanover Med i -
cal Uni ver sity, Ger many
Many re cent stud ies have in ves ti gated im mu no -
log i cal in ter ac tions in atopic der ma ti tis or neuro -
dermitis. In flux of ac ti vated CD4+ T-lym pho cytes
and eosinophils and an in crease in an ti gen-pre -
sent ing Langerhans-cells, which are im por tant
play ers of in flam ma tory ac tions, rep re sent a hall -
mark of lesional skin in atopic der ma ti tis (AD). Un -
like in other al ler gic dis eases, cytokines of the Th2
as well as Th1 type are im por tant me di a tors in AD.
In acute AD le sions, Th2 cytokines, such as inter -
leukin (IL)-4, IL-5, and IL-13 may be de tected,
whereas chronic le sions are char ac ter ized by a
Th1-cytokine pat tern, such as in ter feron (IFN)-g. It
is not clear whether the in ter ac tion of pe riph eral
nerves and im mune cells plays a role in AD. Char -
ac ter is tic fea tures and strong pru ri tus in the acute
and chronic re cur rent in flam ma tory skin le sions
strongly sug gests that, from the clin i cal point of
view, the ac ti va tion of the ner vous sys tem must
con trib ute to the pathophysiology of AD. The term
“neurodermitis”, de fined by Brocq at the end of the
19th cen tury, had al ready sug gested a neurogenic
rea son be hind the pathophysiology of AD. In deed,
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the den sity of nerve fi bers in sub acute AD, as well
as lichenified and prurigo le sions, are sig nif i cantly
more pro nounced than in un in volved skin. More -
over, the nerve di am e ter in AD pa tients is higher
than in non-atopics. Bulg ing of ax ons with many mi -
to chon dria and a loss of their sur round ing sheath of
Schwann cells sug gests that free nerve end ings in
skin le sions of AD are in an ac tive state of ex ci ta -
tion. Nerve hy per tro phy and hy per pla sia is fre -
quently ob served in AD, which is why the func tion of 
the neurotrophin nerve growth fac tor (NGF) is of
spe cial in ter est, as basal keratinocyte-de rived NGF 
in duces hy per tro phy of pe riph eral nerve fibres. AD
pa tients of ten suf fer from se vere pru ri tus. The mod -
u la tors of pru ri tus are neuropeptides, such as sub -
stance P and a subpopulation of re cep tive nerve
end ings of unmyelinated C-fi bers. NGF in duces
sub stance P pro duc tion in sen sory neu rons. The
role of pe riph eral nerves in lo cal in flam ma tion in AD
is em pha sized by the de tec tion of neuropeptide-po -
s i tive nerve fi bers, con tain ing sub stance P and
calci tonine gene-re lated pep tide (CGRP), es pe -
cially in skin le sions. Re cently, a de creased electro -
ni cal per cep tion thresh old of skin nerves has been
shown in AD pa tients. This hy per-re spon sive ness
could very likely be the ex pla na tion for the nerve hy -
per-re ac tiv ity to un spe cific stim uli, such as wool
clothes, re sult ing in the de vel op ment of pru ri tus and 
in flam ma tion. Psy cho log i cal stress, scratch ing, and 
un spe cific stim uli of ten re sult in an ag gra va tion of
AD. As pe riph eral nerves, neurotrophins, and neu -
ro peptides are in creased in AD skin le sions, it is
very likely that these neuronal com po nents mod u -
late lo cal in flam ma tion.
To sum ma rize, neuronal as pects gain in creas -
ing in ter est and im por tance in the reg u la tory mech -
a nisms of AD and pres ent a broad spec trum of new
ther a peu tic as well as in ves ti ga tive op tions. We,
there fore, think that the old term “neurodermitis”
char ac ter izes better this chronic inflammatory skin
disease.
O 13 
NEW DE VEL OP MENTS IN ATOPIC EC ZEMA
T. Ruzicka
De part ment of Der ma tol ogy, Uni ver sity of Düsseldorf, Ger -
many
Atopic ec zema af fects ap prox i mately 10-20% of
chil dren and 1% of adults in west ern Eu rope. The
dis ease is multifactorial and re quires an in te grated
ther a peu tic ap proach tak ing into ac count its com -
plex pathophysiology. New in sights have been
gained into the mech a nism of in flam ma tion in
atopic der ma ti tis. The re cruit ment of leu ko cytes into 
the dermis is brought about by the in ter ac tion of
chemokines and their cor re spond ing re cep tors.
Drugs aim ing at chemotactic mech a nisms are be -
ing de vel oped. Ma jor steps for ward have been
made in the ther a peu tic sec tor. UVA-1 ir ra di a tion
has shown ben e fi cial in se vere cases. For in ter me -
di ate to se vere form of dis ease, top i cal tacrolimus
can be re garded as a break through. An other break -
through has been achieved in the field of hand ec -
zema, which was a ma jor ther a peu tic prob lem. A
con trolled dou ble-blind study showed allitretinoin
(9-cis-retinoid acid) to be highly ef fec tive.
O 14
THE SIG NIF I CANCE OF MALASSEZIA
FURFUR IN ETIOPATHOGENESIS OF
ATOPIC DER MA TI TIS
Z. Bukviæ Mokos, J. Lipozenèiæ, A. Basta-
 Juzbašiæ, M. Skerlev
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb, Croatia
The aim of the study was to de ter mine the sig nif -
i cance of M. furfur in the etiopathogenesis of atopic
der ma ti tis. The study in cluded 50 pa tients with
atopic der ma ti tis, 50 pa tients with seborrheic der -
ma ti tis, and 30 healthy examinees as a con trol
group. Im me di ate and con tact hy per sen si tiv ity were 
de ter mined by skin prick test and patch test, which
were car ried out with wa ter-sol u ble ex tract of M.
furfur (pro tein con cen tra tion of 5 mg/mL). Skin prick 
test to M. furfur was pos i tive in 27 of 50 pa tients with 
atopic der ma ti tis, 9 of 50 pa tients with seborrheic
der ma ti tis, and only in a sin gle healthy con trol sub -
ject. Pos i tive re ac tions to patch test to M. furfur
were ob served in 7 pa tients with atopic der ma ti tis.
and in none of the pa tients with seborrheic der ma ti -
tis and healthy con trols. Pos i tive re ac tions to skin
prick test were sig nif i cantly more fre quent among
the pa tients with atopic der ma ti tis than in the other
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two groups of examinees (p<0.05); the same re sult
was ob tained for patch test re sults. Pre sent study
proved the role of im me di ate and con tact hy per sen -
si tiv ity to M. furfur in ex ac er ba tion of atopic der ma ti -
tis, but not in seborrheic der ma ti tis.
O 15
AN TI GEN-SPECIFICITIES AND FUNC TIONS 
OF T-LYM PHO CYTES IN ATOPIC
EC ZEMA/DER MA TI TIS SYN DROME
T. Werfel
De part ment of Der ma tol ogy and Allergology, Hanover Med i -
cal Uni ver sity, Hanover, Ger many
T-lym pho cytes rep re sent the ma jor ity of skin-in -
fil trat ing cells in atopic ec zema/der ma ti tis syn -
drome (AEDS). When stained with immunohisto -
chemical tech niques, the mononuclear in fil trate in
lesional skin of AEDS is sim i lar to that of al ler gic
con tact der ma ti tis, ie, a T-cell me di ated al ler gic skin 
dis ease char ac ter ized by a de layed type hy per sen -
si tiv ity re ac tion. CD4+ T-helper cells dom i nate the
cel lu lar in fil trate and many intralesional T-cells
show signs of ac ti va tion, as de fined by the mem -
brane ex pres sion of interleukin (IL)-2R a and
HLA-DR mol e cules. Pa tients suf fer ing from this dis -
ease also have in creased con cen tra tions of ac ti -
vated cir cu lat ing T-cells, L-selectin, and the se cre -
tory IL-2R, which are the mark ers of lym pho cyte ac -
ti va tion and cor re late with dis ease se ver ity. The
num ber of CD4+ cells is in creased, and CD8+ sup -
pres sor/cytotoxic lym pho cytes are de creased in
pe riph eral blood. How ever, psy cho log i cal stress
has re cently been shown to lead to sig nif i cantly
higher in creases in the num ber of cir cu lat ing CD8+
T-lym pho cytes in AD pa tients com pared to healthy
con trols. The ma jor ity of al ler gen-spe cific T cells
de rived from skin le sions that had been pro voked in
pa tients with AEDS by epicutaneous ap pli ca tion of
in hal ant al ler gens was found to pro duce pre dom i -
nantly Th2 cytokines, such as IL-4 or IL-5. This was
con sid ered to be a spe cific fea ture re flect ing im -
mune dysregulation in AD. How ever, po lar ized type
2 cytokine pat tern is con fined to atopy patch test
sites since al ler gen-spe cific T cells in the blood and
in chronic skin le sions of the same pa tients se crete
both type 1 and type 2 cytokines. The type 1 cytoki -
ne in ter feron (IFN)-g seems to be par tic u larly im por -
tant for the per pet u a tion of the cu ta ne ous in flam ma -
tory re ac tion. Be sides in hal ant al ler gens, foods are
well-es tab lished trig ger fac tors of atopic der ma ti tis.
The stud ies into the role of food-spe cific T-lym pho -
cytes in these pa tients have shown that, by use of
lim it ing di lu tion cul tures, al ler gen-spe cific T cells
rep re sent only a mi nor ity (1-5%) of in fil trat ing T-
 cells in lesional skin. There fore, other fac tors lead -
ing to the ac ti va tion of T-cells at the site of in flam -
ma tion (e.g., autoallergens, bac te rial cell wall com -
po nents, and exotoxines) are prob a bly in volved in
the pathogenesis of AEDS.
O 16
MECH A NISM OF ATOPIC EC ZEMA
K. Blaser
Swiss In sti tute of Al lergy and Asthma Re search, Davos,
Swit zer land
Ab stract not re ceived.
O 17
MICROMORPHOLOGY OF ATOPIC
DER MA TI TIS
I. Dobriæ, J. Radoš
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb, Croatia
Atopic der ma ti tis (AD) has a typ i cal spec trum of
acute, sub acute, and chronic phases as seen in
some other spongiotic (ec zem a tous) pro cesses. Bi -
opsy, al though rarely used to di ag nose atopic der -
ma ti tis, may yield find ings in dis tin guish able from
those seen in nummular der ma ti tis and al ler gic con -
tact der ma ti tis. The di ag no sis of atopic der ma ti tis is
made on the ba sis of a con stel la tion of ma jor and
mi nor clin i cal fea tures. De pend ing on the clin i cal
stage of the dis ease, ei ther acute spongiotic der ma -
ti tis or more chronic pro cess with re ac tive epi der -
mal changes may be found. Acute le sions show
spongiosis, some spongiotic vesiculation, mod er -
ate intracellular edema, exocytosis of lym pho cytes,
a perivascular in fil trate of lym pho cytes and macro -
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pha ges around ves sels of the su per fi cial plexus,
and oc ca sional eosinophils. Sub acute le sions show 
ir reg u lar acanthosis with pos si ble epi der mal pso -
riasi form hy per pla sia. With in creas ing chronicity of
the le sions, the changes of rub bing and scratch ing
be come more and the spongiosis less ob vi ous.
Chronic le sions show hyperkeratosis, mod er ate to
pro nounced psoriasiform hy per pla sia, and vari able
but usu ally only mild spongiosis. Mast cells are now
sig nif i cantly in creased in the su per fi cial perivas cu -
lar in fil trate. Small ves sels ap pear prom i nent due to
an in crease in their num ber and thick en ing of their
walls. Langerhans cells are in creased in both the
epi der mis and dermis. With fur ther lichenification of
the le sions, there is prom i nent hyperkeratosis and
some vertical streaking of collagen in the papillary
dermis – the changes recognized as lichen simplex
chronicus.
O 18
THE ROLE OF AIR BORNE AL LER GENS IN
THE ETIOPATHOGENESIS OF ATOPIC
DER MA TI TIS
W. Silny, M. Czarnecka-Opereacz
De part ment of Der ma tol ogy and Al ler gic Dis eases, Di ag -
nos tic Cen ter, Uni ver sity of Med i cal Sci ences, Poznañ, Po -
land
Atopic der ma ti tis (AD) is a chronic and re cur rent
in flam ma tory skin dis ease, which af fects ap prox i -
mately 12-24% of the Eu ro pean pop u la tion. In
about 10-20% of all cases mod er ate or se vere clin i -
cal course is ob served. Up to 60% of pa tients with
AD may de velop atopic re spi ra tory dis or ders. Dur -
ing the past 40 years, we have seen a pro nounced
in crease in the prev a lence of AD in the in dus tri al -
ized world and re search has largely been di rected
to wards the eti ol ogy of this dis ease. Ge netic in -
volve ment is an im por tant fac tor that may pre dis -
pose cer tain in di vid u als to de velop AD. How ever,
more data on the role of ge net ics in the de vel op -
ment of AD is re quired. Pa tients with AD show an
ab er rant T-cell-me di ated im mune re sponse, in -
creased se rum IgE con cen tra tions, and eosinop -
hilia. Th2-re lated cytokines re lease pre dom i nates
in the acute phase and Th1 lym pho cytes pre dom i -
nate in the chronic phase of the dis ease. The early
on set of AD sug gests that the en vi ron ment may be
of im por tance for the de vel op ment of the dis ease. It
seems that par tic u larly ex po sure to the early en vi -
ron ment, de fined as the time from con cep tion of the
child un til the end of the third year of life, may be
cru cial. Fac tors in our en vi ron ment that may in flu -
ence the de vel op ment and ex pres sion of AD are re -
lated to al ler gen ex po sure – air borne and di etary al -
ler gens, in fec tions, vac ci na tions, and oth ers. Al ler -
gen ex po sure re sults in an in creased risk of sen si ti -
za tion and in ap prox i mately 50-80% of pa tients with 
AD, we are able to prove an IgE-me di ated type of
al lergy. Air borne al lergy seems to be of spe cial im -
por tance in cases of AD pa tients, both adults and
chil dren. Such pa tients tend to pres ent with se vere
course of the dis ease and atopic in volve ment of re -
spi ra tory sys tem. Air borne al ler gens, such as
house dust mites, plant pol len al ler gens, moulds,
an i mal-de rived al ler gens, and bac te rial al ler gens,
may be re spon si ble for ex ac er ba tions of skin in -
flam ma tion in AD pa tients on the ba sis of an
IgE-me di ated con tact re ac tion. Our knowl edge on
this phenomenon is still incomplete, but from the
clinical point of view, we should diagnose patients
with AD towards airborne IgE-mediated allergy in
order to propose the most appropriate type of
treatment.
O 19
SE RUM EOSINOPHIL CATIONIC PRO TEIN
(ECP) IN CHIL DREN WITH ATOPIC
DER MA TI TIS
S. Murat-Sušiæ, J. Lipozenèiæ, V. Žižiæ1, K.
Husar
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter; and 1Chil dren’s Hos pi tal, Zagreb,
Croatia
Eosinophil cationic pro tein (ECP) is a cytotoxic
agent se creted by ac ti vated eosinophils dur ing al -
ler gic and in flam ma tory pro cesses. The main aim of 
the study was to de ter mine the ex is tence of cor re la -
tion be tween ECP se rum con cen tra tions and clin i -
cal se ver ity (eval u ated by SCORAD in dex), as well
as some rel e vant lab o ra tory find ings, in chil dren
with atopic der ma ti tis (AD). The study in cluded 70
chil dren, 49 with AD aged 3-36 months, and 21
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non-atopic chil dren of the same age as a con trol
group. De tailed his tory, se rum ECP con cen tra tions
(UniCAP FEIA), rel a tive and ab so lute eosinophil
counts, and to tal se rum IgE an ti bod ies were de ter -
mined in both groups. The skin in volve ment was
mea sured by SCORAD in dex in AD chil dren. The
cal cu lated SCORAD in dex was be tween 16 and 83. 
IgE an ti bod ies, rel a tive and ab so lute eosinophil
counts showed a wider range of val ues and a sig nif -
i cantly higher me dian (p<0.001) in the AD pa tients
than in the con trol group. The se rum ECP me dian
con cen tra tion in chil dren with AD was 16.2 mg/L
com pared with 5.92 mg/L in the con trol group. The
cor re la tion of SCORAD in dex and se rum ECP con -
cen tra tions was neg a tive, weak (r= -0.0655), and
not sig nif i cant. The same was found for the cor re la -
tion be tween se rum ECP and in ten sity of skin
changes (r= -0.0952) and sub jec tive symp toms
(r= -0.0451). For se rum ECP and ex tent of skin le -
sions the cor re la tion was pos i tive (r=0.0795), but
not sig nif i cantly. Al though the cor re la tion be tween
ECP and SCORAD in dex was not de ter mined in
this study, this lab o ra tory find ings as well as IgE an -
ti bod ies and eosinophils should be monitored as
they represent an additional, non-invasive lab o ra -
tory method in the evaluation, follow up, and
treatment of patients with AD.
O 20
OVER VIEW ON ETIOPATHOGENESIS OF
ATOPIC DER MA TI TIS
J. Lipozenèiæ, Z. Paštar1, S. Ljubojeviæ, T.
Batinac2
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter; 1Min is try of De fense of the Re pub lic of
Croatia, Zagreb; and 2De part ment of Der ma tol ogy, Rijeka
Uni ver sity Hos pi tal Cen ter, Rijeka, Croatia
In the etiopathogenesis of atopic der ma ti tis
(AD), there are well known in ter ac tions among ge -
netic, en vi ron men tal, skin bar rier, phar ma co logic,
stress and other emo tional prob lems and im mune
fac tors. Ge netic de ter mi nate of ex pres sion of AD,
as a pure or mixed with con com i tant re spi ra tory or
in tes tine al lergy, de pends on ge netic sus cep ti bil ity.
Al though many genes are in volved in the de vel op -
ment of al ler gic dis eases, there has been a par tic u -
lar in ter est in chro mo some 5q31-33, 3q21, 1q21,
and 17q25. Im mu no logic ab nor mal i ties of type I and 
type IV re ac tions have been de scribed in pa tients
with AD. Im mu no logic trig gers are aeroallergens,
food al ler gens, mi cro bial prod ucts, autoallergens,
and con tact al ler gens. The im mu no logic re ac tions
de ter mi nate many fea tures of AD, as well as a
cell-me di ated or de layed hy per sen si tiv ity. Type 2
(TH2) and type 1 (TH1) cytokines con trib ute to the
pathogenesis of skin in flam ma tion in AD. The cur -
rently ac cepted model pro poses a pre dom i nant
TH2 cytokine mi lieu in the ini ti at ing stages or acute
le sions of AD and a mixed TH1 and TH2 pat tern in
chronic le sions. This biphasic pat tern of T-cell ac ti -
va tion has been dem on strated af ter epicutaneous
ap pli ca tion of aeroallergens by use of patch test.
The in creased ex pres sion of interleukin (IL)-4
mRNA and pro tein, IL-5, and IL-13 may be ob -
served af ter 24 hours, when IL-4 ex pres sion starts
to de cline to ba sic lev els. In con trast, in ter feron
(IFN)-g mRNA is strongly ex pressed at the 48-72 h
time points, as de vel op ment of TH1 lym pho cytes is
me di ated by the cytokines IFN-g and IL-2. Type 2
cytokines are thought to ac count for co in ci dent
eosinophilia and in crease IgE pro duc tion and at -
trac tion of macrophages, which in turn pro duce
IL-12, a known ac ti va tor of the TH1-type im mune
re sponse sup press ing IgE pro duc tion. Thus, AD
skin con tains an in creased num ber of IgE-bear ing
Langerhans cells (LC) that, via the high-af fin ity IgE
re cep tor FCeR1, are thought to bind al ler gens, as a
ma jor IgE-bind ing re cep tor. LC play an im por tant
role in cu ta ne ous al ler gens pre sen ta tion to TH2
cells via ma jor histocompatibility mol e cules. These
bridg ings trig ger a cas cade of im mu no logic events.
In chronic AD le sions, LC are pres ent in in creased
num bers and have in creased amounts of IgE bound 
to high-af fin ity sur face re cep tors. LC have been
shown to be hyperstimulatory to helper T cells and
can ac ti vate helper T cells to the TH2 phe no type in
the ini ti at ing phase of the dis ease. Degranulation of
eosinophils oc curs in the dermis with the re lease of
toxic pro teins like ma jor ba sic pro teins and could
ac count for the in flam ma tion. Mast cells are in -
creased in num ber and pro duce me di a tors other
than his ta mine that in duce pru ri tus, and may have
an ef fect on IFN-g ex pres sion. Mast cell cytokines
IL-4 and IL-13 are im por tant for IgE pro duc tion and
mast cell chymase may in duce eosinophil in fil tra -
tion into AD lesional skin. The pro duc tion of pros ta -
118 ACTA DERMATOVENEROLOGICA CROATICA
 
Acta Dermatovenerol Croat 2004;12(2):106-140
glan din E2 (PGE2) by pe riph eral monocytes is in -
creased. Pros ta glan din E2 (PGE2) has at least two
po ten tial roles in the ini ti a tion of AD: it re duces
IFN-a pro duc tion from T helper cells thereby fa vor -
ing the ini tial pre dom i nantly TH2 im mune re sponse, 
and it di rectly en hances IgE pro duc tion by B lym -
pho cytes by in creased se cre tion of IL-4, IL-5, and
IL-13. As many le sions of AD re sult from scratch ing, 
it is tempt ing to spec u late that im mune per tur ba -
tions in ge net i cally pre dis posed in di vid u als pro voke 
the re lease of lo cal pruritogens and keratinocyte-
 de rived cytokines fur ther ex ac er bat ing the pre vi -
ously de scribed im mune re sponse.
3. IM MU NO LOGIC BA SIS OF ATOPIC
DER MA TI TIS
O 21
AS SO CI A TION BE TWEEN CD30
EX PRES SION AND ATOPIC DER MA TI TIS
D. Bobek, J. Lipozenèiæ1, O. Badovinac2, J.
Jakiæ-Razumoviæ2
De part ment of Phys i cal Med i cine, Dubrava Uni ver sity Hos -
pi tal; 1De part ment of Der ma tol ogy and Venerology; and 2De -
part ment of Pa thol ogy, Zagreb Uni ver sity Hos pi tal Cen ter,
Zagreb, Croatia
Atopic der ma ti tis (AD) is chronic pruritic in flam -
ma tory skin dis or der char ac ter ized by sev eral clin i -
cal, im mu no log i cal, and bio chem i cal al ter ations.
Atopic der ma ti tis le sions con tain TH2-like cells and
TH2 cytokines. It has been re cently re ported that
CD30, a 120 kDa mem brane-bound glycoprotein, is 
an ac ti va tion marker of T-cell clones, show ing a
TH2-re lated cytokine pat tern of pro duc tion. We in -
ves ti gated the pres ence of CD30+ cells in the
lesional skin of pa tients with atopic der ma ti tis. We
ob tained 30 bi opsy spec i mens (3-4 mm punch bi -
opsy) from var i ous skin re gions of 15 AD pa tients (7 
women and 7 men) and 15 vol un teers with healthy
skin (12 women and 3 men). The immunohisto -
chemistry peroxidase-antiperoxidase method with
monoclonal an ti bod ies was used for the anal y sis of
par af fin-em bed ded skin sec tion bi op sies, as well as 
anti-CD30, anti CD45RO+, anti-CD3, and anti-CD4
di lu tions of an ti body sera (Multi-link Swine anti
Goat-Mouse-Rab bit Immunoglobulins biotimylated, 
Dako, Co pen ha gen, Den mark). The num ber of
CD30+ cells in the whole bi opsy tis sue (x40) was
counted. A semiquantative grad ing was used. In all
bi opsy spec i mens from pa tients with acute AD,
most in fil trat ing cells were CD3+ T cells. In AD pa -
tients, high CD30 ex pres sion was ob served in a re -
mark able pro por tion of in fil trat ing cells. In the
healthy skin spec i mens, CD30+ cells were very
rare. Av er age CD30 ex pres sion was sig nif i cantly
higher in AD pa tients than in con trols (p<0.01). Our
anal y sis of CD30, CD3, and CD4 cells in skin bi op -
sies of AD pa tients showed that CD30 ex pres sion in 
AD might be help ful in histologic dif fer en ti a tion of
AD, which is in ac cor dance with the re sults ob -
tained by Caproni et al (1997) and Dumner et al
(1998). The re sults sug gested a spe cific reg u la tory
func tion of CD30+ T cells in acute atopic der ma ti tis
le sions.
O 22
FINE MAP PING OF ATOD2 IN ITAL IAN
NU CLEAR FAM I LIES
G. Novelli1,6, E. Giardina1, C. Sinibaldi1, M.
Paradisi2, C. Pedicelli2, F. Nasorri3, S.
Chimenti4, G. Marulli4, P. Rossi5, V.
Moschese5, L. Chini5, G. Girolomoni3
1De part ment of Biopathology, Tor Vergata Uni ver sity of
Rome; 2De part ment of Pe di at ric Der ma tol ogy, Istituto
Dermopatico dell’Immacolata IDI – IRCCS; 3Lab o ra tory of
Im mu nol ogy and De part ment of Immunodermatology,
Istituto Dermopatico dell’ Immacolata, IRCCS; 4De part ment
of Der ma tol ogy, Tor Vergata Uni ver sity; 5Di vi sion of Im mu -
nol ogy and In fec tious Dis eases, De part ment of Pe di at rics,
Chil dren’s Hos pi tal ‘Bambino Gesu’ and De part ment of Pe -
di at rics, Tor Vergata Uni ver sity of Rome, It aly; and 6De part -
ment of Car dio vas cu lar Med i cine, Uni ver sity of Ar kan sas for
Med i cal Sci ences, Lit tle Rock, Ark, USA
Atopic der ma ti tis (AD) is a chronic in flam ma tory
skin dis ease char ac ter ized by itchy in flamed skin
as so ci ated with cu ta ne ous er y thema, and se vere
pru ri tus. The dis ease mainly starts in early child -
hood. AD is a multifactorial dis ease trig gered by
both ge netic and en vi ron men tal risk fac tors and
twin stud ies in di cate that the ge netic con tri bu tion is
sub stan tial. Many ge nome-wide link age stud ies
mapped a num ber of sus cep ti bil ity re gions on chro -
mo somes 1q21 (ATOD2), 3q21 (ATOD1), 5q31-q33 
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(ATOD6), 13q12-q14 (ATOD5), 17q25 (ATOD4),
and 20p (ATOD3). Three of these loci (1q21, 17q25, 
and 20p) are closely co in ci dent with pso ri a sis sus -
cep ti bil ity loci, al though AD is quite dis tinct from
pso ri a sis and rarely the two dis eases oc cur to -
gether in the same pa tient. AD is likely to be in flu -
enced by the same genes that reg u late the der mal
re sponses to en vi ron men tal fac tors (like in pso ri a -
sis), in de pend ently from atopic mech a nisms. In the
last years, we mapped the pso ri a sis sus cep ti bil ity
lo cus (PSORS4) on chro mo some 1q21 and per -
formed a fine map ping of PSORS4. In this study, we 
adopted the link age dis equi lib rium ap proach to nar -
row the PSORS4 lo cus to re fine the ATOD2 sus -
cep ti bil ity lo cus. We re cruited 100 nu clear fam i lies
orig i nat ing from dif fer ent Ital ian re gions and geno -
typed them for mark ers pre vi ously shown to have
link age dis equi lib rium to pso ri a sis. Since pre lim i -
nary re sults do not seem to show close over lap be -
tween PSORS4 and ATOD2 fine-mapped sus cep ti -
bil ity lo cus, we be lieve that the clinic ho mo ge ne ity
of AD could lead to a better re fine ment of the com -
mon sus cep ti bil ity lo cus on chro mo some 1q21. In
fact, it should be kept in mind that re cent stud ies
have shown five over lap ping chro mo somal re gions
(1q21, 2q33, 5q31.1–q33.1, and 6p21, 11q13) that
co-lo cal ize with dis ease loci for the fol low ing dis -
eases: di a be tes, asthma, atopic der ma ti tis, os teo -
po ro sis, and in flam ma tory bowel dis ease (IBD). It is 
most likely that the same pre dis pos ing genes are
involved in different complex diseases. Finally, we
are focusing on association studies approach
based on maps of single nucleotide polymorphisms
to achieve the exact localization of ATOD2.
O 23
IM MU NO LOGIC FAC TORS IN VOLVED IN
ATOPIC DER MA TI TIS
L. Lugoviæ, J. Lipozenèiæ1
De part ment of Dermatovenerology, Sestre milosrdnice Uni -
ver sity Hos pi tal; and 1De part ment of Der ma tol ogy and
Venerology, Zagreb Uni ver sity Hos pi tal Cen ter, Zagreb,
Croatia
Atopic der ma ti tis (AD) is an al ler gic skin dis or der 
that oc curs in in di vid u als with atopy. It is char ac ter -
ized by im mune dis or ders of humoral (type I) and
cel lu lar (type IV) im mu nity. The aim of this study
was to eval u ate im mu no logic fac tors in the blood
and the skin le sions of AD pa tients, and to an a lyze
the pres ence of in flam ma tory cell-sur face mark ers
in the blood and skin bi op sies. The pa ram e ters for
mon i tor ing 40 pa tients with AD in cluded re sults of
cu ta ne ous tests: prick and intradermal test to
inhalatory and nu tri tive al ler gens, scratch test to
pre ser va tives and ad di tives, and epicutaneous
(patch) test to con tact al ler gens; val ues of to tal IgE,
se rum immunoglobulins (IgG, IgA, and IgM), and
dif fer ent cell mark ers in the sera (CD3, CD4, CD8,
CD20, CD21, CD23, and HLA-DR). We also an a -
lyzed the pres ence of in flam ma tory cell-sur face
mark ers (CD3, CD4, CD8, CD20, CD20, CD1a,
CD23, CD29, CD45Ro, and in ter feron [IFN]-g+
mark ers) in the bi op sies of skin le sions from 10 AD
pa tients and 5 healthy con trols by immunohisto -
chemical anal y sis (method of avidin-bi o tin immuno -
pe ro xidase). The re sults showed mostly pos i tive
skin tests (prick 9/13, intradermal 24/27, scratch
23/40, and patch 26/40 tests), high val ues of IgE
(29/40), and mainly nor mal val ues of IgG, IgA, IgM
in AD pa tients. In con trast to healthy con trols, AD
pa tients had sig nif i cantly in creased CD23+cells
and sig nif i cantly de creased CD21+ cells (p<0.05).
Sta tis ti cally sig nif i cant dif fer ence was found be -
tween the two groups for higher ex pres sion of CD3,
CD21, CD23 in the blood, for CD3, CD4, CD8,
CD29, CD45Ro, IFN-g + mark ers in the skin, and
intraepidermal CD23+ and intradermal CD1a+ cells 
in AD pa tients. We con cluded that dif fer ent im mu -
no log i cal fac tors in the pe riph eral blood and within
the skin in AD pa tients might be me di ated by both
type I and IV hypersensitivity mech a nisms.
4. DI AG NOS TIC STATE OF THE ART IN
ATOPIC DER MA TI TIS
O 24
DI AG NO SIS OF FOOD AL LERGY IN
IN FANTS WITH ATOPIC EC ZEMA US ING
SKIN PRICK AND PATCH TESTS
K. Turjanmaa
De part ment of Der ma tol ogy and Venerology, Tampere, Fin -
land
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The prev a lence of atopic dis eases is in creas ing
world wide. Food al ler gies are the ear li est man i fes -
ta tion of atopy. Atopic ec zema af fects about 18% of
in fants in the first two years of life and the main
cause is al lergy to mul ti ple foods. A strong as so ci a -
tion has been shown be tween atopic ec zema and
IgE-me di ated al lergy to milk, egg or pea nut, but
more than two-thirds of pa tients in tol er ant to food
pro teins show no ev i dence of IgE sen si ti za tion to
the rel e vant food pro tein. Re cently, patch test ing
with pro teins has been found to be help ful in di ag -
nos ing food al lergy in cases where skin prick tests
(SPT) and es ti ma tion of spe cific IgE-an ti bod ies
have failed. The meth od ol ogy of atopy patch test ing 
(APT) with foods has not been stan dard ized, and
con tra dic tory re sults have been re ported. In con -
trast to the more stan dard ized APT meth od ol ogy
with aeroallergens, the sen si tiv i ties and specificities 
of food al ler gens can eas ily be es ti mated with food
chal lenge tests. In multi-al ler gic chil dren, per form -
ing APTs in ad di tion to the SPTs and es ti ma tion of
spe cific IgE an ti bod ies gives more in for ma tion for
plan ning of a suf fi ciently wide elim i na tion diet to get
the skin and gas tro in tes ti nal tract free of symp toms
in or der to per form the chal lenge test, which re -
mains the only re li able test for food al lergy. Hill et al
(1999) in tro duced the term “mul ti ple food pro tein in -
tol er ance of in fancy”, whereby more than two-thirds 
of their pa tients in tol er ant to food pro teins showed
no ev i dence of IgE sen si ti za tion to the rel e vant food 
pro tein. There fore, new di ag nos tic meth ods are
needed since chal leng ing with ev ery sus pected
food is not pos si ble. At the Tampere Uni ver sity Hos -
pi tal, all in fants un der two years with atopic ec zema
and/or gas tro in tes ti nal dis or ders are tested on a
reg u lar ba sis with SPT for milk, egg, soy, pea, fish,
nat u ral rub ber la tex, po tato, ba nana, ha zel nut,
mus tard, cat, birch pol len, wheat, bar ley, rye, oat,
rice, corn, mil let, and buck wheat. The APT in cludes
milk pow der, lyophilized egg white, soy flour, wheat, 
bar ley, rye, and oat with microcristalline cel lu lose as 
a neg a tive con trol. To tal IgE and the ma jor spe cific
IgE-an ti bod ies are also es ti mated. Open oral chal -
lenge tests of one-week du ra tion are rou tinely
made with milk and wheat. Small co horts an a lyzed
from our ma te rial (Majamaa et al; 1998, 1999) give
a sen si tiv ity of 14% and a spec i fic ity of 98% for milk
SPT and 44% and 71% for APT, re spec tively. In in -
fants pos i tive to wheat chal lenge the cor re spond ing 
num bers with SPT were 23% and 100%, with APT
86% and 35%. Niggemann (2000) and Strömberg
(2002) ob tained better re sults for sen si tiv ity and
spec i fic ity us ing APTs for chil dren with atopic ec -
zema. Boissieu et al (2003) also re ported sim i lar re -
sults for study ing cow’s milk al lergy with di ges tive
symp toms. Test ing with prick-prick method for sen -
si ti za tion of fruit and veg e ta bles has given much rel -
e vant in for ma tion in small chil dren. Test ing with raw 
po tato gave pos i tive SPT re sults in 15 out of 146
chil dren un der two years in 2000, and in 12 out of
123 in 2001 at our clinic. Ec zema symp toms were
in duced by cooked po tato in some these chil dren
(Majamaa et al, 2001). It can be con cluded that in
chil dren with atopic ec zema and/or gas tro in tes ti nal
symp toms, al lergy to foods is the most com mon
cause of skin symp toms, al lergy to an i mal dan der
be ing the next most com mon cause. De vel op ment
of new and better skin and se rum tests and their
rou tine use in in fancy can be rec om mended to de -
tect all pos si ble al ler gens.
O 25
RE SULTS OF PATCH AND PRICK TEST ING
WITH EGG, MILK AND PEA NUT IN
PA TIENTS WITH ATOPIC DER MA TI TIS
S. Seidenari, F. Giusti
De part ment of Der ma tol ogy, Uni ver sity of Modena and
Reggio Emilia, It aly
At the De part ment of Der ma tol ogy in Modena,
251 pa tients with atopic der ma ti tis (AD) of mean
age of 12.6 years un der went patch and prick test ing 
with egg, cow’s milk, and pea nut. Pos i tive re -
sponses to atopy patch tests were ob served in
24%, 11%, and 19% of cases, re spec tively, where -
as skin prick tests proved pos i tive in 10%, 7%, and
12% of pa tients. Rel e vance of pos i tive skin tests re -
sponses was as sessed by re peated open chal -
lenges with egg, cow’s milk, and pea nut, per formed
in 112, 103, and 132 cases, re spec tively. Sen si tiv ity
val ues of atopy patch tests for the iden ti fi ca tion of
food al ler gic AD pa tients ranged from 44% (milk) to
75% (pea nut), whereas spec i fic ity val ues var ied be -
tween 82% (egg) and 91% (milk). As re gards skin
prick tests, sen si tiv ity ranged from 19% (milk) to
48% (egg) and spec i fic ity from 90% (pea nut) to
95% (both egg and milk). Whereas spec i fic ity fig -
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ures were high for both prick and patch tests, we
ob served lower sen si tiv ity for the for mer. From our
find ings it is ad vis able to in clude atopy patch tests
with food allergens in the routine diagnostic work-
 up of AD patients.
O 26
USE OF CAST-ELISA TEST IN THE
DI AG NO SIS OF ATOPIC DER MA TI TIS
V. Milavec-Puretiæ, M. Rudolf1, J. Lipozenèiæ,
B. Malenica1
De part ment of Der ma tol ogy and Venerology; and 1Di vi sion
of Im mu nol ogy, Clin i cal In sti tute of Lab o ra tory Di ag no sis,
Zagreb Uni ver sity Hos pi tal Cen ter, Zagreb, Croatia
Atopic der ma ti tis (AD) is a com mon, in flam ma -
tory skin dis ease that af fects 10-20% of the pop u la -
tion and usu ally rep re sents the first man i fes ta tion of 
atopy in in fancy. Al though al ler gen-spe cific T-cells
and im mu no glob u lin E (IgE) are in volved in the clin -
i cal re sponses to in hal ant and food al ler gens, iden -
ti fi ca tion of rel e vant al ler gens is usu ally very dif fi -
cult. In this study, we in ves ti gated the di ag nos tic po -
ten tial of cel lu lar an ti gen stim u la tion test (CAST) in
the di ag no sis of hy per sen si tiv ity re ac tions to in hal -
ant and food al ler gens in pa tients with atopic der -
ma ti tis. CAST-ELISA is based on the de ter mi na tion
of sulfidoleukotrienes re lease by re ac tive cells af ter
al ler gen-spe cific stim u la tion in vi tro. We stud ied 28
pa tients with al ler gic re ac tion to the fol low ing al ler -
gens: Der p, Der f, grass polen, milk, egg, and soya. 
We found that 18 out of 26 pa tients had pos i tive
CAST to Der p, 10 out of 16 pa tients to Der f, 7 out of 
7 to grass pol len, 4 out of 17 to milk, 7 out of 18 to
egg, and 4 out of 10 to soya. Our data showed that
CAST-ELISA was more sensitive for diagnosing
hypersensitivity reaction to inhalant than to food
allergens in patients with AD.
O 27
HY PER SEN SI TIV ITY TO FOOD AD DI TIVES
IN ADULT ATOPIC PA TIENTS
S. Ljubojeviæ, J. Lipozenèiæ, V. Milavec-
 Puretiæ
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb, Croatia
Ad di tives and pre ser va tives added to food can
be broadly sep a rated ac cord ing to their func tions,
but a sin gle ad di tive may per form a va ri ety of de -
fined func tions. There are thou sands of agents that
are added to food we con sume. These in clude pre -
ser va tives, sta bi liz ers, con di tion ers, col or ings, fla -
vor ings, sweet en ers, an ti ox i dants, and many oth -
ers. Food di a ries and avoid ance of some prob lem
foods may be help ful in avoid ing ex ac er ba tion of al -
ler gic re ac tion. Only a small num ber of them can in -
duce a wide range of ad verse re ac tions in sen si tive
in di vid u als (pa tients with atopy, ur ti caria, angioed -
ema, rhinoconjunctivitis, asthma, or gas tro in tes ti nal 
dis tur bances), as well as in some “healthy” in di vid u -
als. Our study in cluded 123 adult (48 men and 75
women) pa tients with atopic der ma ti tis. Scratch test 
to food ad di tives and pre ser va tives was per formed
in all 123 pa tients. Food pre ser va tives and ad di -
tives panel in cluded acetylsalicylic acid, so dium
ben zo ate, po tas sium meta bi sul fite, tartrazine, cit ric
acid, so dium glu ta mate, and glutaraldehyde. Fifty-
 three (43%) pa tients had pos i tive skin tests to at
least one com pound, whereas 70 (57%) were neg -
a tive. Most pa tients were pos i tive to so dium ben zo -
ate (24%), acetylsalicylic acid (20%), and glutara -
ldehyde (14%), whereas a smaller per cent age of
pa tients were pos i tive to po tas sium meta bi sul fite
(11%), cit ric acid (7%), and so dium glu ta mate (7%).
The low est per cent age of pa tients was sen si tive to
tartrazine (3%). Now a days, the sen si tiv ity to food
ad di tives is be com ing more and more fre quent. We
sug gest test ing of all sus pected in di vid u als, par tic u -
larly pa tients with atopy to food ad di tives and pre -
ser va ti ves.
5. PRE VEN TION OF TRIG GER
FAC TORS IN ATOPIC DER MA TI TIS
O 28
PUB LIC AND PRO FES SIONAL ED U CA TION 
PRO GRAMS ON ATOPIC DER MA TI TIS: A
COM MU NITY-BASED AP PROACH TO
PRE VEN TION AND RE DUC TION OF
SE VER ITY
R. Marks
Uni ver sity of Mel bourne De part ment of Med i cine (Der ma tol -
ogy), St. Vin cent’s Hos pi tal Mel bourne; Skin and Can cer
Foun da tion, Mel bourne, Aus tra lia
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Com mu nity-based ep i de mi o log i cal stud ies on
the fre quency of atopic der ma ti tis re veal that the
dis ease fre quency is high, par tic u larly in young chil -
dren, in Aus tra lia. Stud ies re port ing on the mor bid -
ity and cost of hav ing atopic der ma ti tis in Aus tra lia
also show that the dis ease causes con sid er able
mor bid ity and con sid er able cost to those af fected
and those re spon si ble for their care. There is a lack
of un der stand ing of the dis ease amongst the com -
mu nity and par tic u larly on what sim ple mea sures
might be of value in pre ven tion of the dis ease, par -
tic u larly at a time when the dis ease ex pres sion is
mild. For these rea sons, com mu nity-based ed u ca -
tion pro grams were de vel oped in Aus tra lia for the
pro fes sion als see ing young chil dren. These in clude 
a pro gram for Ma ter nal and Child Health Nurses
staff ing baby health cen ters for chil dren from birth
up to the age of four; a Pri mary Schools Ed u ca tion
Pro gram for teach ers of chil dren aged 4-12 years;
and a Sec ond ary Schools Ed u ca tion Pro gram for
the teach ers of chil dren aged 12-18 years. Each of
these Pro grams in cludes a com po nent on atopic
der ma ti tis; the na ture of the dis ease; what may pre -
cip i tate it; how it may be pre vented; and how it may
be treated, if treat ment is nec es sary. An Ed u ca tion
Pro gram for com mu nity phar ma cists was also de -
vel oped and tested in the com mu nity phar macy set -
ting. It gave sim i lar de tails of the na ture of atopic
der ma ti tis; the treat ment that might be re quired;
and the pre ven tive ap proach that may be of value in 
those af fected. Pre vi ous stud ies have shown that
par ents of chil dren with atopic der ma ti tis and pa -
tients with atopic der ma ti tis fre quently seek ad vice
from phar ma cists in Aus tra lia. A user-spe cific
website has been de vel oped to ac com pany the ed -
u ca tion pro grams with In for ma tion Sheets for the
pro fes sion als as well as for the com mu nity. These
have been trans lated into 12 com mu nity lan -
guages, apart from Eng lish, in clud ing Cro atian.
Pre lim i nary anal y sis in di cates that the ed u ca tion
pro grams have been taken up well and are be ing
used ap pro pri ately in the com mu nity setting.
O 29
QUAL ITY OF LIFE AND PSY CHO LOG I CAL
SYMP TOMS IN PA TIENTS WITH ATOPIC
DER MA TI TIS
M. Šitum, L. Kotrulja, M. Vurnek
De part ment of Dermatovenereology, Sestre Milosrdnice
Uni ver sity Hos pi tal, Zagreb, Croatia
Atopic der ma ti tis (AD), with its vari able clin i cal
pre sen ta tions and course, con sti tutes a syn drome
com posed of an iden ti fi able group of signs and
symp toms that rep re sents the dermatological man i -
fes ta tion of atopic diathesis. It is char ac ter ized by
se vere pru ri tus and a chron i cally re laps ing course.
AD is one of the most fre quent skin dis or ders with a
pre sumed psy cho so matic fac tor. The dis ease does
not only cause phys i cal dis com fort, but can also
have im pair ing con se quences for the per sonal and
so cial life and daily func tion ing of the pa tients. AD
may have sig nif i cant ef fects on qual ity of life, in ter -
fer ing with sleep, school ac tiv i ties, be hav ior, sports
par tic i pa tion, va ca tions, and in ter ac tions with other
chil dren. It is a chronic dis ease, vis i ble to oth ers,
and of ten causes em bar rass ment and dis com fort.
Fam ily re la tion ships may be com pro mised; par ents
of ten be come frus trated by their child’s dis com fort
caused by itch ing, the chronic course of the dis -
ease, and the lack of sleep. Ad o les cents and adults
with AD re port changes in self-im age and so cial re -
la tion ships, fi nan cial con cerns, and oc cu pa tional
dif fi cul ties. The psy cho log i cal im pact of the dis ease
on the pa tients lead ing to de pres sion, anx i ety, and
frus tra tion may cause re duced itch thresh old and
in crease the in her ent ir ri ta bil ity of the skin, thus
con trib ut ing to the pathogenesis of the dis ease.
Psy cho log i cal fac tors play a role in trig ger ing and
main tain ing the le sions, while emo tional as pects
also have a strong im pact on the itch-scratch cy cle.
Itch ing can be as sumed as the cen tral as pect as so -
ci ated with AD and pro vokes ex treme psy cho log i cal 
dis tress. Itch per cep tion and con sec u tive scratch -
ing be hav ior are mod u lated by psy cho log i cal fac -
tors. Pa tients with AD con sider pru ri tus as the
symp tom that af fects their health-re lated qual ity of
life the most. Neuropeptides may be in volved in the
pathogenesis of AD. Pro teas es, kinins, prostaglan -
dins, neuropeptides, ace tyl cho line, cytokines, and
opioids can cause itch. Psychological stress also
has been implicated as a major contributor to
disease development. Stressful events often have
been observed to occur before an AD exacerbation.
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IM PACT OF AIR BORNE POL LEN,
TEM PER A TURE, AND HU MID ITY ON
SE VER ITY OF ATOPIC DER MA TI TIS IN
CHIL DREN
H. Behrendt
De part ment of Der ma tol ogy and Al lergy Biederstein, Tech ni -
cal Uni ver sity Mu nich, and Di vi sion of En vi ron men tal Der -
ma tol ogy and Al lergy GSF/TUM, Mu nich, Germany
Ab stract not re ceived.
O 33
ITCH ING IN ATOPIC DER MA TI TIS
J. C. Szepietowski
De part ment of Der ma tol ogy, Venereology, and Allergology,
Uni ver sity of Med i cine, War saw, Po land
Itch ing is de fined as an un pleas ant pri mary cu ta -
ne ous sen sa tion, which leads to ex ten sive scratch -
ing. It is the ma jor symp tom in pa tients suf fer ing
from atopic der ma ti tis (AD). Itch is an im por tant di -
ag nos tic fea ture of AD, in cluded al most in all scor -
ing meth ods for se ver ity as sess ment of this dis -
ease. Itch is not only a symp tom of AD, the
itch-scratch cy cle usu ally ag gra vates skin le sions in 
these pa tients. Al though itch ing is pres ent in ev ery
AD in di vid ual, the clin i cal fea tures of this symp tom
have rarely been stud ied and the pathogenesis is
not com pletely un der stood. There fore, the aim of
this talk is to give an over view of clin i cal and
pathogenetical as pects of pru ri tus in AD pa tients. In 
more than three-quar ters of AD pa tients itch ing ap -
pears on daily ba sis. It seems to be most com mon
dur ing night, caus ing sleep dis tur bances, and least
fre quent in the morn ing. The in ten sity of itch ing var -
ies among pa tients; it is a very both er some symp -
tom re sult ing in low er ing qual ity of life and even de -
pres sion. The in ten sity of pru ri tus in AD is usu ally
lower than in psoriatic pa tients. All the skin ar eas
could be in volved, lower ex trem i ties be ing the most
com monly af fected. The pathogenesis is prob a bly
multifactorial with sev eral fac tors in volved with doc -
u mented or hy poth e sized roles. His ta mine does not 
seem to play a ma jor role. In re cent lit er a ture, at ten -
tion has been given to the in creased re lease of sev -
eral neuropeptides (sub stance P and CGRP), opio -
id pep tides, dis tur bances in tryptase and chy mase
ac tiv ity, and cytokines (IL-2). More over, xero sis, de -
creased itch thresh old, pro longed itch du ra tion to
pruritogenic stim uli, as well as mul ti ple trig ger ing
fac tors with stress could be of great im por tance in
the pathogenesis of itch in AD. In con clu sion, al -
though many studies have been per for med on itch
in AD, further research is required to clarify the
exact pathomechanism of this symptom in AD
individuals.
O 34
TREAT MENT OF PRU RI TUS IN ATOPIC
DER MA TI TIS
F. Gruber, M. Kaštelan, L. Prpiæ, V. Peharda
De part ment of Dermatovenerology, Rijeka Uni ver sity Hos pi -
tal Center, Rijeka, Croatia
Atopic der ma ti tis is a com mon chronic in flam -
ma tory itch ing skin dis ease. The on set of atopic
der ma ti tis fre quently oc curs in child hood and can
have a broad im pact on pa tient so cio eco nomic sta -
tus. Its etiopathogenesis is still not com pletely un -
der stood, but ge netic, en vi ron men tal, humoral, and
cel lu lar im mu no logic fac tors have a role. Pru ri tus is
one of the ma jor di ag nos tic cri te ria of the dis ease. It
is an un pleas ant and frus trat ing cu ta ne ous symp -
tom, pro vok ing the de sire to scratch one self. The in -
ten sity is hard to mea sure but can be dis tress ing
and lead to sleep dis tur bance. The cel lu lar and mo -
lec u lar bases of pru ri tus in atopic der ma ti tis are not
clear. Be sides an in crease in some in flam ma tory
cells, mast cells are also pres ent in the skin. Rel e -
vant me di a tors of pru ri tus are his ta mine, pro teas es, 
neurotransmitters (sub stance P and CGRP),
cytokines, and arachidonic deri vates (pros ta glan -
din E2 and leukotriens). Soaps, de ter gents, or low
hu mid ity can ex ac er bate pru ri tus in atopic der ma ti -
tis. The treat ment of this trou ble some symp tom
may some times pres ent a chal lenge for the phy si -
cian. The treat ment can be top i cal (emol lients,
corticosteroids, doxepin cream, or capsaicin) and
sys temic based on the use of se dat ing an ti his ta -
mines, immunomodulators (cyclosporin A), photo -
the rapy, or photochemotherapy. The patients must
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avoid excessive bathing, wool fabrics, and alcoholic 
beverages.
6. ATOPIC DER MA TI TIS AND OTHER
DIS EASES
O 35
ATOPIC DER MA TI TIS – RE SEM BLANCE
WITH OTHER COM MON FACE SKIN
CHANGES
A. Basta-Juzbašiæ, Z. Bukviæ-Mokos, S.
Ljubojeviæ, G. Bubièiæ-Bajek
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen tre, Zagreb, Croatia
Atopic der ma ti tis on the face is chronic pruritic,
clin i cally vari able skin dis ease as so ci ated with
atopy. Clin i cal fea tures vary greatly with age of the
pa tient. In young pa tients, the changes are quite
acute with er y thema, blis ters, and crusts, whereas
later on more chronic changes, in clud ing lichenifi -
cation, are pre dom i nat ing. A sin gle con stant symp -
tom seems to be pru ri tus, re sult ing in pa tients rub -
bing and scratch ing their skin. Pa tients with atopic
der ma ti tis on the face have very dry skin, which is
of ten made worse by al most any cleans ing agent or
even just fre quent ex po sure to wa ter. In adult pa -
tients, skin changes ap pear mostly with red patches 
on eye lids, fore head, perioral re gion, nape, and
neck, of ten fol low ing emo tional stress. The skin ac -
quires a gray-yel low color mak ing the pa tient ap -
pear older and sad der. Postinflammatory hyperpig -
men tation is com mon, most fre quently seen around 
the eyes, and of ten as so ci ated with in creased skin
folds. While atopic der ma ti tis in in fancy and child -
hood is not a di ag nos tic prob lem, it can be in older
pa tients. Atopic der ma ti tis can re sem ble other com -
mon fa cial skin changes, such as seborrheic der -
ma ti tis, con tact der ma ti tis (al ler gic or ir ri tant), num -
mular ec zema, pso ri a sis vulgaris, ichthyoses, and
cu ta ne ous T-cell lym phoma. Atopic der ma ti tis can
also be com pli cated with bac te rial (Staphyloccocus
aureus), vi ral, and fun gal (Pityrosporum ovale) in -
fec tions that can mod ify a clin i cal pic ture. One of the 
se ri ous prob lems is the abuse or un con trolled ap pli -
ca tion of top i cal ste roids. In ex am ple, one of our pa -
tients, a 55-year-old woman with atopic der ma ti tis
from early in fancy, ap plied top i cal ste roids for 25
years on her face. Lately she has de vel oped heavy
con tact al ler gic der ma ti tis with pos i tive patch test
on sev eral al ler gens.
O 36
IS THERE ANY AS SO CI A TION BE TWEEN
PSO RI A SIS AND ATOPIC DISORDES?
V. Barišiæ-Druško, N. Šustiæ, I. Ruèeviæ, Z.
Jukiæ
De part ment of Dermatovenerology, Osijek Uni ver sity Hos pi -
tal, Osijek, Croatia
The aim of this study was to de ter mine the prev -
a lence of al ler gic dis or ders, es pe cially atopic der -
ma ti tis (AD), among pa tients with pso ri a sis vulgaris
(PV). In Osijek Uni ver sity Hos pi tal, De part ment of
Der ma tol ogy, we ex am ined 60 pa tients aged 0-90
years of both sexes who were di ag nosed with pso ri -
a sis vulgaris. The pa tients with atopic dis or ders
were se lected on the ba sis of med i cal his tory, ques -
tion naire on pso ri a sis vulgaris and atopic der ma ti -
tis, to tal IgE se rum con cen tra tions, and skin al ler gic 
tests. The results will be presented in the tables.
O 37
ATOPIC DER MA TI TIS AND EARLY ASTHMA 
ON SET
S. Dragišiæ-Ivuliæ, N. Pav lov
Pe di at ric Clinic, Split Uni ver sity Hos pi tal , Split, Croatia
The aim of study was to re search in flu ence of
atopic der ma ti tis (AD) on asthma (A) on set in child -
hood. The study in cluded 400 asth matic chil dren
aged 1-18 years (mean±SD, 8.7±4.0) vis it ing out -
pa tient clinic from 1998 to 1999. Boys com prised
63% of the pa tients. The first at tack of air way ob -
struc tion was at the mean age of 3.6±3.4 years, with 
mean an nual fre quency of 7.0±6.6. Examinees
were di vided in four groups ac cord ing to the as so ci -
a tion of asthma with AD and al ler gic rhi ni tis (AR): 1)
only A; 2) A + AD; 3) A + AR; and 4) A + AR + AD.
The groups did not sig nif i cantly dif fer ac cord ing to
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the sex, fam ily his tory of al ler gic dis or ders, breast
feed ing, an nual fre quency of at tacks, and al ler gic
pa ram e ters. But in the mo men tary age (p<0.001)
and age of the first at tack (p<0.001), the groups sig -
nif i cantly dif fered (Kruskal-Wallis anal y sis of vari -
ances; ex plic itly by Mann-Whit ney’s test). The
group A + AD was the youn gest group (6.7±3.8
years) and sig nif i cantly dif fered from groups A + AR
and A + AR + AD. The A + AD group was the youn -
gest (2.1±2.3 years) at the time of the first at tack of
air way ob struc tion, sig nif i cantly youn ger spe cially
from groups A + AR and A + AR + AD. In the same
group, 80% of pa tients had the first at tack at age
un der 3 years. Many fac tors, par tic u larly atopic der -
ma ti tis, have a strong in flu ence on early asthma on -
set in child hood. In group A + AD pa tients, atopic
der ma ti tis ap peared 1.5-2 years be fore the first
symp toms of asthma. Thus, we may in fer that early
detection and treatment of atopic dermatitis can
delay development of serious disease as asthma.
7. MAN AGE MENT OF ATOPIC
DER MA TI TIS
O 38
TREAT MENT STRAT E GIES TO CON TROL
THE ITCH
U. Darsow, J. Ring
De part ment of Der ma tol ogy and Al lergy Biederstein, Tech ni -
cal Uni ver sity Mu nich; and Di vi sion of En vi ron men tal Der -
ma tol ogy and Al lergy GSF/TUM, Mu nich, Germany
Itch is a cru cial di ag nos tic fea ture of atopic ec -
zema (AE) and has sub stan tial im pact on the qual -
ity of life of pa tients. Itch per cep tion has many
psychophysiologic as pects. In stru ments for qual i ta -
tive and quan ti ta tive reg is tra tion of these cen tral
ner vous fac tors and eval u a tion of ther a peu tic mea -
sures are still un der de vel op ment. The itch re cep -
tors, re cently con firmed by hu man microneuro -
graphic stud ies, are free end ings of thin, unmyelina -
ted, slow-con duct ing C-fi bers in the up per skin.
Apart from his ta mine, mast cell tryptase and to date
un known itch me di a tors are likely to play a role in
pruritic dis eases like AE. Stud ies us ing the “Eppen -
dorf Itch Ques tion naire” and skin re flex ex per i -
ments showed that itch can only par tially be quan ti -
fied by a sin gle scale. Clin i cal itch, but also itch in
atopy patch test mod els in pa tients with AE needs
an in creas ing num ber of descriptors with higher in -
ten si ties. This can be in ter preted as cen tral ner vous 
sys tem (CNS) pro cess ing of a no ci cep tive sen sa -
tion. A com plex pat tern of cor ti cal ac ti va tion af ter
ex per i men tal his ta mine stim uli was ob served in a
H215O PET cor re la tion study in healthy vol un teers, 
in volv ing mo tor ar eas, insula, and cingulate. These
re sults sug gest to com bine top i cal treat ment of clin -
i cal itch (un spe cific and spe cific, phys i cal and
antiinflammatory) with ther a pies tar get ing the CNS
and other sys temic ther a pies. Im prov ing the course
of AE is based on a com bi na tion of ap pro pri ate top i -
cal antiinflammatory, an ti bac te rial and rehydrating
treat ment, and pa tient ed u ca tion (“pa tient man age -
ment”). The use of top i cal corticosteroids with im -
proved risk/ben e fit ra tio has led to sig nif i cantly
better re sults in the long-term man age ment of AE. A 
new group of antiinflammatory and thus antipruritic
drugs for top i cal use are calcineurin-in hib i tors like
tacrolimus and pimecrolimus. They in hibit the T
cell-de pend ent in flam ma tory re sponse and the re -
lease of cytokines with out caus ing skin at ro phy or
ob vi ous sys temic side ef fects. Immunomodulatory
ap proaches in clud ing al ler gen-spe cific immunothe -
rapy, anti-IgE, sol u ble interleukin-4 re cep tor, and
an ti bod ies to ad he sion mol e cules or costimulatory
mol e cules may prove ef fec tive. In ad di tion, new
antagonists and synthesis inhibitors of mediators of
inflammation will be developed in the future. New
models to measure itch may be useful for the




THE TREAT MENT OF ATOPIC DER MA TI TIS
S. Murat-Sušiæ
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb, Croatia
Top i cal corticosteroids still rep re sent the first line 
treat ment for pa tients with atopic der ma ti tis. Al -
though their ap pli ca tion car ries the risk of lo cal and
sys temic side ef fects, if pre scribed by phy si cians fa -
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mil iar with these drugs, this kind of treat ment can be 
highly ef fec tive as well as safe. Fac tors that need to
be con sid ered when pre scrib ing top i cal corticoste -
ro ids are po tency and base of corticosteroid prep a -
ra tion, age of the pa tient, site of the le sions, ex tent
of ec zema, and method of ap pli ca tion. It is ex -
tremely im por tant that the phy si cian is fa mil iar with
a few prep a ra tions from each po tency cat e gory.
Some pre fer to pre scribe a short burst of a po tent
ste roid fol lowed by a ste roid-free pe riod. The ma jor -
ity, in clud ing us at the De part ment, start the treat -
ment with a more po tent prep a ra tion, taper down
the po tency as the ec zema sub sides, and use pro -
longed, if nec es sary con tin u ous, treat ment with a
less-po tent corticosteroids prep a ra tion, usu ally
mild or mod er ate, to con trol the dis ease. Since the
ma jor ity of pa tients with atopic der ma ti tis need pro -
longed treat ment with corticosteroids to achieve
good dis ease con trol and avoid side ef fects, a mild
corticosteroid prep a ra tion, es pe cially when treat ing 
chil dren or sen si tive body ar eas, is man da tory.
Alclometasone dipropionate is a mild non-flu o ri -
nated syn thetic corticosteroid that co mes in a
0.05% cream and oint ment. Many clin i cal tri als in
chil dren and adults with atopic der ma ti tis treated
with alclometasone cream and oint ment showed
better re sults than those ob tained with hy dro cor ti -
sone 1.0%, hy dro cor ti sone butirate 0.1%, or deso -
nide 0.05%. Com pa ra ble re sults to clobetha sone
bu tir ate 0.05% were ob served, as well as equal
safety re sults com pared with treat ment with the
men tioned corticosteroids. Un to ward ef fects, in -
clud ing burn ing, itch ing, sting ing, ir ri ta tion or red -
ness, oc curred in only 4% of adult pa tients and 6%
of treated chil dren. In healthy adult vol un teers
treated with 30 g of alclometasone dipropionate
cream 0.05% twice a day to 80% of the body BID for 
three weeks and un der oc clu sion (plas tic body
suits) dur ing 12 h, no clin i cally sig nif i cant sup pres -
sion of hy po thal a mus-pi tu itary gland-ad re nal glad
(HPA) axis was ob served. Alclometasone has been
pres ent on the Cro atian mar ket as Afloderm cream
and oint ment (0.05%) for 15 years and pre scribed
to chil dren and adults with atopic der ma ti tis. In ad di -
tion to the orig i nal cream or oint ment (Afloderm), it
can also be used in a di luted form, i.e. 20%, 40%, or
60% of the orig i nal cream in an emol lient (Belo -
baza). In our treat ment of pa tients with atopic der -
ma ti tis, the con cen tra tion de pends on the in ten sity
of the ec zema, site and ex tend of skin le sions, and
age of the pa tient. The pa tients and par ents are
given de tailed in struc tion re gard ing corticosteroids
ap pli ca tion and are asked to write a di ary con cern -
ing any ap pli ca tion of corticosteroids, body site on
which it was applied, and the exact amount of prep -
a ra tions used since the last visit to our clinic. In the
majority of patients, the disease can be controlled
as mentioned. Rarely, a short application of a more
potent corticosteroid is necessary.
Even in pro longed ap pli ca tion of alclometasone
in pa tients with atopic der ma ti tis, in clud ing in fants,
we did not ob serve ei ther lo cal or sys temic side ef -
fects. There fore, we con sider alclometasone to be
ef fec tive and safe in treat ment of atopic der ma ti tis
pa tients, even in children.
O 40
MOD ERN AS PECTS OF TOPIC STE ROID
THER APY IN ATOPIC DER MA TI TIS
L. Kaznacheeva
Cen ter of Allergology, Novosobirsk, Rus sia
In the last years, there has been a con stant and
sig nif i cant in crease in the num ber of chil dren with
the al ler gic dis eases. The share of atopic der ma ti tis 
(AD) in pe di at ric al ler gic pa thol ogy is 50-75%. One
of the stan dard prin ci ples in the treat ment of AD is
ap pli ca tion of topic ste roids. In this study, the ef fects 
of ap pli ca tion of alclometasone (Afloderm cream;
Belupo, Pharmaceuticals & Cos me tics Inc.) in pa -
tients with AD were as sessed. There were two
groups of pa tients: 35 chil dren aged be tween 6
months and 3 years with “in fan tile form” of AD
(group 1), and 27 chil dren aged 4-7 years with “chil -
dren’s form” of AD (group 2). Forty-four out of a to tal 
of 62 pa tients had a wide spread dis ease, and 18
pa tients had the lim ited form of skin pro cess.
Afloderm was ap plied 2 times per day over 7-14
days. Sig nif i cant pos i tive dy nam ics of skin cel lu lar
in flam ma tory pa ram e ters was ob served dur ing the
ther apy in all chil dren, with a pro nounced de crease
in the rel a tive quan tity of neu tro phils and
eosinophils in “skin win dow” sam ples. Clin i cal ef fi -
ciency of Afloderm was es ti mated by us ing
SCORAD in dex; there was a pos i tive dy nam ics in
all pa tients. The mean SCORAD in dex de creased
in group 1 from 40.0±6.8 be fore the treat ment to
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12.2 ±1.4 af ter two-week treat ment, and from
39.6±8.2 to 10.9±1.5 in group 2. There were no side 
ef fects, ei ther sys temic or topic, and Afloderm was
well tol er ated by all chil dren.
O 41
EVAL U A TION OF A NEW SE QUEN TIAL
TREAT MENT WITH FUSIDIC ACID IN
ATOPIC DER MA TI TIS PA TIENTS
G. A. Vena
Unit of Der ma tol ogy, Uni ver sity of Bari, It aly, on be half of the
“Fucicort/Fucidin H Study Group”
Mi cro bial fac tors, es pe cially Staph y lo coc cus
aureus, play an im por tant role in the pathogenesis
of atopic der ma ti tis (AD). Skin col o ni za tion with S.
aureus is no ta bly in creased in AD pa tients and may
trig ger and/or ex ac er bate the in flam ma tory net work 
of AD. An open study was car ried out to eval u ate
the ac tiv ity of an an ti bi otic-glucocorticoid treat ment
in mild to mod er ate AD. For this pur pose, pa tients
suf fer ing from lo cal ized forms of AD, with signs sug -
ges tive of po ten tial mi cro bial superinfections were
se lected. Treat ment con sisted of two se quen tial
phases as fol lows: ap pli ca tion of fusidic acid as so -
ci ated with betamethasone valerate (phase 1), fol -
lowed by the use of a com bi na tion of fusidic acid
and hy dro cor ti sone ac e tate (phase 2). Clin i cal eval -
u a tions were per formed at base line, af ter phase 1,
and af ter phase 2. The se ver ity of skin signs and
pru ri tus was as sessed us ing a 4-point semiquanti -
tative scale. A to tal of 178 pa tients were en rolled; of
these, 42 were adults, 87 were 3-15 years old, and
49 aged <3 years. At the base line, AD was mild in
67% of cases and mod er ate in 33%. Treat ment was 
well tol er ated. A rel e vant and pro gres sive im prove -
ment of AD signs and symp toms was noted
through out the treat ment pe riod: AD se ver ity was
no ta bly re duced af ter phase 1 and fur ther im proved
af ter the sub se quent phase. The pa tients’ or par -
ents’ opin ion on ef fi cacy and ac cept abil ity of the
treat ment was pos i tive in most cases.
O 42
WHAT`S NEW IN MAN AGE MENT OF
ATOPIC DER MA TI TIS?
J. Lipozenèiæ, R. Wolf1, Z. Paštar2, D.
Marasoviæ3
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb, Croatia; 1Kaplan Med i cal Cen -
ter, Rechovot, Is rael; 2Min is try of De fense of the Re pub lic
Croatia, and 3De part ment of Der ma tol ogy and Venerology,
Split Uni ver sity Hos pi tal, Split, Croatia
Atopic der ma ti tis (AD) is a chronic, re laps ing
skin dis ease. Com plex in ter ac tions among ge netic,
en vi ron men tal, skin bar rier, phar ma co logic, and im -
mu no logic fac tors con trib ute to the pathogenesis of
AD. Ther apy in cludes iden ti fi ca tion and elim i na tion
of trig ger ing fac tors, top i cal ther apy (cu ta ne ous
hydration, top i cal corticoid treat ment, or top i cal
immunomodulators), and sys temic ther apy. Sys -
temic corticosteroids are most of ten used to con trol
flares and should be re served pri mar ily for con trol
of acute ex ac er ba tions. Cyclosporine, a macrolide
agent, is an ef fec tive treat ment for AD in adults as
well as chil dren. It is pre scribed on a short-term ba -
sis for re cal ci trant cases of AD, with a typ i cally
rapid, 2-3 week re sponse that in cludes pro nounced 
re duc tion of pru ri tus, and re duc tion of lichenification 
and ex tent and ac tiv ity of der ma ti tis af ter 6-8 weeks
of ther apy. Re lapses usu ally oc cur af ter treat ment,
and post treat ment dis ease of ten does not re turn to
base line lev els. Long-term treat ment is also pos si -
ble. Azathioprine, a pu rine an a log that rap idly con -
verts in vivo to 6-mercaptopurine, has a slow on set
of ac tion of about 4-6 weeks. In many re ports there
is ev i dence of a con sis tent, sig nif i cant, and per sis -
tent re duc tion in dis ease ac tiv ity sus tained for at
least 3-6 months. Methotrexate is safer on a
long-term ba sis and its con sid er ation as a ste -
roid-spar ing agent is jus ti fied. Phototherapy should
be added to the methotrexate treatment reg i men
once the drug has effectively controlled the level of
inflammation.
Mycophenolate mofetil is use ful in dermatologic
in flam ma tory dis eases, but it is not ap proved for the 
treat ment of AD yet. Re cent stud ies showed no ta -
ble im prove ment in sub jects with mod er ate to se -
vere AD. In ter feron g was ap plied in sev eral
open-la bel stud ies for AD and the sta tis ti cally sig nif -
i cant im prove ment was seen in ex co ri a tions/ero -
sions and er y thema in pa tients with the low est se -
rum IgE lev els and blood eosinophil per cent age at
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the be gin ning of the study. In tra ve nous im mu no -
glob u lin (IVIG), phosphodiesterase in hib i tors, tha -
lid o mide, and leukotriene in hib i tors have been used 
in AD but their ef fec tive ness has not been con -
firmed. Data from ex per i men tal stud ies pro vide
struc ture, mech a nism of ac tion, ef fi cacy, op ti mal
doses, safety, clin i cal guide lines, costs, and per -
spec tive of broad use of these drugs and in sight into 
pos si ble fu ture treat ment meth ods.
O 43
MAN AGE MENT OF ATOPIC DER MA TI TIS
IN IN FANCY
S. Murat-Sušiæ
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb,
Atopic der ma ti tis (AD) is a chronic, in flam ma -
tory, itchy dermatosis with high prev a lence. It is
char ac ter ized by on set at early age, with first symp -
toms ap pear ing in in fancy in over 50% of cases. Ini -
tial as sess ment of pa tients must in clude de tailed
med i cal his tory, de ter mi na tion of dis ease se ver ity
and po ten tial trig ger fac tors. The goal of treat ment
is to con trol the symp toms, not cure of the dis ease.
The treat ment con sists of adjuvant ba sic ther apy,
iden ti fi ca tion and avoid ance of trig ger fac tors, and
anti-in flam ma tory mea sures. Adjuvant ba sic ther -
apy in cludes bath ing and reg u lar ap pli ca tion of
mois tur iz ers, which re duce clin i cal signs of dry -
ness, scal ing, and rough ness; de crease itch and
tight ness; im prove skin bar rier func tion; give the
skin pro tec tion from en vi ron men tal ir ri tants and al -
ler gens; and rep re sent a ste roid spar ing al ter na tive. 
En vi ron men tal pro voc a tive fac tors, such as low hu -
mid ity, ex po sure to hard wa ter, house dust mites,
mould, cat and dog dan der, cig a rette smoke or skin
con tact with wool, syn thet ics, and cer tain food
should be avoided. Data on prev a lence of food al -
lergy in chil dren with AD are quite vari able (from
15-30%). Clin i cally rel e vant ad verse re ac tion to
food should be con sid ered in pa tients with mod er -
ate to se vere AD. In gen eral, the more se vere the
clin i cal pic ture and the youn ger the pa tient, the
more likely the symp toms of AD be ag gra vated by
food hy per sen si tiv ity. To prove food al lergy skin
prick tests (SPT), de ter mi na tion of spe cific IgE an ti -
bod ies and atopy patch tests (APT) with food are
per formed. Sen si tiv ity of skin prick tests are ex cel -
lent in de ter min ing food al lergy and neg a tive pre dic -
tive ac cu racy is ex cel lent (>95%). Spec i fic ity and
pos i tive pre dic tive ac cu racy, though, are poor
(<40%). Thus, a pos i tive skin prick test can not be
con sid ered a proof of food al lergy but a neg a tive
test vir tu ally rules out al lergy to the tested an ti gen.
The re sults of al ler gen-spe cific IgE an ti body val ues
de ter mi na tion are com pa ra ble to those of skin prick
tests. Quan ti ta tive mea sure ment of al ler gen-spe -
cific IgE may rep re sent a step for ward in the di ag no -
sis of food al lergy in AD. “De ci sion points” for the
lev els of spe cific IgE to some food have been de ter -
mined as pro vid ing >95% con fi dence that the pa -
tient has food hy per sen si tiv ity. APT may be a valu -
able ad di tional tool in di ag nos ing food hy per sen si -
tiv ity. Stan dard iza tion of this test is still in prog ress.
Pos i tive re sults of pre vi ously men tioned tests are
usu ally only sug ges tive of clin i cally rel e vant food
hy per sen si tiv ity. Al though dou ble-blind pla cebo-
 con trolled food chal lenge test (DBPCFC) is con sid -
ered to be the gold stan dard for di ag no sis of food al -
lergy, it is time consuming and can be replaced with
opened food challenge test in infants. When the
diagnosis of food allergy is determined adequate
diet is introduced. Evaluation of nutritional status is
extremely important because inadequate diets can
lead to malnutrition in infants.
Top i cal corticosteroids (CS) are still first-line
ther apy for AD. Low to mid-po tency top i cal CS, ap -
plied twice a day, are usu ally ef fi cient in con trol of
in flam ma tion. Once the ac tiv ity of the dis ease is
con trolled, the goal is in ter mit tent ap pli ca tion or
with drawal of CS. The least po tent prep a ra tion that
ad e quately con trols the dis ease should be se -
lected. Po ten tial lo cal and sys temic side ef fects limit 
their use and fre quently lead to undertreatment, es -
pe cially in in fants and chil dren. Use of top i cal
immunomodulatory agents, such as tacrolimus and
pimecrolimus, are still not ap proved for use in chil -
dren less than two years of age. Oral an ti his ta mines 
may di min ish pru ri tus and fa cil i tate sleep, es pe -
cially those with sed a tive ef fect, given at bed time.
Top i cal and oral an ti bi ot ics can be help ful in cases
with clin i cal ev i dence of Staphylococcus aureus in -
fec tion.
O 44
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THE LIGHT IN ATOPIC DER MA TI TIS
TREAT MENT
A. Pašiæ, J. Lipozenèiæ, K. Kostoviæ, R.
Èeoviæ, K. Husar, S. Murat-Sušiæ, M. Skerlev,
D. Hrsan
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Center, Zagreb, Croatia
Atopic der ma ti tis (AD) is a com mon, multifac -
torial, chronic, and of ten re laps ing in flam ma tory
skin dis ease. Cur rent treat ment of se vere AD con -
sists al most ex clu sively of top i cal and sys temic
corticosteroid ther apy. Be cause long-term cortico -
ste roid ther apy is known to cause a va ri ety of side
ef fects, at tempts have been made to de velop al ter -
na tive treat ments, such as phototherapy with UVB
(narrowband) and UVA ir ra di a tion. We in ves ti gated
the ap pli ca tion of UV light in the treat ment of AD in
child hood and treated 21 chil dren (7 boys and 14
girls, mean age 11.5 years) with AD with a com bi na -
tion of UVA and UVB (UVAB) ir ra di a tion three or five 
times a week. All of them had ac tive dis ease in volv -
ing at least 40% of the body area de spite the use of
top i cal ste roids, emol lients, an ti his ta mines, and an -
ti bi ot ics. Ten of these chil dren had a pos i tive fam ily
his tory of atopy. Six pa tients had co ex ist ing hay fe -
ver. The en tire body was ir ra di ated in clud ing the
face. The cu mu la tive dose of UVB ranged from 1.3
to 10.4 J/cm2 (mean dose, 6.14 J/cm2). The cu mu -
la tive dose of UVA ranged from 27.5 J/cm2 to 182
J/cm2. The num ber of treat ments ranged from 9 to
47 (me dian, 18). Ex cel lent re sponse to UVAB ther -
apy that re sulted in al most com plete dis ap pear ance 
of ec zema and pru ri tus was ob served in 9 out of 21
chil dren. Good and mod er ate re sponse to UVAB
ther apy was re corded in 5 and 7 pa tients, re spec -
tively. Only mi nor side ef fects, such as mild er y -
thema, were ob served in four pa tients. Based on
these re sults, we con cluded that UVA and UVB
(UVAB) is a useful and acceptable method for
treating mild to moderate atopic dermatitis in the
childhood.
O 45
RUS SIAN EX PE RI ENCE OF MAN AG ING OF 
ATOPIC DER MA TI TIS PA TIENTS
E. Fedenko, N. Ilina, I. Gushchin
Fed eral Sci en tific Cen ter – In sti tute of Im mu nol ogy, Mos -
cow, Rus sia
There is no uni fied po si tion pa per on atopic der -
ma ti tis (AD) in the world. Mu tual un der stand ing be -
tween the phy si cians be comes rather com pli cated
be cause of dis crep ancy be tween dif fer ent schools
about AD. Rus sian Na tional AD Po si tion Pa per was 
cre ated in 2002. It con sists of 4 doc u ments, Guide -
lines for Prac ti tio ners, At las of Top i cal Treat ment
and Skin Care, Diet ther apy, and Phar ma ceu ti cal
Guide, which unite co or di nated po si tions about the
sub ject of allergologists, der ma tol o gists, and pe di a -
tri cians. The man ag ing pro to col of AD pa tients pro -
posed in the Pa per was based on the world and na -
tional ex pe ri ence in man age ment of AD pa tients.
Our re port will be devoted to Russian experience of
managing of AD patients.
O 46
STAPHYLOCOCCUS AUREUS
ALLERGOVACCINE FOR DI AG NOS TICS
AND TREAT MENT OF ATOPIC DER MA TI TIS
E. Fedenko, O. Elissioutina, N. Lapshin
Fed eral Sci en tific Cen ter – The In sti tute of Im mu nol ogy,
Mos cow, Rus sia
Our aim was to in ves ti gate the ef fi cacy of
allergovaccination with S. aureus al ler gen in atopic
der ma ti tis pa tients sen si tized to S. aureus and suf -
fer ing from re cur rent pyoderma. For this pur pose,
we used allergovaccine pre pared from S. aureus
taken from the skin of AD pa tients. The vac cine was 
pre pared with a method of cul tur ing mi cro or gan -
isms on cel lo phane film. The pa tient group con -
sisted of 22 pa tients suf fer ing from AD com pli cated
with re cur rent pyoderma. In 76.6% of AD pa tients,
spe cific IgE to S. aureus was de tected by us ing
UniCap 100 sys tem, Pharmacia Upjohn. Skin test -
ing with S. aureus allergovaccine (scarification and
intradermal tests) was car ried out in 22 AD pa tients
with re mis sion of AD pyoderma. In 9 of these pa -
tients, the test was pos i tive. Spe cific immunothe -
rapy with S. aureus allergovaccine was per formed
in 4 pa tients. The con trol group con sisted of 6 pa -
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tients with chronic furunculosis with out atopy.
Allergovaccine pre pared from S. aureus can be
used for di ag nos tics of S. aureus sen si ti za tion in
AD pa tients suf fer ing from re cur rent pyoderma and
for the treat ment of these pa tients.
O 47
BASE CREAMS FOR THE PRE VEN TION
AND TREAT MENT OF ATOPIC DER MA TI TIS
H. Lautenschlaeger
KOKO GmbH & Co.KG, Leichlingen, Ger many
Ac cord ing to gen eral con sid er ations on
corneotherapy (Al bert M. Kligman), the chem i cal
com po si tion and the phys i cal struc ture of base
creams play a ma jor role in sup port ing the ho moeo -
sta sis of the skin. From the phys i o log i cal point of
view, mem brane-form ing in gre di ents should be
pre ferred due to the com pounds and the bilayer
struc ture of intercellular lipids of the horny layer.
Typ i cal mem brane form ing agents are ceramides,
cho les terol, fatty ac ids, and phospholipids. Among
phospholipids, phosphatidylcholine (PC) is the
most im por tant start ing ma te rial, be cause of its
avail abil ity and dif fer ent be hav ior with re gard to
chem i cally bonded fatty ac ids. Na tive PC is a
source of linoleic acid. It fluidizes the skin bar rier
and sup ports ceramide I for ma tion, whereas hy dro -
ge nated PC (PC-H) shows strong bar rier pro tec tion 
ac tiv i ties. In this re spect, def i nite ra tios of PC and
PC-H to gether with ma te ri als in flu enc ing the skin
hydration and skin rough ness are of spe cial in ter est 
for pre vent ing and treat ing atopic skin. Be cause of
the lamellar struc ture of such sys tems, they be have 
like the skin, i.e., they are able to take up hy dro philic 
and lipophilic ac tive agents at room tem per a ture, an 
im por tant pre req ui site for their use as base creams. 
As a re sult, the base creams en able a mod u lar sys -
tem in com bi na tion with sim ple skin anal y sis pro ce -
dures like corneometry, sebumetry, and tewametry.
Fur ther more there is no break be tween med i cal
treat ment and cosmetic prevention. Experiences
from practice have shown a high efficacy and
tolerance with regard to atopic dermatitis.
O 48
SO PHIS TI CATED SCI EN TIFIC SKIN
DI AG NOS TIC METHOD – CK ELEC TRONIC
GmbH – COLOGNE
M. Rogiæ
Ab stract not re ceived.
8. NEW DRUGS FOR ATOPIC
DER MA TI TIS
O 49
EF FI CACY AND SAFETY CHAL LENGE WITH
PIMECROLIMUS
LEC TURE SPON SORED BY NOVARTIS
T. Luger
De part ment of Der ma tol ogy and Venerology, Uni ver sity of
Mun ster, Ger many
Ab stract not re ceived.
O 50
TACROLIMUS 0.1% IN THE TREAT MENT
OF ATOPIC EC ZEMA: OUR EX PE RI ENCE
F. Kokelj, F. Mellina Bares, G. Trevisan
In sti tute of Der ma tol ogy, Uni ver sity of Trieste, It aly
Atopic ec zema (AE) is a chron i cally re laps ing in -
flam ma tory skin dis ease, which se ri ously af fects
the life qual ity. Tacrolimus is a non-ste roid calcine -
urin in hib i tor orig i nally de vel oped as a sys temic
immunosuppressant to be used in or gan trans plan -
ta tion. We treated 9 pa tients (4 men and 5 women;
mean age, 36.5 years) af fected with mod er ate to
se vere AE with tacrolimus 0.1% ac cord ing to the
stan dard method of ad min is tra tion. Af ter the eval u -
a tion of first re sults, we treated other 8 pa tients (4
men and 4 women; mean age, 28 years). Only 4 out 
of the first 12 pa tients com pleted the study, with
only 2 of them show ing good clear ance of the skin.
All 8 pa tients from the sec ond group fin ished the
treat ment, with 6 of them show ing a good re sponse
to the treat ment with tacrolimus. These data point to 
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the ne ces sity to give com plete and ex haus tive in for -
ma tion to the pa tients to ob tain their full com pli ance
and con se quently good re sults. In our ex pe ri ence,
the main prob lem for this treat ment seems to be,
be sides the rel a tively high cost, skin burn ing and
pru ri tus, which were pres ent in more than 70% of
our patients, particularly at the beginning of the
treatment.
O 51
COM BINED THER APY IN ATOPIC
DER MA TI TIS
E. Berardesca
San Gallicano Dermatological In sti tute, Rome, It aly
Top i cal corticosteroids have been the main stay
of treat ment for atopic der ma ti tis. They in duce sev -
eral changes in skin me tab o lism lead ing to re duc -
tion of in flam ma tion and itch ing, and can be used
both in acute and chronic phases of the dis ease.
Their mech a nism of ac tion is broad and com plex,
af fect ing sev eral path ways of in flam ma tion and
gene ex pres sion. Due to their po ten tial side ef fects
and de pend ing upon the clin i cal se ver ity of the dis -
ease, their use should be lim ited to the acute
phases and then re placed by other treat ments. Low 
to mild po tency ste roids should be pre ferred. Pulse
ste roid ther apy in as so ci a tion with emol lients or
bar rier re struc tur ing creams has been shown to be
ef fec tive, safe and use ful in keep ing dis ease-free
chronic pa tients. In par tic u lar, phys i o logic mix tures
con tain ing free fatty ac ids, cho les terol, and cerami -
des can pen e trate a dis rupted stra tum corneum,
reach the nu cle ated epi der mal cell lay ers, and be
in cor po rated into na scent lamellar bilayers of the
stra tum corneum in ter stices. Clin i cal tri als of
ceramide-dom i nant bar rier re pair mois tur izer has
been shown to re duce the se ver ity scor ing of atopic
der ma ti tis, nor mal iz ing TEWL and im prov ing stra -
tum corneum in teg rity. Com bi na tion ther apy of mild
corticosteroids with phys i o logic lipid mixtures can
be a useful, low cost, and safe approach to the
long- term management of atopic dermatitis.
O 52
TOP I CAL TACROLIMUS IS MORE
EF FEC TIVE THAN PIMECROLIMUS IN
PE DI AT RIC ATOPIC DER MA TI TIS PA TIENTS
I. Law rence
Fujisawa Healthcare, Inc., Deerfield, Il li nois, USA
The safety and ef fi cacy of tacrolimus oint ment
and pimecrolimus cream in the treat ment of pe di at -
ric pa tients with atopic der ma ti tis (AD) was com -
pared in a multi-cen ter ran dom ized, 6-week in ves ti -
ga tor-blinded study. Pa tients (2-15 years of age)
with mod er ate to se vere AD were ran dom ized 1:1
to ap ply ei ther tacrolimus oint ment 0.1% or pime -
cro limus cream 1% twice daily as monotherapy.
Other AD treat ments were pro hib ited dur ing the
wash-out pe riod and study. Study vis its oc curred at
base line and at weeks 1, 3, and 6/end of study
(EOS). Ef fi cacy pa ram e ters in cluded the Ec zema
Area and Se ver ity In dex (EASI), In ves ti ga tor’s
Global Atopic Der ma ti tis As sess ment (IGADA),
per cent body sur face area (% BSA) af fected, and
pa tient as sess ment of itch. Safety was eval u ated
based on ad verse events (AEs) re ported through -
out the study, both cu ta ne ous AEs and sys temic
AEs (study drug-re lated). A to tal of 198 pa tients
were con sid ered evaluable for safety and 193 eva -
luable for ef fi cacy. Tacrolimus oint ment showed sta -
tis ti cally sig nif i cant su pe ri or ity to pimecrolimus
cream by the change from base line in EASI (-79.9% 
vs. -68.2%, re spec tively; p<0.001), the per cent of
pa tients clear or al most clear by IGADA at week
6/EOS (38.3% vs. 20.2%, re spec tively; p=0.006),
change from base line in % BSA af fected (-17.0%
vs. -10.0%, re spec tively; p<0.001), and change
from base line in pa tient as sess ment of itch (-3.4 vs.
-1.7, re spec tively; p=0.001). Ad verse events oc -
curred at less than an 11% in ci dence rate for any in -
di vid ual event. There were no sta tis ti cally sig nif i -
cant dif fer ences with re gard to any AEs, in clud ing
skin burn ing/sting ing (p=0.49) be tween the two
treat ment groups. The re sults showed that
tacrolimus ointment was more effective than
pimecrolimus cream with a similar safety profile in
pediatric patients with atopic dermatitis.
O 53
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SPE CIFIC IMMUNOTHERAPY IN THE
TREAT MENT OF PA TIENTS WITH ATOPIC
DER MA TI TIS: RE SULTS OF DOU BLE BLIND
PLA CEBO CON TROLLED TRIAL
W. Silny, M. Czarnecka-Operacz
De part ment of Der ma tol ogy and Al ler gic Dis eases, Di ag -
nos tic Cen ter, Uni ver sity of Med i cal Sci ences, Poznañ, Po -
land
We in ves ti gated 20 pa tients (15 women and 5
men) with atopic der ma ti tis (AD), aged 5-40 years,
who were al ler gic to house dust mites or grass pol -
len al ler gens. Spe cific immunotherapy was per -
formed with Novo Helisen De pot al lergy vac cines of 
ap pro pri ate com po si tion for the time pe riod of 12
months. Pla cebo for our trial was sup plied by
ALLERGOPHARMA phar ma ceu ti cal com pany. In
the treat ment of 14 pa tients al ler gic to house dust
mites, Novo Helisen De pot al lergy vac cines com -
posed of Dermatophagoides pteronyssinus 50%
and Dermatophagoides farinae 50% were used (7
pa tients – an ac tive vac cine; 7 pa tients – pla cebo).
Six pa tients al ler gic to grass pol len al ler gen were
treated with vac cines com posed of 100% grass pol -
len ex tract (3 pa tients – an ac tive vac cine; 3 pa -
tients – pla cebo). Af ter 12 months of treat ment, we
ob served a sig nif i cant im prove ment of the clin i cal
sta tus of pa tients (based on W-AZS in dex) treated
with an ac tive vac cine (p<0.01). We also re corded a 
sig nif i cant dif fer ence in the se ver ity of AD be tween
an ac tive and pla cebo group af ter one year of ther -
apy (p<0.01). In our trial, we mon i tored se lected
allergological (t IgE, as IgE, ECP) and im mu no log i -
cal pa ram e ters (IL-4, IL-5, IL-10, sIL-2R, and
IFN-g). Our con clu sion was that spe cific immuno -
therapy may be an ef fec tive method in the treat -
ment of se lected pa tients with atopic der ma ti tis and
air borne al lergy.
O 54
SPE CIFIC IMMUNOTHERAPY IN ATOPIC
DER MA TI TIS PA TIENTS – OUR EX PE RI ENCE
V. Milavec-Puretiæ, J. Lipozenèiæ, S.
Ljubojeviæ, S. Špoljar1
De part ment of Der ma tol ogy and Venereology, Zagreb Uni -
ver sity Hos pi tal Cen ter; and 1Min is try of De fense of the Re -
pub lic of Croatia, Zagreb, Croatia
Spe cific immunotherapy (hyposensitization) is
in prac tice based on re peated sub cu ta ne ous or oral 
(swal low or sublingual) ap pli ca tion of spe cific al ler -
gens (with in creas ing con cen tra tions). These al ler -
gens re spon si ble for the al ler gic symp toms in pa -
tients are used in immunotherapy un til the main -
tained dose is ob tained or symp toms dis ap pear.
The mech a nism of immunotherapy in atopic der ma -
ti tis pa tients is based on de creas ing of spe cific IgE
an ti bod ies, and at the same time in creas ing of spe -
cific IgG. We have di ag nosed pa tients with pure
atopic der ma ti tis (AD) and mix ture AD pa tients with
con com i tant al lergy: al ler gic rhi ni tis (AR), al ler gic
rhinoconjunctivitis (AC), and al ler gic bron chi tis
(AB). All pa tients were sen si tive to in hal ant al ler -
gens proved by in vivo and in vi tro tests. Dur ing
1985-2003 pe riod, there were 218 atopic pa tients in 
the Al lergy Clinic of the De part ment of Der ma tol ogy 
and Venereology, Zagreb Uni ver sity Hos pi tal Cen -
ter, Croatia, in cluded in the study. All pa tients were
skin prick tested (SPT) ac cord ing the Eu ro pean
stan dard and White pa per 2003. Pa tients with im -
mu no de fi ciency, immunoinflammatory dis ease,
ma lig nan cies, nonstabile asthma, car dio vas cu lar
man i fes ta tions, chil dren un der five years, el derly
pa tients, and dur ing preg nancy and lac ta tion were
ex cluded from the study. The al ler gens used for
hyposensitization were Dermatophagoides ptero -
ny s sinus, house dust mite (to gether or sep a rately),
pol len mix tures (grass, tree, weed), or sin gle al ler -
gens (Cocksfoot, Tim o thy, Meadow grass; Birch,
Ha zel tree; and Rag weed, Mugwort weed) from In -
sti tute of Im mu nol ogy Zagreb; Bencard; Allergo -
pharm; or Stallergeéns. For the con trol of use ful -
ness of spe cific immunotherapy, val ues of immuno -
glo bulins, es pe cially to tal and spe cific IgE val ues
were used. For to tal and spe cific IgE de ter mi na tion, 
we used Pharmacia UniCAP sys tem FEIA and
Upjohn re agents (kU/l). The con cen tra tion of the
spe cific IgE (Pharmacia UniCAP sys tem FEIA, and
Upjohn re agents) were 0-6 kUA/L. All 218 atopic
pa tients (AP) un der went spe cific sub cu ta ne ous
immu notherapy for two or three years. In four of AR
pa tients, good re sults were also achieved with
sublin gual immunotherapy. Three of 218 pa tients
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had ad verse re ac tion (wors en ing of the atopic dis -
ease) dur ing one year of immunotherapy, and with -
drew from the study. All 215 atopic pa tients showed
im prove ment. Im prove ment was also ob served in
high per cent age of other pa tients: 77 pa tients with
AD, 29 with com bi na tion of AD and AR, 13 with AC
and 12 with AB. Af ter 19 years of ex pe ri ence with
spe cific immunotherapy in the Al lergy Clinic, we
had very good re sults in atopic pa tients by us ing in -
hal ant al ler gens. The best re sults were ob tained by
us ing grass pol len mix ture, house dust mite
(Derma tophagoides pteronyssinus), and Rag weed
(Am bro sia elatior) as al ler gens. The high est level of 
im prove ment was seen in pa tients with AD+AR or
AD+AC. Spe cific immunotherapy in our 215 pa -
tients was suc cess ful ac cord ing to clin i cal find ings
and spe cific IgE re sults. Pa tients who have co ex is -
tence of AD with mucosal dis ease had better out -
come then the pa tients with pure AD.
O 55
NAPHTHALAN IN THE TREAT MENT OF
PA TIENTS WITH ATOPIC DER MA TI TIS
A. Smeh-Skrbin, I. Dobriæ1, G. Krnjeviæ-Peziæ, 
P. Vržogiæ
Naftalan, spe cial hos pi tal for med i cal re ha bil i ta tion, Ivaniæ
Grad;1De part ment of Der ma tol ogy and Venereology, Zagreb 
Uni ver sity Hos pi tal Cen ter, Zagreb, Croatia
In the last two years we have made sev eral pre -
lim i nary re ports about our ex pe ri ence in the treat -
ment of atopic der ma ti tis with naphthalan. As our
re search is com ing to an end, we re port the re sults
of the ther apy of 20 pa tients. We be lieve that this re -
port is even more valu able since the fol low-up is
now 2 years. In this re search, we in cluded 20 pa -
tients aged 15 and above, who had dif fer ent clin i cal
forms of atopic der ma ti tis. Naphthalan ther apy was
ap plied for 3 weeks. Dur ing that pe riod the pa tients
were tak ing baths in tubs con tain ing Naphthalan oil
(tem per a ture 34-38°C) once a day for 12-14 min -
utes. This is a com mon ther apy ap plied in the last
15 years in the treat ment of pa tients with pso ri a sis
and rheu matic dis eases. Be sides naphthalan
baths, pa tients were also ap ply ing neu tral cream
and oral an ti his ta mines. The meth ods for the eval u -
a tion of the ther a peu tic re sults were as fol lows: 1)
eval u a tion of skin changes; a) pho to graphs taken
be fore and af ter the 3-week ther apy; b) SCORAD
in dex (Eu ro pean ex pert group for atopic der ma ti tis)
be fore and af ter the 3-week ther apy; 2) skin bi opsy
be fore and af ter the 3-week ther apy; 3) to tal IgE;
and 4) he ma to log i cal and bio chem i cal tests be fore
and af ter the 3-week ther apy. On the ba sis of our re -
sults, we may say that naphthalan was a good treat -
ment op tion in 70% of pa tients with atopic der ma ti -
tis. This kind of ther apy can be rec om mended in the 
treat ment of atopic der ma ti tis for adults as well as
for chil dren. The ef fi ciency of the naphtalan ther apy
was eval u ated ac cord ing to SCORAD in dex (75.4
be fore and 30.9 af ter the 3-week ther apy), photo
doc u men ta tion (re mis sion of skin changes af ter the
3-week ther apy) and histopathological ex am i na tion
(sig nif i cant re duc tion of in flam ma tory in fil tra tion as
well as the re duc tion of acanthosis in about 2/3 of
the ex am ined pa tients). Stan dard laboratory anal y -
sis did not detect pathologic changes, which could
perhaps suggest nephrotoxicity, hematotoxi citiy or
hepatotoxicity of the naphthalan oil.
POST ERS
P 1
REPRODUCIBILITY OF ATOPY PATCH
TESTS WITH AEROALLERGENS AND FOOD 
AL LER GENS
S. Seidenari, F. Giusti
De part ment of Der ma tol ogy, Uni ver sity of Modena and
Reggio Emilia, It aly
Atopy patch tests (APT) are be lieved to be a
use ful di ag nos tic pro ce dure for atopic der ma ti tis
(AD), but their reproducibility has been poorly in -
ves ti gated so far. We in ves ti gated APT reproduci -
bility by si mul ta neously ap ply ing two iden ti cal patch 
test se ries in 85 pa tients with AD. The test sub -
stances in cluded two com mer cially avail able ma te -
ri als (Dermatophagoides mix 20% pet. and Alter -
naria alternata 2.4% pet.) and 8 self-made food
prep a ra tions con tain ing egg yolk, egg white, pea -
nut, cow’s milk, soy milk, wheat flour, rice, and corn
meal. The per cent age of agree ment in the fre -
quency of pos i tive re ac tions ranged from 87% (corn 
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meal) to 100% (soymilk). The reproducibility was
sat is fac tory for Dermatophagoides mix, Alternaria
alternata, egg yolk, soymilk, and pea nuts. In con -
clu sion, for com mer cial al ler gens, such as Derma -
to phagoides and Alternaria alternata, the agree -
ment rate was sim i lar to that of stan dard patch tests
and, there fore, APTs may be con sid ered suf fi ciently 
re pro duc ible to be used as a di ag nos tic test ing pro -
ce dure. As re gards food ma te ri als, such as egg
yolk, pea nuts, and soymilk, APT reproducibility may 
be acceptable. For other foodstuffs, preparation
methods should be improved.
P 2
ATOPY PATCH TESTS WITH
DERMATOPHAGOIDES IN PA TIENTS
WITH OUT ATOPIC DER MA TI TIS
S. Seidenari, F. Giusti
De part ment of Der ma tol ogy, Uni ver sity of Modena and
Reggio Emilia, It aly
So far the is sue of atopy patch tests (APTs ) in
sub jects not af fected by atopic der ma ti tis (AD) has
been in ves ti gated by few au thors with con trast ing
re sults. Our aim was to eval u ate the fre quency and
in ten sity of APT re sponses to mite al ler gens in
non-AD sub jects in com par i son with AD pa tients.
APTs were per formed em ploy ing a mix of Derma -
tophagoides pteronyssinus/farinae on 75 non-AD
sub jects, in clud ing 33 pa tients with al ler gic rhi ni tis
and/or asthma and 42 healthy vol un teers, and on
210 AD pa tients. Pos i tive re ac tions were ob served
in 23% of non-AD sub jects and in 49% of AD ones.
The for mer showed re sponses of lower in ten sity
(mean score, 1.4) than AD pa tients (mean score,
2.1). The fre quency of pos i tive re ac tions to house
dust mites proved sig nif i cantly higher in the sub -
group of healthy vol un teers than in pa tients with re -
spi ra tory symp toms. In con clu sion, pos i tive re -
sponses to APTs with Dermatophagoides are ob -
serv able also in sub jects not af fected by AD, but
their fre quency and in ten sity are sig nif i cantly lower
in com par i son with AD pa tients. De layed skin re ac -
tiv ity in non-AD sub jects may be re garded as equiv -
a lent to the find ing of spe cific IgE by skin prick tests
or RAST in healthy sub jects, in di cat ing an atopic
state. For the oc cur rence of both, the in duc tion and
the elic i ta tion of the der ma ti tis other skin fac tors
should prob a bly be con com i tant.
P 3
A CASE OF ATOPIC DER MA TI TIS WITH
SUD DEN AP PEAR ANCE OF AC QUIRED
ICH THY O SIS
S. Ljubojeviæ, A. Pašiæ, J. Lipozenèiæ, I.
Dobriæ
De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver -
sity Hos pi tal Cen ter, Zagreb, Croatia
Ac quired ich thy o sis is not in her ited and oc curs
for the first time in adult hood. It is usu ally as so ci -
ated with some gen eral sys temic dis ease, such as
can cer (lung, breast, ovary, or cer vix), Hodg kin dis -
ease, lym phoma, sarcoidosis, Kaposi sar coma,
lep rosy. thy roid dis ease, nu tri tion dis or ders, or HIV
in fec tion. It may be pro voked by cer tain med i ca -
tions, such as nic o tinic acid, hydroxyurea, cho les -
terol-low er ing agent, or cimetidine clofazimine. A
25-year-old men with out past his tory of skin dis -
ease was ad mit ted to our De part ment. Two months
be fore, he had no ticed hyperkeratosis on his palms
and soles with a pain ful fis sur ing. Grad u ally, his
skin be came dry with sym met ri cal lamellar hyper -
pigmented scal ing, par tic u larly on the extensor sur -
faces of the ex trem i ties and lat eral as pects of his
trunk and back. At birth his skin ap peared nor mal.
No body in the fam ily had a his tory of atopic dis -
eases. Lab o ra tory re sults re vealed low con cen tra -
tion of vi ta min A in the se rum and in creased con -
cen tra tion of IgE. Histological find ings con firmed
vul gar ich thy o sis as so ci ated with atopic der ma ti tis.
Prick test was pos i tive to many in hal ant al ler gens.
In ter nal dis eases and ma lig nan cies were ex cluded. 
He was treated with lo cal keratolitics and neu tral
oint ments to gether with vi ta min A prep a ra tions. Ac -
quired ich thy o sis is ex tremely rare. When it is sud -
denly pre sented in adult pa tient, as so ci ated in ter nal 
dis eases should be ex cluded. Recognition of these
conditions is necessary to institute therapy that will
reduce discomfort experienced by affected in di vi d -
u als.
P 4
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PRE VEN TIVE MEA SURE MENT OF pH –
VALUE IN COS METIC DER MA TI TIS
PA TIENTS
B. Vincetiæ, J. Lipozenèiæ1, S. Ljubojeviæ1
“Saponia” Chem i cal, Food and Phar ma ceu ti cal In dus tries,
Osijek; and 1De part ment of Der ma tol ogy and Venerology,
Zagreb Uni ver sity Hos pi tal Cen ter, Zagreb, Croatia
Al pha hydroxy ac ids (AHAs) di min ish the co he -
sion be tween corneocytes at lower stra tum corn -
eum lay ers, af fect ing the intercellular ionic bonds.
Ac cord ing to E. J. Van Scott, the weak en ing of co -
he sive intercellular forces hap pens via three mech -
a nisms: hydratization; re duc tion of electronegative
ionic groups in the cells; and chang ing the me dium
be tween charges lead ing to the dis so lu tion of
desmosomes in the intercellular space. There are
vis i ble ef fects of AHA-based cos metic prod ucts on
re ju ve na tion of skin af ter long-term us age. For cos -
metic prod ucts based on AHA, the pH value of the
skin is one of the most im por tant in di ca tors of their
ef fi cacy, since their mech a nism of ac tion has a di -
rect in flu ence on the pH changes at the epi der mal
cell level. We mea sured skin pH changes in 120
sub jects aged be tween 19 and 66 years. The pH
was de ter mined on the left and right cheek be fore
the ap pli ca tion of a cream, and then at 30 min utes,
4 weeks, and 8 weeks af ter ap pli ca tion of a par tic u -
lar cream. Skin pH was de ter mined by electrometric 
method in vivo by us ing a dig i tal pH me ter equipped 
with a Mett ler ”sin gle pore flat” elec trode. Mea sure -
ment points were cheek skin sur face of 9 cm2 near
the left and right ear. En vi ron men tal con di tions
were also mea sured: tem per a ture as 21°C, and hu -
mid ity 42% on the first, 60% on sec ond, and 50% on 
third and fourth mea sure ments. Sub ject re sponse
was 42% (50 out of 120 pa tients). The pla cebo
cream (A) and AHA cream with pH 2.9 (B), pH 3.6
(C), and pH 5.1 (D) were tested. Skin pH for the
cream A (pH 6.1) changed on av er age from 0.29 to
-0.18 and -0,15; for the cream B (pH 2.9) it changed
from –0.36 to .0.11, and from -0.32 to -0.46. For the
cream C (pH 3.6), pH changed from -0.12 to -0.20
and from -0.18 to –0.23, and for the cream D (pH
5.1) from 0.26 to 0.33, and 0.30 to –0.07. More acid
AHA-based creams with lower pH of about three
causes a greater de crease in skin pH than the
creams with pH higher than five, which do not con -
tain AHAs in the form of free acid, or at all. The im -
prove ment of the method of electrometric mea sure -
ment of skin sur face pH in vivo will al low a quick
con trol of the skin pH de crease, which is the ba sic
pre req ui site for the ef fi cacy of AHA-based cos metic 
prod ucts. It is to be ex pected that fur ther re search
into all the mech a nisms of ac tion of AHAs will help
to wards es tab lish ing these sub stances as more
than a “pass ing fash ion”, i.e., as a true contribution
of our decade to the cosmetics of 21st century.
P 5
CON COM I TANT RE SPI RA TORY AL LERGY
IN ATOPIC DERMATTIS
L. Lugoviæ, J. Lipozenèiæ1
De part ment of Dermatovenerology, Sestre Milosrdnice Uni -
ver sity Hos pi tal, and 1De part ment of Der ma tol ogy and
Venerology, Zagreb Uni ver sity Hos pi tal Cen ter, Zagreb,
Croatia
Pre vi ous stud ies showed that sim i lar mech a -
nisms were in volved in the pathogenesis of atopic
dis eases, e.g., al ler gic bron chial asthma (AB), al ler -
gic rhinoconjunctivitis (AR), and atopic der ma ti tis
(AD). Be cause of the sim i lar ity of these dis eases,
there is a pro posal to dis tin guish three main sub -
types of AD: “mixed” type with con com i tant re spi ra -
tory al lergy (RA); “ex trin sic” type of “pure” AD with -
out RA, but with al ler gen-spe cific IgE; and “in trin sic” 
type with out im me di ate type sensitizations. The aim 
of this study was to de ter mine the dif fer ence of test
re sults be tween pa tients with “pure” AD (n=10) and
“mixed” AD (n=20). There were 30 AD pa tients in -
ves ti gated. The pa ram e ters for mon i tor ing were
per sonal and fam ily his tory; cu ta ne ous tests (skin
prick, scratch, and patch test), and val ues of to tal
se rum im mu no glob u lin E ac cord ing stan dard Eu ro -
pean pro ce dures. The re sults showed the age of
on set was mostly in the early in fancy – 15 pa tients
had de vel oped the dis ease while un der the age of
2: 2 out of 10 de vel oped “pure” AD, and 13 out of 20
de vel oped “mixed” AD. Twenty pa tients had a his -
tory of RA (“mixed” AD), whereas the re main ing 10
had “pure” AD. Sev en teen AD pa tients also had
one al ler gic dis ease, whereas 3 had two con di tions
(AR and AB). Fam ily his tory was pos i tive for atopy
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in 22 AD pa tients (14 pa tients in a first-de gree rel a -
tive). Twenty-four pa tients had pos i tive prick tests: 9 
out of 10 with “pure” AD, and 15 out of 20 with
“mixed” AD, mostly to house dust (n=20). Scratch
test re ac tions were pos i tive in 4 out of 10 pa tients
with “pure” AD and 12 out of 20 with “mixed” AD.
Patch test re ac tions were pos i tive in 5 pa tients with
“pure” AD and in 15 with “mixed” AD. Twenty-one
out of 30 AD pa tients had higher se rum IgE (7 out of 
10 with “pure” AD and 14 out of 20 with “mixed” AD), 
but the con cen tra tions were sim i lar in both “pure”
and “mixed” AD. No sta tis ti cally sig nif i cant dif fer -
ences be tween the “pure” and “mixed” AD pa tient
groups were found, ex cept for the age at on set,
which was lower in the group of pa tients with con -
com i tant RA. The re sults of our study did not show
any differences in the allergologic parameters and
the status between AD patients with concomitant
RA and those without RA.
P 6
CLIN I CAL SAFETY OF PHOTOTHERAPY
AND PIMECROLIMUS CREAM IN ATOPIC
DER MA TI TIS PA TIENTS
N. Lapshin, T. Latysheva, O. Elissioutina
Fed eral Sci en tific Cen ter – The In sti tute of Im mu nol ogy.
Mos cow, Rus sia
We in ves ti gated the safety of phototherapy
(280-400 nm) and pimecrolimus cream 1% (Elidel)
in atopic der ma ti tis pa tients. The pa tient group con -
sisted of 36 pa tients (13 male and 23 fe male) aged
7-25 years, who suf fered from AD. Pa tients were
ran dom ized 1:1 to re ceive ei ther pimecrolimus
cream 1% or phototherapy. Pimecrolimus cream
was ap plied daily un til the signs and symp toms
were re solved. Phototherapy was used dur ing 20
days ac cord ing to the stan dard method, i.e., 2
courses with 3-month in ter val in-be tween. The pa -
tients treated with pimecrolimus cream did not de -
velop pyoderma or her pes sim plex dur ing the ob -
ser va tion. In the group of pa tients un der go ing pho -
to therapy, there were 3 cases of pyoderma and one
case of her pes sim plex dur ing the ob ser va tion pe -
riod. Long ap pli ca tion of Elidel cream and pho -
totherapy are the meth ods of treat ing mild and mod -
er ate atopic der ma ti tis. In this study, Elidel cream
application proved to be safer then photo therapy.
P 7
CELL-ME DI ATED AU TO IM MUNE
RE AC TIONS BE TWEEN SKIN-HOM ING
T-LYMFOCYTES AND PE RIPH ERAL
MONONUCLEAR BLOOD CELLS IN
PA TIENTS WITH ATOPIC DER MA TI TIS
J. Baumgartner-Niel sen, C. Vestergaard, M.
Deleuran, K. Thestrup-Pedersen
De part ment of Der ma tol ogy and Venerology, Aarhus, Den -
mark
Atopic Der ma ti tis (AD) is dom i nated by
skin-hom ing T-lym pho cytes. The aim of this study
was to de scribe if there are any in ter ac tions in an
autologous sys tem be tween T-lym pho cytes in the
skin and pe riph eral mononuclear blood cells
(PBMC), i.e. signs of a cell-me di ated au to im mune
re ac tion. T cell lines were ob tained from skin bi op -
sies from clin i cally af fected skin of pa tients with AD.
The bi op sies were placed in RPMI-1640 with 10%
hu man AB se rum, interleukin (IL)-2 and IL-4, but
with out feeder cells, an ti gen, or mitogen. Af ter four
weeks, T-cell lines (9-12 cell doublings) were pres -
ent in the me dia. Four weeks af ter the bi op sies
were taken and placed in growth me dium, 30 mL
heparinized blood was drawn from the pa tients.
PBMC was iso lated with Lymphoprep®. T-lym pho -
cytes from the cul ture or PBMCs were treated with
Mitomycin-C and mixed in 96-well plates with
non-Mitomycin-C treated cul ture T-lym pho cytes or
PBMC. Af ter 6 days, a pro lif er a tion as say was per -
formed by us ing Cell Ti ter 96® Aque ous One So lu -
tion Cell Pro lif er a tion As say, re cord ing absorbance
of 490 nm, and a 96-well plate reader. PBMC mixed
with Mitomycin-C treated cul ture T-lym pho cytes
showed a sig nif i cant higher pro lif er a tion rate than
PBMC with out cul ture T-lym pho cytes. The re sults
of the study in di cated there was an in ter ac tion be -
tween PBMC and T-lym pho cytes from the skin. This 
in ter ac tion could be an au to im mune reaction, a
finding that may open up new perspectives for the
understanding and the treatment of AD.
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P 8
SE RUM IgE LEV ELS IN CON TACT AL LER GIC 
DER MA TI TIS
I. Kuljanac, E. Kneževiæ, H. Cvitanoviæ
De part ment of Der ma tol ogy, Karlovac Gen eral Hos pi tal,
Karlovac, Croatia
Sev eral cor re la tions have been found be tween
se rum IgE con cen tra tions and clin i cal find ings in
atopic der ma ti tis (AD). Ob ser va tions sug gest that
the patho genic in crease in IgE may not be causal.
In creased se rum IgE con cen tra tions are not unique 
to AD and have been doc u mented in pa tients with
con tact al ler gic der ma ti tis (CAD), dyshidrotic ec -
zema, and pso ri a sis. Most re sults sug gest that in -
creased se rum IgE con cen tra tion is a sec ond ary
phe nom e non rather than a pri mary caus ative fac -
tor. The aim of this study was to de ter mine IgE se -
rum con cen tra tions in CAD, ac cord ing to his du ra -
tion. Pa tients (N=122) with CAD were di vided into
three groups ac cord ing to the du ra tion of the dis -
ease: ill for one year, 1-5 years, and over 5 years. In
all of them the di ag no sis of CAD was con firmed with 
clin i cal find ings and epicutaneous patch test. Se -
rum con cen tra tions of IgE (sin gle ra dial immuno -
diffusion) were de ter mined and com pared with 58
con trol val ues in healthy per sons. No cor re la tion
be tween du ra tion of CAD and se rum IgE con cen tra -
tions was found. Se rum concentrations of IgE in
patients with CAD and healthy persons were not
significantly different.
P 9
CON TACT HY PER SEN SI TIV ITY IN ATOPIC
DER MA TI TIS PA TIENTS
I. Kuljanac, E. Kneževiæ, H. Cvitanoviæ
De part ment of Der ma tol ogy, Karlovac Gen eral Hos pi tal,
Karlovac, Croatia
Atopic der ma ti tis (AD) is a com mon chronic in -
flam ma tory dis ease, which gen er ally be gins in early 
in fancy. Symp toms in clude rashes, ves i cles, and
itches, and are char ac ter is tic of the dis ease. Fam ily
his tory of atopy has con firmed that AD must have a
dis tinct ge netic back ground. Stud ies sup port the
con cept of an im mu no log i cal ba sis of humoral and
cell-me di ated im mune dysfunctions. An equal or
higher oc cur rence of con tact al lergy in atopic than
in nonatopic sub jects has been re ported. Dur ing
1998-2003 pe riod, patch test ing was car ried out in
65 pa tients (31% men and 69% omen). Twenty-six
pa tients, 7 men and 19 women, showed pos i tive re -
ac tions to one or more al ler gens. Al ler gic re ac tions
were more fre quently found in women. The most
com mon al ler gen was nickel (33%), fol lowed by co -
balt (11%), fra grance mix (11%), Hg pp albi (8%),
and other al ler gens (36%). The as so ci a tion be -
tween nickel al lergy and co balt al lergy was sig nif i -
cant. We have con cluded that contact hy per sen si -
tiv ity is not rare in patients with atopic dermatitis.
P 10
SPE CIFIC IMMUNOTHERAPY OF ATOPIC
DIS EASES-OUR EXPIRIENCES
N. Sijerèiæ, N. Hadžigrahiæ, S. Kamberoviæ
De part ment of Der ma tol ogy and Venerology, Tuzla Uni ver -
sity Hos pi tal Cen ter, Tuzla, Bosnia and Herzegovina
Atopy is a very com plex dis ease of ten ac com pa -
nied by high IgE con cen tra tions, re spi ra tory, and
cu ta ne ous dis or ders. Ge netic fac tor has an im por -
tant role in ap pear ance of the dis ease. We show our 
ex pe ri ence with hyposensibilization in atopic dis -
eases. From Jan u ary 1996 to Jan u ary 2004, we
treated 160 pa tients with atopic dis or ders: al ler gic
rhi ni tis (n=60), atopic der ma ti tis (n=20), ur ti caria
and edema angioneuroticum (n=36), asthma bron -
c hiale (n=32), and al ler gic con junc ti vi tis (n=12). We
used stan dard ized so lu tion of al ler gens made by
Im mu no log i cal In sti tute in Zagreb, Croatia, and
treated pa tients by stan dard scheme, al though
some times it was nec es sary to adapt the dose in di -
vid u ally. Pa tients for immunotherapy were cho sen
upon the re sults of intradermal test ing and con cen -
tra tions of to tal IgE. The most fre quent al ler gens for
immunotherapy were mixed house dust mite,
dermato phagoides, mixed pol lens, sin gle pol lens,
plum age, an i mal dander, and pelt. De gree of suc -
cess in spe cific immunotherapy was es ti mated ac -
cord ing to the pa tient’s judg ment of sub jec tive prob -
lems by us ing a 5-level scale (5 – very se vere, 4 –
se vere, 3 – mod er ate, 2 – mild, and 1 – very mild).
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The best re sults were achieved in pa tients suf fer ing 
from atopic rhi ni tis, fol lowed by those with asthma
bronchiale and atopic der ma ti tis. Dur ing ap pli ca -
tions of spe cific immunotherapy, we noted four
cases of gen er a l ized urticaria with bronchial
obstruction and two cases of urticaria with
abdominal colic.
P 11
ARE IN CREASED CON CEN TRA TIONS OF
EOSINOPHIL CATIONIC PRO TEIN IN THE
SERA OF CHIL DREN WITH ATOPIC
DER MA TI TIS MARK ERS OF
IN FLAM MA TION SE VER ITY?
V. Žižiæ, J. Lipozenèiæ1, S. Murat-Sušiæ1, K.
Husar1, N. Pustišek
Zagreb Chil dren’s Hos pi tal, Zagreb Uni ver sity School of
Med i cine, and 1De part ment of Der ma tol ogy and Venerology, 
Zagreb Uni ver sity Hos pi tal Cen ter, Zagreb, Croatia
Eosinophilia ac com pa nies dif fer ent in flam ma -
tory dis or ders, in clud ing atopic der ma ti tis. Eosino -
phils and their toxic prod ucts can be found in the in -
flamed tis sue, e.g. in asthma, where their gran ule
prod ucts seem to be ma jor causes of the de struc -
tion of ep i the lial cells in the air ways. In ac ti vated
eosinophils, eosinophil cationic pro tein (ECP) is
pres ent in in creased con cen tra tions. The aim of our 
study was to de ter mine the ECP val ues in chil dren
with atopic der ma ti tis and com pare them with
SCORAD in dex. Fluoroenzymeimmunoassay Uni-
 CAP ECP sys tem (Pharmacia Di ag nos tics, Uppsala, 
Swe den) was used for in vi tro quan ti ta tive mea -
surement of ECP in the sera of 80 chil dren with
atopic der ma ti tis aged 1-7 years. Uni-CAP ECP as -
say was per formed on a Uni-CAP 100 in stru ment
(2.5 mL or 4 mL vacutainer hemogard and SST
glass tube). The as say is based on the re ac tion be -
tween anti-ECP, co va lently cou pled to ImmunoCAP, 
and the ECP in the se rum. Af ter wash ing, en -
zyme-la beled an ti bod ies against ECP are added to
form a com plex. Af ter in cu ba tion, un bound en -
zyme- anti-ECP is washed out and the bound com -
plex in cu bated with a de vel op ing agent. The flu o -
res cence of the eluate mea sured af ter the re ac tion
stops is trans formed into the con cen tra tion by use
of a cal i bra tion curve. Ref er ent val ues of ECP con -
cen tra tion in the sera were 20 mg/L, and SCORAD
in dex was cal cu lated ac cord ing to the ETAC study
group. ECP con cen tra tions in the sera of 80 chil -
dren ranged be tween 3.25 mg/L and 75.70 mg/L. In -
creased ECP con cen tra tions were found in the sera 
of 25 children (range, 20.8-75.7 mg/L; av er age, 35.7
mg/L). The high est ECP con cen tra tions were mea -
sured in chil dren with SCORAD in dex be tween 55
and 60. In creased ECP con cen tra tions in the sera of
25 chil dren with atopic der ma ti tis in di cated the pres -
ence of ac ti vated eosinophils. De ter mi na tion of re -
leased ECP may a way to mon i tor dis eases in volv ing 
eosinophil ac ti va tion and the ef fect of ther apy.
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Marko Polo´s Di ary
Stella Fatoviæ-Ferenèiæ, ESHDV rep re sen ta tive of Croatia
On Art Nou veau es thet ics, and on the re la tion of med i cine and art – Re flec tions
on the “Se ces sion in Croatia” ex hi bi tion in the Mu seum of Arts and Crafts,
Zagreb
This time I did not board an air plane, cross the
bor ders, and leave the coun try. Yet, the visit to the
Mu seum of Arts and Crafts made me equally ex -
cited, and left me with the ex traor di nary feel ing of a
travel through out time, a fas ci na tion with beauty,
which only the re la tion with art can cre ate. The ex hi -
bi tion of Se ces sion in Croatia in the Mu seum of Arts 
and Crafts in Zagreb was an im pres sive and ex -
traor di nary event, where more than a thou sand art
ob jects were dis played, rep re sent ing one of the
most ex u ber ant and in no va tive of all styles. Since
1897, when a group of art ists in Vi enna gave birth to 
an other form of mod ern ism in the vi sual arts by for -
mu lat ing the Se ces sion, the in flu ence of this new
es thet ics of de sign quickly spread through out the
Eu rope (un der dif fer ent names, such as Mod ern
Style, Jugendstil, Lib erty Style, Stile Floreal, Art
Nou veau, or El modernismo.), in clud ing Croatia.
The di ver sity of paint ings, sculp tures, graph i cally
de signed ob jects, ar chi tec ture, ce ram ics and glass, 
as well as fur ni ture, fash ion, the ater, mu sic, and all
other as pects of life de picted an im pres sive land -
scape of har mony, ad mi ra tion, and nos tal gia. Ev ery 
seg ment of the ex hi bi tion was rep re sented by the
most prom i nent mas ter pieces from Cro atian art ists, 
paitners Vlaho Bukovac, Bela Èikoš Sesija, Mirko
Raèki, Rob ert Frangeš, and Ivan Meštroviæ, and ar -
chi tects Rudolf Lubynski, Aladar Barany, Ignjat
Fischer, Dionis Sunko, and many oth ers. The life -
style of that pe riod was also pre sented through ob -
jects im ported from other cit ies of Jugendstil, e.g.,
the fur ni ture of Jo seph Hoffmann and glass ob jects
of Louis Com fort Tif fany, show ing in de tail the
aware ness that ev ery sin gle art ist had for the “to tal
work of art”. The field of his tory of med i cine, phar -
macy, and den tistry was pre sented by the ar chi tec -
ture of the prom i nent fig ures of the pe riod, such as
Feller, Peèiæ, and the den tist Rado. Eugen Viktor
Feller (1871-1936) was known for his fa mous spe -
cialty pro duc tion Elsa fluid. At the turn of the 19th
cen tury, he be came one of the most suc cess ful
phar ma cists and en tre pre neurs of the pe riod,
whose in vest ments in Zagreb’s ar chi tec ture were
sig nif i cant. Among the most pop u lar build ings of
that time was the four-story Elsa fluid house erected 
in 1905/6 at the cor ner of Jurišiæeva Street and
Jelaèiæ square. This ed i fice rep re sented a de sign of 
the most prom i nent and pro duc tive ar chi tec tural bu -
reau of the pe riod. A huge bot tle paced in the
south-west part where the two main fronts of the
build ing meet rep re sented Elsa fluid and be came a
trade mark of the first big phar ma ceu ti cal com pany
in Zagreb. Ev i dently, Se ces sion was deeply pres ent 
in all as pect of hu man life, and med i cine was not an
ex cep tion. Suf fice it to re mem ber Gustav Klimt
(1862- 1918), one of the found ers of Art Nou veau in
Vi enna and his three al le gor i cal im ages com pleted
for the large am phi theatre at the Uni ver sity of Vi -
enna. Among those paint ings was also Med i cine,
first pre sented in 1901, which showed the pow er -
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less ness of the art of heal ing in stead of the tri umph
of med i cine. The is sue was so se verely crit i cized
and at tacked that it even reached the par lia ment.
With draw ing from work for the uni ver sity, Klimt
believed that no person or institution had the right to 
limit the artistic freedom or ruin the artistic integrity.
This stimulated him further to form The Vienna
Secession.
The con nec tion be tween art and med i cine is
get ting stron ger and re cently, it has been in tro -
duced even into med i cal cur ric ula through out the
world by ef forts of med i cal hu man i ties. Filled with
beauty my eyes had seen in the Mu seum, I thought
that per haps the best way to ed u cate our selves and 
learn about the world around us, in clud ing med i -
cine, is through vi sual arts. This could cre ate a
sense for beauty and abil ity to fo cus on el e ments
we usu ally over see in the mass of data, as well as
en able us to pre serve and re call them and give
them im por tance and space in our lives, for our own 
and our patients’ benefit.
*********************************
The world is wait ing, sretan vam put ! 
stella@hazu.hr
*********************************
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UPCOMING MEDICAL MEETINGS
Continuing Medical Education Course
UP DATE ON PSO RI A SIS
Zagreb, Croatia
Oc to ber 15-16, 2004
The Con tin u ing Med i cal Ed u ca tion Course is or ga nized by the Chair of Dermatovenerology, Zagreb Uni ver sity
School of Med i cine and De part ment of Der ma tol ogy and Venerology, un der the aus pices of
Acad emy of Med i cal Sci ences of Croatia.
Known ex perts in the field of pso ri a sis will also par tic i pate in the Course.
Or ga niz ers:
Prof. Jasna Lipozenèiæ, MD, PhD
Aida Pašiæ, MD, PhD
De part ment of Der ma tol ogy and Venerology
Zagreb Uni ver sity Hos pi tal Cen ter




Marks JG Jr, Elsner P, DeLeo VA, ed i -
tors. Con tact and Oc cu pa tional Der ma tol ogy.
3rd edi tion. St. Louis (MO): Mosby; 2002. Pages:
431. Price: US$134.80 ISBN: 0323014739
The third edi tion of Con tact and Oc cu pa tional
Der ma tol ogy, ed ited by Drs. Marks, Elsner, and
DeLeo, is in tended for cli ni cians to use it in their ev -
ery day prac tice when eval u at ing pa tients with oc cu -
pa tional dermatoses. Prac tic ing der ma tol o gists and 
phy si cians may only ben e fit from brief, in for ma tive,
user-friendly text, free of un nec es sary de tails and
ex ces sive (and of ten daunt ing) chem i cal no men -
cla ture, which they can read with ease. This book is
just what they are look ing for. The clas si fi ca tion of
oc cu pa tions has dif fer ent lev els. This book pro -
vides prac ti tio ners and oc cu pa tional health care
pro fes sion als with a sci en tific tool to develop codes
of practice in exposure to chemical agents.
The book be gins with an over view of the tra di -
tional pathophysiology, mech a nisms, and im mu nol -
ogy of con tact al ler gic and/or ir ri tant der ma ti tis, and
con tin ues with eval u a tion; his tory tak ing; ex am i na -
tion; patch test tech nique; read ing, re cord ing, and
in ter pret ing the re sults; and in struc tions for patients
how to avoid allergens.
Var i ous al ler gens are pre sented in Chap ters
5-11. Ta bles that ac com pany al ler gen de scrip tions
are easy-to-con sult and very prac ti cal. Der ma tol o -
gists per form ing a patch test know how dif fi cult it is
to find a de tailed pro to col for photo-patch test ing,
and one can find it in this book. Be sides clar i fy ing
pro to cols and ta bles, there is a use ful and
easy-to-read guide to patch testing and patient
care.
The con densed chap ters on oc cu pa tional skin
dis eases cover most of the rel e vant pro fes sions/oc -
cu pa tions and sum ma rize a great deal of in for ma -
tion in an ac ces si ble and well-or ga nized way. The
reader can only ben e fit from a gen er ous num ber of
ta bles, fig ures, and il lus tra tions, high lighted in for -
ma tion of spe cial im por tance, and a list of ac cepted
norms regarding occupational dermatology.
For prac tic ing gen eral der ma tol o gists who daily
see in their of fice more than a few pa tients with con -
tact der ma ti tis, this book is an ex cel lent choice as it
would not only en rich the li brary of ev ery der ma tol o -
gist but also find its use in everyday practice.
Aida Pašiæ, MD, PhD
Prof. Jasna Lipozenèiæ, MD, PhD
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Up date on Atopic Ec zema/Der ma ti tis Syn drome, Cavtat, Croatia, April 25-28, 2004. Con tact: Prof.
Jasna Lipozenèiæ, De part ment of Der ma tol ogy and Venerology, Zagreb Uni ver sity Hos pi tal Cen ter, Šalata 4, 
10000 Zagreb; Con tact: jasna.lipozencic@zg.tel.hr; www.cybermed.hr/4dermkh
Sec ond EADV In ter na tional Spring Sym po sium, Bu da pest, Hun gary, April 29-May 1, 2004. Con tact:
info@eadvbudapest2004.com; www.eadvbudapest2004.com
66th An nual Meet ing of the So ci ety for In ves ti ga tive Der ma tol ogy, St. Louis, Mis souri, May 4-7, 2004. 
Con tact: Kate Rader, Meet ings Man ager, 820 W. Su pe rior Av e nue, 7th Floor, Cleve land; Krader@sidnet.org
31st An nual Joint Meet ing of So ci ety for Cu ta ne ous Ultrastructure Re search and Eu ro pean So ci -
ety for Dermatopathology, Rome, It aly, May 6-8, 2004. Con tact: www.prex.it/congressi/scur/in dex.html
9th In ter na tional Con gress of Der ma tol ogy, Beijing, China, May 19-22, 2004. Con tact: ICD2004 Sec -
re tar iat, In ter na tional De part ment, Chi nese Med i cal As so ci a tion, 42 Dongsi Xidajie, Beijing 100710, China;
ICD2004@chinamed.com.cn; www.chinamed.com.cn/der ma tol ogy
  
In ter na tional Sym po sium “Fron tiers in Al lergy and Autoimmunity”, Mainz, Ger many, May 21-22,
2004. Con tact: Anja.Oberlaender@uni-mainz.de
15th Ljudevit Jurak In ter na tional Sym po sium on Com par a tive Pa thol ogy; Main Topic: Head & Neck
Pa thol ogy, Zagreb, Croatia, June 4-5, 2003. Con tact: www.kbsm.hr/jurak/sym po sium.htm
Slo vak Dermatovenerological Con gress with In ter na tional Par tic i pa tion, Bratislava, Slo vak Re pub -
lic, June 4-6, 2004. Con tact: scretarysma@ba.telecom.sk
7th Con gress of the Eu ro pean So ci ety of Con tact Der ma ti tis, Co pen ha gen, Den mark, June 6-8,
2004. Con tact: Or ga niz ing Sec re tar iat PREXY S.r.l. – Vialle Monza 20125 Milano, It aly; Liss@ics.dk;
congressi@prex.it,  www.iscd2004.info
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23rd Con gress of the Eu ro pean Acad emy of Allergology and Clin i cal Im mu nol ogy, Am ster dam,
Neth er lands, June 12-16, 2004. Con tact: Dept. Allergology, Uni ver sity Hos pi tal Rot ter dam, dr.
Molewaterplein 40, NL-3015 GD Rot ter dam, The Neth er lands; degroot@algo.azr.nl;
www.congrex.com/eaaci2004
28th An nual Meet ing of the Is rael So ci ety of Der ma tol ogy and Venereology, Eilat, Is rael, June 16-17,
2004. Con tact: Prof. Sa rah Brenner, The Tel Aviv Sourasky Med i cal Cen ter, Weizman Street, Tel Aviv 64239, 
Is rael; tel: 972 3 6974287; fax: 972 3 6974810
10th Con gress of the Eu ro pean Con fed er a tion of Med i cal My col ogy, June 17-20, 2004, Warsaw, Po -
land. Con tact: Con gress Care, Muntelbolwerk 1, P.O. Box 440, 5201 AK’s-Hertogenbosch, The Neth er -
lands; info@congresscare.com , www.congresscare.com
4th Eu ro pean Con gress of Aestetic Med i cine and 6th Con gress of the Swiss So ci ety of Aestetic
Med i cine, Zurich, Swit zer land, June 25-26, 2004. Con tact: Pro Ser vices Con sult ing - Pa tri cia Lafitte,
Chemin des Baules 14, CH - 1268 Begnins - Swit zer land; patricialafitte@deckpoint.ch; www.ssme.ch
10th World Con gress of Pe di at ric Der ma tol ogy, Rome, It aly, July 7-10, 2004. Con tact: Tri umph
Congressi, Via Lucilio, 60, 00136 Rome, It aly; der mo@gruppotriumph.it; www.gruppotriumph.it
19th Con tin u ing Med i cal Ed u ca tion Course for Prac ti cal Der ma tol ogy and Venerology, Mu nich,
Ger many, July 25-30, 2004. Con tact: www.fortbildungswoche.de
Amer i can Acad emy of Der ma tol ogy, Acad emy ’04, New York, USA, July 28-Au gust 1, 2004. Con tact:
Amer i can Acad emy of Der ma tol ogy, De part ment of Meet ings & Con ven tions, 930 E Wood field Road,
Schaumburg, IL 60173; fax: 847 330 1090
7th Dresden Sym po sium on Autoantibodies, Dresden, Ger many, Sep tem ber 1-4, 2004. Con tact:
k_conrad@rcs.urz.tu-dresden.de
3rd Con gress of the Dermatovenerologists, Struga, Mac e do nia, Sep tem ber 15-18, 2004.; Con tact:
Con gress Sec re tar iat, Clinic of Dermatovenerology, Vodnjanska 17, 91000 Skopje, Mac e do nia;
makderm@unet.com.mk
Allergie Kongress 2004, Aachen, Ger many, Sep tem ber 15-19, 2004. Con tact:
Gerhard.Schultze-Werninghaus@ruhr-uni-bochum.de; www.allergie-kongress-2004.de
1st Cro atian Con gress of Psychodermatology, Cavtat, Croatia, Sep tem ber 23-26, 2004. Con tact: Prof. 
Mirna Šitum, De part ment of Der ma tol ogy and Venerology, Sestre milosrdnice Uni ver sity Hos pi tal,
Vinogradska 29, 10000 Zagreb, Croatia; msitum@kbsm.hr
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7th In ter na tional Con gress of Der ma tol ogy, Te he ran, Iran, Sep tem ber 29-Oc to ber 2, 2004. Con tact:
info@iranderm.org; www.iranderm.org
25th An nual Meet ing of the In ter na tional So ci ety of Dermatologic Sur gery, Bar ce lona, Spain, Oc to -
ber 6-9, 2004. Con tact: isds2004@mccann.es; www.isds2004.com
Up date on Pso ri a sis, Con tin u ing Med i cal Ed u ca tion Course or ga nized by Chair of Dermatovenerology
of the Zagreb Uni ver sity School of Med i cine, Šalata 4, 10000 Zagreb, Croatia, Oc to ber 15-16, 2004. Con -
tact: Prof. Jasna Lipozenèiæ, Šalata 4, 10000 Zagreb, Croatia. Phone/Fax: +385-1-4920-014;
jasna.lipozencic@zg.tel.hr
Pso ri a sis 2004, Eu ro pean Con gress on Pso ri a sis, Paris, France, Oc to ber 21-24, 2004. Con tact:
www.pso2004.com; pso2004@mci-group.com 
Ther a peu tic In no va tions in Der ma tol ogy and Dermatocosmetology, Bang kok, Thai land, Oc to ber
23-25, 2004. Con tact: thadapiaru.@thaicosderm.org
4th In ter na tional Con gress on Autoimmunity, Bu da pest, Hun gary, No vem ber 3-7, 2004. Con tact:
fax:0041 22 732 2850; phone 0041 22 908 0488
Ital ian-Cro atian Meet ing on Pso ri a sis and 1st Meet ing on the Lyme Dis ease, Grado, It aly, No vem ber 
12-13, 2004.
13th Con gress of the Eu ro pean Acad emy of Der ma tol ogy and Venereology, Flor ence, It aly, No vem -
ber 17-21, 2004. Con tact: pres i dent@eadv2004.org; reg is tra tion@eadv2004.org; www.eadv2004.org
10th World Con gress on Can cers of the Skin, Vi enna, Aus tria, March 19-23, 2005. Con tact: Elfriede
Pomp, De part ment of Der ma tol ogy, Uni ver sity of Vi enna, Vi enna Gen eral Hos pi tal, Waehringer Guertel
18-20, A-1090 Vi enna; info@wccs.at; www.wccs.at
Spring Sym po sium of the Eu ro pean Acad emy of Der ma tol ogy and Venerology, So fia, Bul garia,
2005. Con tact: Bul gar ian Dermatological So ci ety; dermven@bg.com
8th Con gress of the Eu ro pean So ci ety for Pe di at ric Der ma tol ogy, Bu da pest, Hun gary, May 5-7, 2005. 
Con tact: www.con ven tion.hu; www.espd2005.com
World Al lergy Con gress – 19th In ter na tional Con gress of Allergology and Clin i cal Im mu nol ogy
and 24th Con gress of the Eu ro pean Acad emy of Allergology and Clin i cal Im mu nol ogy, Mu nich, Ger -
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many, June 26-July 1, 2005. Con tact: wac2005@congrex.se www.congrex.com/wac2005
16th Biennal Meet ing of the In ter na tional So ci ety for Sex u ally Trans mit ted Dis eases Re search
(ISSTDR), Am ster dam, Neth er lands, July 10-13, 2005. Con tact: isstdr@aidsfonds.nl; www.isstdr.org 
4thIACD (In ter na tional Acad emy of Cos metic Der ma tol ogy) World Con gress, Paris, France, July
3-5, 2005. Con tact: iacd2005@mci-group.com; www.iacd-paris2005.com
6th World Con gress on Mel a noma, Van cou ver, B.C., Can ada, Sep tem ber 2-9, 2005. Con tact: Venue
West Con fer ence Ser vices Ltd., Van cou ver, B.C., Can ada; con gress@venuewest.com
15th World Con gress of the In ter na tional Un ion of Phlebology, Rio de Ja neiro, Oc to ber 2-7, 2005;
Con tact: RIO UIP 2005 - Sec re tary, Rua Santa Clara, 494 - Sorocaba - 108030-421 SP - Brasil;
inspemoc@dglnet.com.br; angelo.scuderi@flebologiabrasil.com.br;  www.flebologiabrasil.com.be
6th Der ma tol ogy and Dermatopathology Meet ing of the Turk ish So ci ety of Dermatopathology, Is -
tan bul, Tur key, Oc to ber 7, 2004. Con tact: Rana Yavuzer Anadolu, M.D., An kara Uni Koza sok. 114-86,
00670 An kara Tur key; ranaadolu@hotmail.com
14th Con gress of the Eu ro pean Acad emy of Der ma tol ogy and Venereology, Lon don, Oc to ber 12-15,
2005. Con tact: Prof. Mar tin Black, Con gress Pres i dent; Brit ish As so ci a tion of Der ma tol o gists Con fer ence
Ser vices;  eadv@bad.org.uk; pres i dent@eadv2005.org; www.eadv2005.org
21st World Con gress of Der ma tol ogy, Bue nos Ai res, Ar gen tina, Oc to ber 1-5, 2007. Con tact:
info@dermato2007.org
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IN STRUC TIONS TO AU THORS
ACTA DERMATOVENEROLOGICA CROATICA (ADC)
is a quar terly peer-re viewed jour nal, in dexed in In dex Medi -
cus/MEDLINE and Excerpta Medica/EMBASE. It pub -
lishes orig i nal sci en tific ar ti cles, short sci en tific com mu ni -
ca tions, clin i cal ar ti cles, case re ports, re views, re ports,
news and comments, and an nounce ments in the fields of
der ma tol ogy and venerology.
Gen eral Guide lines
Type the com plete manu script dou ble-spaced, on one 
side of A4 bond pa per, with a left side mar gin of at least 4
cm.
The manu scripts should not ex ceed 12-15 typed
pages in case of orig i nal sci en tific pa pers, and 6-8 pages
in case of short com mu ni ca tions, clin i cal ar ti cles, case re -
ports, and re views.
The manu scripts should be writ ten in Eng lish. The au -
thors are re spon si ble for en sur ing that the Eng lish used is 
suit able for pub li ca tion. All ma te rial is as sumed to be sub -
mit ted ex clu sively to this jour nal.
All manu scripts are sub ject to peer re view.
Prep a ra tion of Manu scripts for Sub mis sion
Ti tle Page
The ti tle page should carry (a) the ti tle of the pa per,
which should be con cise but in for ma tive; (b) full name of
each au thor, with in sti tu tional af fil i a tion; (c) name(s) of de -
part ment(s) and in sti tu tion(s) to which the work should be
at trib uted; (d) name and ad dress (with tele phone and fax
num bers as well as the e-mail adress) of the au thor to
whom re quests for re prints should be ad dressed; (f)
source(s) of sup port in the form of grants, equip ment,
drugs, or all of these; and (g) a short run ning head of not
more than 40 char ac ters (count let ters and spaces) at the
foot of the ti tle page.
Sec ond Page
The sec ond page should carry a sum mary of not more 
than 250 words, fol lowed by three to six key words from
the Med i cal Sub ject Head ings (MeSH) list of In dex
Medicus.
Manu script
The text of ob ser va tional and ex per i men tal is usu ally,
but not nec es sar ily, di vided into sec tions with the head -
ings In tro duc tion, Ma te rial (Pa tients) and Methods, Re -
sults, and Dis cus sion. Long ar ti cles may need sub head -
ings within some sec tions to clar ify their con tents, es pe -
cially Re sults and Dis cus sion sec tions. Other types of ar -
ti cles, such as case re ports, re views, and ed i to ri als, are
likely to need other for mat.
Ab bre vi ated terms should be writ ten in full the first
time they are used in the text, with ab bre vi a tion in pa ren -
the ses.
Un der line the words that must be printed in italic.
Ref er ences should be iden ti fied in the text by arabic
nu mer als in pa ren the ses, and be num bered and listed
con sec u tively at the end of the manu script in the or der in
which they are first cited in the text.
In di cate in the text where the il lus tra tions (fig ures and
ta bles) should be in serted. 
Ta bles and fig ures should be pro vided each on a sep -
a rate sheet of pa per af ter the ref er ences. De scrip tive leg -
ends to fig ures should be typed dou ble-spaced on a sep -
a rate sheet of pa per, whereas fig ures should be sub mit -
ted in an en ve lope, with the num ber, the name of the (first) 
au thor, and ti tle of the manu script on the back: each ta ble
should be typed on a sep a rate sheet of pa per, num bered
in the or der in which they are first cited in the text, with a ti -
tle and de scrip tive leg end. Terms used in ta bles should
not be ab bre vi ated.
Eth ics
When re port ing ex per i ments on hu man sub jects, in di -
cate whether the pro ce dures were in ac cor dance with the
eth i cal stan dards of the re spon si ble com mit tee on hu man 
ex per i men ta tion (in sti tu tional or re gional) or with the Hel -
sinki Dec la ra tion from 1975 as re vised in 1983. Do not
use pa tients, names, ini tials or hos pi tal num bers, es pe -
cially any il lus tra tive ma te rial.
Sta tis tics
De scribe sta tis ti cal meth ods and pro vide enough data 
to en able a knowl edge able reader to as sess the re ported
re sults him or her self. Please state the sta tis ti cal pack age 
(ver sion, man u fac turer) used for sta tis ti cal anal y sis.
Ac knowl edge ments
Please spec ify: (a) con tri bu tions that need ac knowl -
edg ing but do not jus tify au thor ship, such as gen eral sup -
port by a de part men tal chair man; (b) ac knowl edge ments
of tech ni cal help; (c) ac knowl edge ments of fi nan cial and
ma te rial sup port, spec i fy ing the na ture of sup port; (d) fi -
nan cial re la tion ship that may be a source of con flict of in -
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ter est. Tech ni cal help should be ac knowl edged in a sep a -
rate para graph as well as other con tri bu tions.
Ref er ences
Ref er ences should be typed dou ble-spaced on a sep -
a rate sheet of pa per. The Van cou ver style, pro posed by
the In ter na tional Com mit tee of Med i cal Jour nal Ed i tors, is
used (Engl J Med 1991,324:421-8, BMJ 1991,302:338-41, 
or www.icmje.org) . Ex am ples of cor rect forms of ref er -
ences are given be low:
Jour nal ar ti cle
Stan dard jour nal ar ti cle (list all au thors, but if their
num ber ex ceeds six, give six fol lowed by et al.)
You CH, Lee KY, Chey RY, Menguy R. Electrogastro -
graphic study of pa tients with un ex plained nau sea, bloat -
ing and vom it ing. Gastroenterology 1989;79:311-4.
Chap ter in a book
Weinstein L, Swartz MN. Patho logic prop er ties of in -
vad ing mi cro or gan isms. In: Sodeman WA Jr, Sodeman
WA, ed i tors. Patho logic phys i ol ogy: mech a nisms of dis -
ease. Phil a del phia: Saunders; 1974. p. 457-72.
Ar ti cle not in Eng lish
Massone L, Borghi S, Pestarino A, Piccini R, Gambini
C. Lo cal isa tions palmaires purpuriques de la dermatite
herpetiforme. Ann Dermatol Venerol 1987;114:1545-7.
Con fer ence pa per
Harley NH. Com paring ra don daugh ter dosimetric
and risk mod els. In: Gammage RB, Kaye SV, ed i tors. In -
door air and hu man health. Pro ceed ings of the Sev enth
Life Sci ences Sym po sium; 1984 Oct 29-31; Knox ville
(TN). Chelsea (MI):Lewis, 1985:69-78.
Disertation
Youssef NM. School ad just ment of chil dren with con -
gen i tal heart dis eases (dis ser ta tion). Pitts burgh (PA):
Uni ver sity of Pitts burgh; 1988.
Sub mis sion of Manu scripts
Manu scripts should be printed on pa per and sub mit -
ted in trip li cate, with one copy on a floppy disk, and sent
to:
Ed i to rial Of fice
De part ment of Der ma tol ogy and Venerology
Zagreb Uni ver sity Hos pi tal Cen ter
Šalata 4, 10000 Zagreb, Croatia
e-mail: jasna.lipozencic@zg.tel.hr
Manu scripts on Disks
Floppy disks should be 3.5-inch (1.44 MB) IBM for -
mat ted and la beled with the name of the au thor.
The file, the word-pro cess ing pro gram, and ver sion
used should be in di cated by pen. MS-Word for Win dows
is pre ferred, al though manu scripts pre pared us ing any
other IBM-com pat i ble word-pro ces sor are ac cept able.
Avoid com plex for mat ting; the text will be styled ac -
cord ing to the ADC de sign spec i fi ca tions. Do not use
bold, cap i tal ized text, or a run ning head. Do not use foot -
notes or endnotes. Sub mit the text, ta bles, and il lus tra -
tions as sep a rate files. For ta bles, al ways use ta ble ed i tor
func tion; en sure that each data point is con tained within a
unique cell, i.e. do not use car riage re turns within cells.
For il lus tra tions, the pre ferred for mats are TIFF of 300 dpi 
res o lu tion, al though any for mat in gen eral use is ac cept -
able pro vided it is not ap pli ca tion-spe cific. If MS Excell is
used for charts make sure to en close orig i nal Excell file.







